[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-2-7b-chat-hf_response": "Acrokeratosis paraneoplastica is also known as Ackerman's syndrome.",
    "llama-2-7b-chat-hf_fact_raw": "1. Acrokeratosis paraneoplastica is known as Ackerman's syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Acrokeratosis paraneoplastica is known as Ackerman's syndrome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Acrokeratosis paraneoplastica is also known as Bazex syndrome. Ackerman's syndrome is another name for verrucous carcinoma of the skin.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-2-7b-chat-hf_response": "Yes, Weaver syndrome is similar to Sotos syndrome. Both are genetic disorders that affect the brain and nervous system, and they share many similar symptoms, including intellectual disability, growth delays, and distinctive facial features. However, Weaver syndrome is a milder form of the disorder than Sotos syndrome.",
    "llama-2-7b-chat-hf_fact_raw": "1. Weaver syndrome is similar to Sotos syndrome.\n2. Both Weaver syndrome and Sotos syndrome are genetic disorders.\n3. Both disorders affect the brain and nervous system.\n4. Intellectual disability, growth delays, and distinctive facial features are common symptoms shared by Weaver syndrome and Sotos syndrome.\n5. Weaver syndrome is a milder form of the disorder compared to Sotos syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Weaver syndrome is similar to Sotos syndrome.",
      "Both Weaver syndrome and Sotos syndrome are genetic disorders.",
      "Both disorders affect the brain and nervous system.",
      "Intellectual disability, growth delays, and distinctive facial features are common symptoms shared by Weaver syndrome and Sotos syndrome.",
      "Weaver syndrome is a milder form of the disorder compared to Sotos syndrome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: Weaver syndrome does share similarities with Sotos syndrome, as both are overgrowth syndromes that can have similar clinical features.\n2. TRUE: Both Weaver syndrome and Sotos syndrome are indeed genetic disorders.\n3. TRUE: Both disorders can affect the brain and nervous system, among other systems within the body.\n4. TRUE: Intellectual disability, accelerated growth, and distinctive facial features are symptoms that are common to both Weaver syndrome and Sotos syndrome.\n5. FALSE [correction]: The severity of symptoms can vary from individual to individual in both Weaver syndrome and Sotos syndrome. It is not accurate to say that one is uniformly milder than the other; different cases can present with varying degrees of severity.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-2-7b-chat-hf_response": "JASPAR (Joint Anthropological and Genetic Analysis of Protein-DNA Bindings) is a database of transcription factor binding site (TFBS) matrices that have been collected and analyzed from various sources. Here are the releases of the JASPAR database:\n1. JASPAR Release 1 (2002): This was the first release of the JASPAR database, which contained 16 TFBS matrices from 12 different organisms.\n2. JASPAR Release 2 (2006): This release added 24 new TFBS matrices from 15 different organisms, bringing the total number of matrices to 40.\n3. JASPAR Release 3 (2010): This release added 48 new TFBS matrices from 22 different organisms, bringing the total number of matrices to 88.\n4. JASPAR Release 4 (2013): This release added 72 new TFBS matrices from 33 different organisms, bringing the total number of matrices to 160.\n5. JASPAR Release 5 (2016): This release added 96 new TFBS matrices from 46 different organisms, bringing the total number of matrices to 256.\n6. JASPAR Release 6 (2019): This release added 120 new TFBS matrices from 60 different organisms, bringing the total number of matrices to 376.\n7. JASPAR Release 7 (2022): This is the latest release of the JASPAR database, which contains 426 TFBS matrices from 156 different organisms.\nPlease note that the JASPAR database is constantly updated, and new releases may be available that include additional matrices or improvements to existing ones.",
    "llama-2-7b-chat-hf_fact_raw": "1. JASPAR Release 1 was in 2002 and contained 16 TFBS matrices from 12 different organisms.\n2. JASPAR Release 2 occurred in 2006 and increased the total number of TFBS matrices to 40.\n3. JASPAR Release 4 in 2013 brought the total number of TFBS matrices in the JASPAR database to 160.\n4. JASPAR Release 5 added 96 new TFBS matrices from 46 different organisms, with a resulting total of 256 matrices.\n5. JASPAR Release 7, which happened in 2022, contains 426 TFBS matrices from 156 different organisms.",
    "llama-2-7b-chat-hf_fact": [
      "JASPAR Release 1 was in 2002 and contained 16 TFBS matrices from 12 different organisms.",
      "JASPAR Release 2 occurred in 2006 and increased the total number of TFBS matrices to 40.",
      "JASPAR Release 4 in 2013 brought the total number of TFBS matrices in the JASPAR database to 160.",
      "JASPAR Release 5 added 96 new TFBS matrices from 46 different organisms, with a resulting total of 256 matrices.",
      "JASPAR Release 7, which happened in 2022, contains 426 TFBS matrices from 156 different organisms."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: JASPAR Release 4 actually happened in 2014, not 2013, and it brought the total number of TFBS matrices to 145, not 160.\n4. FALSE [correction]: Without the specific release number and year for \"JASPAR Release 5\" and the accurate numbers before this release, it is difficult to verify the exact numbers of new TFBS matrices and organisms, and the resulting total. However, the nomenclature of JASPAR releases typically aligns with the year, so a release 5 seems unlikely to have existed, and the counts provided do not match the usual updates.\n5. FALSE [correction]: JASPAR 2022 (which could presumably be considered Release 7) contains 730 TFBS matrices derived from 131 organisms, not 426 matrices from 156 organisms.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-2-7b-chat-hf_response": "The function of the viral KP4 protein is to inhibit the host cell's innate immune response by blocking the activation of the transcription factor IRF3.",
    "llama-2-7b-chat-hf_fact_raw": "1. The viral KP4 protein functions to inhibit the host cell's innate immune response.\n2. The viral KP4 protein blocks the activation of the transcription factor IRF3.",
    "llama-2-7b-chat-hf_fact": [
      "The viral KP4 protein functions to inhibit the host cell's innate immune response.",
      "The viral KP4 protein blocks the activation of the transcription factor IRF3."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-2-7b-chat-hf_response": "Yes, DITPA (1,1-bis(3-iodo-tyrosine-4-yl)propane-1,3-dione) is a thyroid hormone analog that has been utilized in both experimental and clinical studies. It is a synthetic compound that mimics the action of triiodothyronine (T3), a thyroid hormone that plays a crucial role in regulating metabolism and other physiological processes.\nDITPA has been investigated as a potential treatment for various conditions, including:\n1. Hypothyroidism: DITPA has been shown to restore normal thyroid function in patients with hypothyroidism, a condition characterized by an underactive thyroid gland.\n2. Cancer: DITPA has been studied as a potential treatment for certain types of cancer, including breast, lung, and prostate cancer. It is thought to inhibit the growth of cancer cells by inhibiting the action of thyroid hormones on these cells.\n3. Neurodegenerative diseases: DITPA has been investigated as a potential treatment for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. It is thought to have neuroprotective effects and may help to slow the progression of these diseases.\n4. Obesity: DITPA has been studied as a potential treatment for obesity, as it may help to increase metabolism and promote weight loss.\nWhile DITPA has shown promise in these areas, it is important to note that more research is needed to fully understand its effects and potential side effects in humans. Additionally, DITPA is not yet approved for use in humans, and its long-term safety and efficacy have not been fully established.",
    "llama-2-7b-chat-hf_fact_raw": "1. DITPA is a thyroid hormone analog utilized in experimental and clinical studies.\n2. DITPA mimics the action of triiodothyronine (T3), a thyroid hormone that regulates metabolism.\n3. DITPA has been investigated as a potential treatment for hypothyroidism.\n4. Studies have explored DITPA as a potential treatment for certain types of cancer.\n5. DITPA has been researched for its potential use in treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease.",
    "llama-2-7b-chat-hf_fact": [
      "DITPA is a thyroid hormone analog utilized in experimental and clinical studies.",
      "DITPA mimics the action of triiodothyronine (T3), a thyroid hormone that regulates metabolism.",
      "DITPA has been investigated as a potential treatment for hypothyroidism.",
      "Studies have explored DITPA as a potential treatment for certain types of cancer.",
      "DITPA has been researched for its potential use in treating neurodegenerative diseases such as Alzheimer's and Parkinson's disease."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: DITPA has been investigated as a potential treatment for heart conditions, not hypothyroidism. Hypothyroidism is typically treated with levothyroxine, which is identical to the hormone thyroxine that's produced in the body.\n4. UNKNOWN\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-2-7b-chat-hf_response": "COUGER (Comprehensive Upper-Genome RNA Genome Editor) is a tool used for editing the RNA transcriptome of an organism. It is designed to be a comprehensive and efficient method for editing RNA molecules in a wide range of organisms, including bacteria, yeast, and mammalian cells. COUGER uses a combination of RNA-targeting nucleases and RNA-modifying enzymes to edit RNA molecules with high precision and specificity.",
    "llama-2-7b-chat-hf_fact_raw": "1. COUGER stands for Comprehensive Upper-Genome RNA Genome Editor.\n2. COUGER is used for editing the RNA transcriptome of organisms.\n3. The tool is applicable to a wide range of organisms, including bacteria, yeast, and mammalian cells.\n4. COUGER utilizes RNA-targeting nucleases.\n5. COUGER employs RNA-modifying enzymes to achieve high precision and specificity in RNA editing.",
    "llama-2-7b-chat-hf_fact": [
      "COUGER stands for Comprehensive Upper-Genome RNA Genome Editor.",
      "COUGER is used for editing the RNA transcriptome of organisms.",
      "The tool is applicable to a wide range of organisms, including bacteria, yeast, and mammalian cells.",
      "COUGER utilizes RNA-targeting nucleases.",
      "COUGER employs RNA-modifying enzymes to achieve high precision and specificity in RNA editing."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: COUGER stands for CRISPR-Cas Orthologs for Unconstrained Genome Editing of RNA. \n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-2-7b-chat-hf_response": "Yes, there are drugs available for the treatment of Tick-borne Encephalitis (TBE). The most commonly used drugs for the treatment of TBE are:\n1. Antiviral medications: Ribavirin, an antiviral drug, is the most commonly used medication for the treatment of TBE. It is effective in reducing the severity of symptoms and the duration of illness.\n2. Corticosteroids: Corticosteroids, such as prednisone, may be prescribed to reduce inflammation in the brain and other parts of the body.\n3. Supportive care: Patients with TBE may require supportive care, such as intravenous fluids, oxygen therapy, and management of fever and pain.\nIt is important to note that the effectiveness of these drugs can vary depending on the severity and location of the infection, as well as the individual patient's response to treatment. In some cases, a combination of drugs may be used to treat TBE. It is important to consult a healthcare professional for proper diagnosis and treatment.",
    "llama-2-7b-chat-hf_fact_raw": "1. Ribavirin is an antiviral drug commonly used for the treatment of Tick-borne Encephalitis (TBE).\n2. Corticosteroids, such as prednisone, are prescribed to reduce inflammation in the brain and other parts of the body in TBE patients.\n3. Supportive care for TBE may include intravenous fluids, oxygen therapy, and management of fever and pain.\n4. The effectiveness of drugs for TBE can vary depending on the severity and location of the infection.\n5. Treatments for TBE may involve a combination of drugs.",
    "llama-2-7b-chat-hf_fact": [
      "Ribavirin is an antiviral drug commonly used for the treatment of Tick-borne Encephalitis (TBE).",
      "Corticosteroids, such as prednisone, are prescribed to reduce inflammation in the brain and other parts of the body in TBE patients.",
      "Supportive care for TBE may include intravenous fluids, oxygen therapy, and management of fever and pain.",
      "The effectiveness of drugs for TBE can vary depending on the severity and location of the infection.",
      "Treatments for TBE may involve a combination of drugs."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Ribavirin is an antiviral drug, but it is not commonly used for the treatment of Tick-borne Encephalitis (TBE). There are no specific antiviral drugs recommended for TBE, which is typically managed through supportive care.\n2. UNKNOWN: While corticosteroids are used to reduce inflammation in various medical conditions, it's not universally agreed upon for the treatment of TBE and there is a lack of direct references to confirm their common use in this specific condition.\n3. TRUE: Supportive care is the primary treatment for TBE and may indeed include intravenous fluids, oxygen therapy, and management of fever and pain.\n4. UNKNOWN: As there is no specific antiviral treatment for TBE, the statement about drug effectiveness varying is difficult to assess. Supportive care may need to be adjusted based on severity and symptoms, so this statement can neither be confirmed nor refuted without further specific context.\n5. FALSE [correction]: Since there are no specific antiviral drugs recommended for the treatment of TBE, treatments typically do not involve a combination of antiviral drugs but rather focus on supportive care measures.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-2-7b-chat-hf_response": "The genome browser database for DNA shape annotations is called \"DNA Shape Browser\" (DSB).",
    "llama-2-7b-chat-hf_fact_raw": "1. A genome browser database for DNA shape annotations is named \"DNA Shape Browser\" (DSB).",
    "llama-2-7b-chat-hf_fact": [
      "A genome browser database for DNA shape annotations is named \"DNA Shape Browser\" (DSB)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-2-7b-chat-hf_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Peutz-Jeghers syndrome (PJS): This is a rare genetic disorder characterized by pigmented macules on the skin and a high risk of developing various types of cancer, including breast, ovarian, and colon cancer.\n2. Lhermitte-Duclos disease (LDD): This is a rare genetic disorder characterized by the presence of hamartomatous intestinal polyps, which can lead to gastrointestinal symptoms and an increased risk of colorectal cancer.\n3. Bannayan-Riley-Ruvalcaba syndrome (BRRS): This is a rare genetic disorder characterized by the presence of pigmented macules on the skin, short stature, and an increased risk of developing various types of cancer, including breast, ovarian, and colon cancer.\n4. Cowden syndrome (CS): This is a rare genetic disorder characterized by the presence of multiple hamartomas throughout the body, particularly in the skin, breast, and thyroid gland. It also increases the risk of developing various types of cancer, including breast, thyroid, and colon cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. Mutations in the EZH2 gene are associated with Peutz-Jeghers syndrome (PJS).\n2. Mutations in the EZH2 gene are associated with Lhermitte-Duclos disease (LDD).\n3. Mutations in the EZH2 gene are associated with Bannayan-Riley-Ruvalcaba syndrome (BRRS).\n4. Mutations in the EZH2 gene are associated with Cowden syndrome (CS).",
    "llama-2-7b-chat-hf_fact": [
      "Mutations in the EZH2 gene are associated with Peutz-Jeghers syndrome (PJS).",
      "Mutations in the EZH2 gene are associated with Lhermitte-Duclos disease (LDD).",
      "Mutations in the EZH2 gene are associated with Bannayan-Riley-Ruvalcaba syndrome (BRRS).",
      "Mutations in the EZH2 gene are associated with Cowden syndrome (CS)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Mutations in the STK11 (also known as LKB1) gene are associated with Peutz-Jeghers syndrome (PJS).\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-2-7b-chat-hf_response": "There are several human proteins that are known to undergo a dimer-to-tetramer transition, including:\n1. p53 protein: The tumor suppressor protein p53 undergoes a dimer-to-tetramer transition in response to DNA damage, leading to the activation of its transcriptional activity.\n2. c-Myc protein: The c-Myc transcription factor also undergoes a dimer-to-tetramer transition, which is involved in the regulation of cell growth and proliferation.\n3. HIF1α protein: The hypoxia-inducible factor 1α (HIF1α) protein undergoes a dimer-to-tetramer transition in response to low oxygen levels, leading to the activation of its transcriptional activity.\n4. NF-κB protein: The nuclear factor kappa B (NF-κB) protein undergoes a dimer-to-tetramer transition in response to cytokines and growth factors, leading to the activation of its transcriptional activity.\n5. FOXO protein: The forkhead box O (FOXO) transcription factors undergo a dimer-to-tetramer transition in response to cellular stress and nutrient deprivation, leading to the activation of their transcriptional activity.\n6. STAT3 protein: The signal transducer and activator of transcription 3 (STAT3) protein undergoes a dimer-to-tetramer transition in response to cytokines and growth factors, leading to the activation of its transcriptional activity.\n7. CREB protein: The cAMP-response element-binding protein (CREB) undergoes a dimer-to-tetramer transition in response to cAMP signaling, leading to the activation of its transcriptional activity.\n8. NF-AT protein: The nuclear factor of activated T cells (NF-AT) protein undergoes a dimer-to-tetramer transition in response to T cell receptor signaling, leading to the activation of its transcriptional activity.\n9. PPARγ protein: The peroxisome proliferator-activated receptor gamma (PPARγ) protein undergoes a dimer-",
    "llama-2-7b-chat-hf_fact_raw": "1. The p53 protein undergoes a dimer-to-tetramer transition in response to DNA damage.\n2. The c-Myc protein undergoes a dimer-to-tetramer transition and is involved in the regulation of cell growth and proliferation.\n3. HIF1α protein transitions from dimer to tetramer in response to low oxygen levels.\n4. The NF-κB protein undergoes a dimer-to-tetramer transition in response to cytokines and growth factors.\n5. FOXO transcription factors undergo a dimer-to-tetramer transition in response to cellular stress and nutrient deprivation.",
    "llama-2-7b-chat-hf_fact": [
      "The p53 protein undergoes a dimer-to-tetramer transition in response to DNA damage.",
      "The c-Myc protein undergoes a dimer-to-tetramer transition and is involved in the regulation of cell growth and proliferation.",
      "HIF1α protein transitions from dimer to tetramer in response to low oxygen levels.",
      "The NF-κB protein undergoes a dimer-to-tetramer transition in response to cytokines and growth factors.",
      "FOXO transcription factors undergo a dimer-to-tetramer transition in response to cellular stress and nutrient deprivation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: The p53 protein is known to undergo a conformational change and form tetramers in response to DNA damage, which is essential for its role as a tumor suppressor and in the regulation of the cell cycle.\n2. FALSE [correction]: The c-Myc protein functions as a transcription factor and dimerizes with another protein called Max; however, it is not documented to undergo a dimer-to-tetramer transition. It is indeed involved in the regulation of cell growth and proliferation.\n3. FALSE [correction]: HIF1α (Hypoxia-inducible factor 1-alpha) forms a dimer with HIF1β under low oxygen conditions (hypoxia), but it does not transition to a tetramer in response to low oxygen levels.\n4. UNKNOWN: While NF-κB is known to form dimers and is activated in response to cytokines and growth factors, it is not commonly described as undergoing a dimer-to-tetramer transition in the literature available up to my knowledge cutoff in 2023. NF-κB typically functions as a dimer.\n5. UNKNOWN: FOXO transcription factors are known to play a role in the regulation of cellular stress and nutrient deprivation responses. However, whether they undergo a dimer-to-tetramer transition is not clearly stated in the literature up to my knowledge cutoff in 2023, and they are predominantly understood to function as monomers or dimers.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-2-7b-chat-hf_response": "Bcl-2.",
    "llama-2-7b-chat-hf_fact_raw": "1. Bcl-2 is a protein that interacts with phospholamban (PLN).\n2. Bcl-2 is an anti-apoptotic protein.",
    "llama-2-7b-chat-hf_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN).",
      "Bcl-2 is an anti-apoptotic protein."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-2-7b-chat-hf_response": "Yes, several clinical trials have shown that vitamin D supplementation can reduce the incidence of falls in older people.",
    "llama-2-7b-chat-hf_fact_raw": "1. Vitamin D supplementation has been clinically trialed with older people.\n2. Clinical trials have shown vitamin D can reduce the incidence of falls in older people.",
    "llama-2-7b-chat-hf_fact": [
      "Vitamin D supplementation has been clinically trialed with older people.",
      "Clinical trials have shown vitamin D can reduce the incidence of falls in older people."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE (However, the scientific consensus on this may change with new studies, and the magnitude of the effect can vary depending on the population studied and specifics of the trial design.)",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-2-7b-chat-hf_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-2-7b-chat-hf_response": "The human HoxD cluster contains approximately 30 genes.",
    "llama-2-7b-chat-hf_fact_raw": "1. The human HoxD cluster contains approximately 30 genes.",
    "llama-2-7b-chat-hf_fact": [
      "The human HoxD cluster contains approximately 30 genes."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The human HoxD cluster contains approximately 9 genes.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-2-7b-chat-hf_response": "Casein Kinase 1 (CK1) is a serine/threonine kinase that phosphorylates a variety of substrates in cellular processes, including cell cycle regulation, transcriptional regulation, and protein degradation. The phosphorylation consensus motifs for CK1 are:\n1. Ser/Thr-Pro-X-X-X-Ser/Thr (where X is any amino acid)\nThis motif is recognized by the catalytic subunit of CK1 and is found in many substrates involved in cell cycle regulation, such as CDKN1 (also known as p21) and CDC25A.\n2. Ser/Thr-X-X-X-Ser/Thr (where X is any amino acid)\nThis motif is also recognized by the catalytic subunit of CK1 and is found in substrates involved in transcriptional regulation, such as the transcription factor c-Myc.\n3. Ser-X-X-X-Ser (where X is any amino acid)\nThis motif is recognized by the regulatory subunit of CK1 and is found in substrates involved in protein degradation, such as the ubiquitin ligase SCFSkp2.\nIt's worth noting that these consensus motifs are not exclusive to CK1 and can be recognized by other kinases as well.",
    "llama-2-7b-chat-hf_fact_raw": "1. Casein Kinase 1 (CK1) phosphorylates a variety of substrates in cellular processes.\n2. The phosphorylation consensus motif for CK1 includes Ser/Thr-Pro-X-X-X-Ser/Thr (where X is any amino acid).\n3. CDKN1 (p21) and CDC25A are substrates that involve the cell cycle regulation and possess the motif Ser/Thr-Pro-X-X-X-Ser/Thr that is recognized by CK1.\n4. The transcription factor c-Myc is a substrate involved in transcriptional regulation and contains the CK1 motif Ser/Thr-X-X-X-Ser/Thr.\n5. The ubiquitin ligase SCFSkp2 is a substrate involved in protein degradation and has the CK1 motif Ser-X-X-X-Ser recognized by CK1’s regulatory subunit.",
    "llama-2-7b-chat-hf_fact": [
      "Casein Kinase 1 (CK1) phosphorylates a variety of substrates in cellular processes.",
      "The phosphorylation consensus motif for CK1 includes Ser/Thr-Pro-X-X-X-Ser/Thr (where X is any amino acid).",
      "CDKN1 (p21) and CDC25A are substrates that involve the cell cycle regulation and possess the motif Ser/Thr-Pro-X-X-X-Ser/Thr that is recognized by CK1.",
      "The transcription factor c-Myc is a substrate involved in transcriptional regulation and contains the CK1 motif Ser/Thr-X-X-X-Ser/Thr.",
      "The ubiquitin ligase SCFSkp2 is a substrate involved in protein degradation and has the CK1 motif Ser-X-X-X-Ser recognized by CK1’s regulatory subunit."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The consensus phosphorylation motif for CK1 is usually described as Ser/Thr followed by at least three acidic residues (D or E), which means it generally prefers substrates with acidic residues downstream of the phosphorylation site. Therefore, the correct consensus motif is not limited to Ser/Thr-Pro-X-X-X-Ser/Thr.\n3. UNKNOWN: Without specific information about the phosphorylation sites on CDKN1 (p21) and CDC25A, it’s difficult to confirm their motifs or their recognition by CK1 in the given statement.\n4. UNKNOWN: While c-Myc is a known substrate for phosphorylation by various kinases, the provided statement about the presence of a specific CK1 motif in c-Myc is vague without specific literature references to support it.\n5. UNKNOWN: The statement about SCFSkp2 containing a specific CK1 motif requires further specific information or literature references to confirm its validity, and we do not have enough information to assess the involvement of CK1's regulatory subunit.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-2-7b-chat-hf_response": "The ASPH (aspartate beta-hydroxylase) gene in humans encodes for multiple isoforms of the enzyme aspartate beta-hydroxylase, which is involved in the biosynthesis of the neurotransmitter dopamine. The different isoforms of the ASPH gene are:\n* ASPH-A: This is the most common isoform and is expressed in most tissues, including the brain.\n* ASPH-B: This isoform is expressed in the brain and is thought to play a role in the regulation of dopamine synthesis.\n* ASPH-C: This isoform is expressed in the brain and is involved in the regulation of dopamine metabolism.\n* ASPH-D: This isoform is expressed in the brain and is involved in the regulation of dopamine synthesis.\n* ASPH-E: This isoform is expressed in the brain and is involved in the regulation of dopamine metabolism.\n* ASPH-F: This isoform is expressed in the brain and is involved in the regulation of dopamine synthesis.\n* ASPH-G: This isoform is expressed in the brain and is involved in the regulation of dopamine metabolism.\n* ASPH-H: This isoform is expressed in the brain and is involved in the regulation of dopamine synthesis.\n* ASPH-I: This isoform is expressed in the brain and is involved in the regulation of dopamine metabolism.\n* ASPH-J: This isoform is expressed in the brain and is involved in the regulation of dopamine synthesis.\n* ASPH-K: This isoform is expressed in the brain and is involved in the regulation of dopamine metabolism.\n* ASPH-L: This isoform is expressed in the brain and is involved in the regulation of dopamine synthesis.\n* ASPH-M: This isoform is expressed in the brain and is involved in the regulation of dopamine metabolism.\n* ASPH-N: This isoform is expressed in the brain and is involved in the regulation of dopamine synthesis.\n* ASPH-O: This isoform is",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-2-7b-chat-hf_response": "Empagliflozin was approved by the FDA in July 2014.",
    "llama-2-7b-chat-hf_fact_raw": "1. Empagliflozin was approved by the FDA in July 2014.",
    "llama-2-7b-chat-hf_fact": [
      "Empagliflozin was approved by the FDA in July 2014."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-2-7b-chat-hf_response": "Loss of the protein Lon1 in the plant Arabidopsis results in a range of phenotypes, including:\n1. Increased sensitivity to oxidative stress: Lon1 plays a critical role in protecting against oxidative stress, and loss of this protein leads to increased sensitivity to oxidative stressors such as hydrogen peroxide.\n2. Delayed seed germination and seedling growth: Lon1 is involved in the regulation of seed germination and seedling growth, and loss of this protein leads to delayed germination and slower seedling growth.\n3. Altered leaf morphology: Lon1 is involved in the regulation of leaf morphology, and loss of this protein leads to altered leaf shape and size.\n4. Reduced root growth: Lon1 is also involved in the regulation of root growth, and loss of this protein leads to reduced root growth.\n5. Increased susceptibility to pathogens: Lon1 plays a role in the plant's defense against pathogens, and loss of this protein leads to increased susceptibility to pathogens such as bacteria and fungi.",
    "llama-2-7b-chat-hf_fact_raw": "1. Loss of the protein Lon1 in Arabidopsis leads to increased sensitivity to oxidative stress.\n2. Arabidopsis with Lon1 deficiency has delayed seed germination and slower seedling growth.\n3. Lon1-deficient Arabidopsis exhibits altered leaf morphology.\n4. Loss of Lon1 in Arabidopsis results in reduced root growth.\n5. Arabidopsis plants without Lon1 are more susceptible to pathogens like bacteria and fungi.",
    "llama-2-7b-chat-hf_fact": [
      "Loss of the protein Lon1 in Arabidopsis leads to increased sensitivity to oxidative stress.",
      "Arabidopsis with Lon1 deficiency has delayed seed germination and slower seedling growth.",
      "Lon1-deficient Arabidopsis exhibits altered leaf morphology.",
      "Loss of Lon1 in Arabidopsis results in reduced root growth.",
      "Arabidopsis plants without Lon1 are more susceptible to pathogens like bacteria and fungi."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout access to the specific passage these statements are taken from or pertinent scientific research on the topic, it's impossible for me to verify the accuracy of these statements about the effects of the protein Lon1 on Arabidopsis. These statements would require knowledge of specialized studies in plant biology or genetics that are not available as general knowledge as of my last update.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-2-7b-chat-hf_response": "Yes, a linker histone called H3K5ac exists in the yeast genome.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-2-7b-chat-hf_response": "Yes, there is evidence to suggest that tomato juice can help lower cholesterol levels. Tomatoes contain a powerful antioxidant called lycopene, which has been shown to help reduce cholesterol levels by inhibiting the production of cholesterol in the liver. Additionally, tomato juice is also a good source of fiber, which can help lower cholesterol levels by binding to bile acids and removing them from the body.",
    "llama-2-7b-chat-hf_fact_raw": "1. Tomatoes contain an antioxidant called lycopene.\n2. Lycopene has been shown to reduce cholesterol levels by inhibiting the production of cholesterol in the liver.\n3. Tomato juice is a good source of fiber.\n4. Fiber can help lower cholesterol levels by binding to bile acids and removing them from the body.",
    "llama-2-7b-chat-hf_fact": [
      "Tomatoes contain an antioxidant called lycopene.",
      "Lycopene has been shown to reduce cholesterol levels by inhibiting the production of cholesterol in the liver.",
      "Tomato juice is a good source of fiber.",
      "Fiber can help lower cholesterol levels by binding to bile acids and removing them from the body."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Tomato juice is not a significant source of fiber; whole tomatoes and other forms of tomatoes might be better sources, but the juice itself typically has limited fiber content.\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-2-7b-chat-hf_response": "Hsp70 and Hsp110 are heat shock proteins that play a role in regulating mRNA stability.\nHsp70 can bind to mRNAs and protect them from degradation by the 5' exonuclease of the ribosome, thereby extending their half-life and allowing for more time for translation. Hsp70 can also interact with the translational machinery and influence the initiation of translation.\nHsp110, on the other hand, is involved in the degradation of mRNAs by the RNA exosome complex. The RNA exosome is a complex of proteins and RNAs that degrade RNA molecules, and Hsp110 is a component of this complex. Hsp110 can bind to the 3' untranslated region (UTR) of target mRNAs and facilitate their degradation by the RNA exosome.\nIn summary, Hsp70 can protect mRNAs from degradation, while Hsp110 can promote their degradation.",
    "llama-2-7b-chat-hf_fact_raw": "1. Hsp70 and Hsp110 are heat shock proteins that influence mRNA stability.\n2. Hsp70 can bind to mRNAs to protect them from degradation by the ribosome's 5' exonuclease.\n3. Hsp70 interacts with the translational machinery and can influence the initiation of translation.\n4. Hsp110 is involved in the degradation of mRNAs by the RNA exosome complex.\n5. Hsp110 can bind to the 3' untranslated region of target mRNAs to facilitate their degradation by the RNA exosome.",
    "llama-2-7b-chat-hf_fact": [
      "Hsp70 and Hsp110 are heat shock proteins that influence mRNA stability.",
      "Hsp70 can bind to mRNAs to protect them from degradation by the ribosome's 5' exonuclease.",
      "Hsp70 interacts with the translational machinery and can influence the initiation of translation.",
      "Hsp110 is involved in the degradation of mRNAs by the RNA exosome complex.",
      "Hsp110 can bind to the 3' untranslated region of target mRNAs to facilitate their degradation by the RNA exosome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN: While Hsp70 and Hsp110 are indeed heat shock proteins, their specific role in mRNA stability is not detailed enough in this statement for a definitive true or false designation without additional context.\n\n2. FALSE [correction]: Hsp70 can bind to mRNAs to protect them from degradation, but it is typically not described as protecting from degradation specifically by the ribosome's 5' exonuclease. Protection from degradation is generally associated with preventing the recognition by components of the degradation machinery within the cell.\n\n3. TRUE: Hsp70 is known to interact with translational machinery, and it can influence various stages of translation, including the initiation of translation, by stabilizing protein synthesis intermediates and ribosome-associated nascent polypeptide chains.\n\n4. UNKNOWN: The specific involvement of Hsp110 in the degradation of mRNAs by the RNA exosome complex is not widely established and would require specific context or references to ascertain.\n\n5. FALSE [correction]: Hsp110 does not specifically bind to the 3' untranslated region of mRNAs to facilitate their degradation by the RNA exosome. Hsp110 primarily functions as a chaperone protein assisting in protein folding and preventing aggregation, rather than directly facilitating mRNA degradation.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-2-7b-chat-hf_response": "The deiodinases present in skeletal muscle are DIO1 and DIO2.",
    "llama-2-7b-chat-hf_fact_raw": "1. Deiodinase DIO1 is present in skeletal muscle.\n2. Deiodinase DIO2 is present in skeletal muscle.",
    "llama-2-7b-chat-hf_fact": [
      "Deiodinase DIO1 is present in skeletal muscle.",
      "Deiodinase DIO2 is present in skeletal muscle."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Deiodinase DIO2, not DIO1, is present in skeletal muscle.\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-2-7b-chat-hf_response": "Inflammatory caspase proteins are a family of proteins that play a role in the regulation of inflammation. Here are some examples of inflammatory caspase proteins:\n1. Caspase-1 (also known as interleukin-1 beta converting enzyme, or ICE): This protein is involved in the processing and activation of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).\n2. Caspase-2 (also known as cytosolic protein 16): This protein is involved in the regulation of inflammation and immune response, and has been implicated in various inflammatory disorders, including arthritis and atherosclerosis.\n3. Caspase-3 (also known as apoptosis-related cysteine peptidase 1, or ARC1): This protein is involved in the regulation of apoptosis, or programmed cell death, and has been implicated in various inflammatory disorders, including cancer and neurodegenerative diseases.\n4. Caspase-4 (also known as interleukin-1 beta converting enzyme 2, or ICE2): This protein is involved in the processing and activation of pro-inflammatory cytokines, such as IL-1β and TNF-α.\n5. Caspase-5 (also known as cytosolic protein 17): This protein is involved in the regulation of inflammation and immune response, and has been implicated in various inflammatory disorders, including arthritis and atherosclerosis.\n6. Caspase-6 (also known as apoptosis-related cysteine peptidase 2, or ARC2): This protein is involved in the regulation of apoptosis, or programmed cell death, and has been implicated in various inflammatory disorders, including cancer and neurodegenerative diseases.\n7. Caspase-7 (also known as interleukin-1 beta converting enzyme 3, or ICE3): This protein is involved in the processing and",
    "llama-2-7b-chat-hf_fact_raw": "1. Caspase-1 is involved in the processing and activation of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).\n2. Caspase-2 has been implicated in various inflammatory disorders, including arthritis and atherosclerosis.\n3. Caspase-3 is involved in the regulation of apoptosis and has been implicated in various inflammatory disorders, including cancer and neurodegenerative diseases.\n4. Caspase-4 is involved in the processing and activation of pro-inflammatory cytokines, much like Caspase-1.\n5. Caspase-5 has been implicated in various inflammatory disorders, including arthritis and atherosclerosis.",
    "llama-2-7b-chat-hf_fact": [
      "Caspase-1 is involved in the processing and activation of pro-inflammatory cytokines such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).",
      "Caspase-2 has been implicated in various inflammatory disorders, including arthritis and atherosclerosis.",
      "Caspase-3 is involved in the regulation of apoptosis and has been implicated in various inflammatory disorders, including cancer and neurodegenerative diseases.",
      "Caspase-4 is involved in the processing and activation of pro-inflammatory cytokines, much like Caspase-1.",
      "Caspase-5 has been implicated in various inflammatory disorders, including arthritis and atherosclerosis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Caspase-2 is primarily involved in the regulation of apoptosis and is not typically implicated in inflammatory disorders like arthritis and atherosclerosis; those are more commonly associated with caspases involved in inflammation, such as caspase-1.\n3. TRUE\n4. FALSE [correction]: Caspase-4 is involved in the innate immune response, particularly in the detection of bacterial lipopolysaccharides and the activation of inflammatory responses, but it does not process and activate pro-inflammatory cytokines in the same manner as Caspase-1.\n5. FALSE [correction]: Caspase-5 is involved in the formation of the inflammasome and can contribute to the cleavage of pro-IL-1β, but its specific implications in diseases like arthritis and atherosclerosis are less well characterized compared to caspase-1.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-2-7b-chat-hf_response": "Yes, there is a link between the aurora B kinase and the polycomb protein Ring1B.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-2-7b-chat-hf_response": "Non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are sequences that are not conserved across species and are not recognized by the spliceosome. Some of the most frequent non-canonical sequence motifs found in vertebrates include:\nDonor splice site motifs:\n* GU-rich sequences (e.g. GUGAUGAUGAU)\n* AG-rich sequences (e.g. AGGAGGAGG)\n* G/C-rich sequences (e.g. GCGGGCGGC)\n* A/T-rich sequences (e.g. ATAATATAT)\n* Palindromic sequences (e.g. GGAGGAGG)\nAcceptor splice site motifs:\n* GU-rich sequences (e.g. GUGAUGAUGAU)\n* AG-rich sequences (e.g. AGGAGGAGG)\n* G/C-rich sequences (e.g. GCGGGCGGC)\n* A/T-rich sequences (e.g. ATAATATAT)\n* Palindromic sequences (e.g. GGAGGAGG)\nIt's worth noting that the presence of these non-canonical motifs can affect the splicing efficiency and the choice of the splice site, leading to the production of different isoforms of the gene.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-2-7b-chat-hf_response": "The event that results in the acetylation of S6K1 is the activation of the mTORC1 complex.",
    "llama-2-7b-chat-hf_fact_raw": "1. The acetylation of S6K1 is caused by the activation of the mTORC1 complex.",
    "llama-2-7b-chat-hf_fact": [
      "The acetylation of S6K1 is caused by the activation of the mTORC1 complex."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nThe statement regarding the acetylation of S6K1 (S6 Kinase 1) being caused by the activation of the mTORC1 (mechanistic target of rapamycin complex 1) is specific to cellular biology and biochemistry. Without the relevant scientific literature or passage that provides context for this statement, it's difficult to confirm its accuracy. Acetylation is a post-translational modification process, and mTORC1 is indeed involved in the regulation of S6K1, but the direct relationship between mTORC1 activation and S6K1 acetylation is not common knowledge and would need to be verified by a specific study or expert in the field.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-2-7b-chat-hf_response": "The cause of episodic ataxia type 6 (EA6) is a mutation in the CACNA1A gene, which encodes a subunit of the voltage-gated calcium channel. This mutation leads to an abnormality in the functioning of the calcium channels in the brain, resulting in the episodic ataxia.",
    "llama-2-7b-chat-hf_fact_raw": "1. Episodic ataxia type 6 (EA6) is caused by a mutation in the CACNA1A gene.\n2. The CACNA1A gene encodes a subunit of the voltage-gated calcium channel.\n3. The mutation in the CACNA1A gene leads to abnormal functioning of calcium channels in the brain.\n4. Abnormal functioning of calcium channels in the brain is associated with the symptoms of episodic ataxia.",
    "llama-2-7b-chat-hf_fact": [
      "Episodic ataxia type 6 (EA6) is caused by a mutation in the CACNA1A gene.",
      "The CACNA1A gene encodes a subunit of the voltage-gated calcium channel.",
      "The mutation in the CACNA1A gene leads to abnormal functioning of calcium channels in the brain.",
      "Abnormal functioning of calcium channels in the brain is associated with the symptoms of episodic ataxia."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-2-7b-chat-hf_response": "Yes, chromomethylases are present in animal genomes.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-2-7b-chat-hf_response": "Here are some packages available in R/Bioconductor for transcription factor binding site (TFBS) analysis:\n1. TFBStools: A collection of tools for the analysis of transcription factor binding site (TFBS) data. It includes tools for the prediction of TFBSs, the analysis of ChIP-seq data, and the visualization of TFBSs in 3D.\n2. ChIPseek: A package for the analysis of ChIP-seq data, including the identification of TFBSs and the analysis of peak shape and intensity.\n3. HISAT2: A spliced aligner for RNA-seq data that can also be used for the analysis of TFBSs. It includes tools for the identification of TFBSs and the analysis of ChIP-seq data.\n4. STAR: A high-performance aligner for RNA-seq data that can also be used for the analysis of TFBSs. It includes tools for the identification of TFBSs and the analysis of ChIP-seq data.\n5. DeepTools: A package for the analysis of ChIP-seq data, including the identification of TFBSs and the analysis of peak shape and intensity. It also includes tools for the visualization of TFBSs in 3D.\n6. ChIPster: A package for the analysis of ChIP-seq data, including the identification of TFBSs and the analysis of peak shape and intensity. It also includes tools for the visualization of TFBSs in 3D.\n7. peaks: A package for the analysis of ChIP-seq data, including the identification of TFBSs and the analysis of peak shape and intensity. It also includes tools for the visualization of TFBSs in 3D.\n8. ChIPseekR: A package for the analysis of ChIP-seq data, including the identification of TFBSs and the analysis of peak shape and intensity. It also includes tools for the visualization of TFBSs in 3D.\n9. TFBS-tools: A collection of tools for the analysis of transcription factor binding site (TFBS) data. It includes tools for the prediction of TFBSs, the analysis of ChIP-seq data, and the visualization of TFBSs in 3D.",
    "llama-2-7b-chat-hf_fact_raw": "1. TFBStools is a package in R/Bioconductor used for transcription factor binding site (TFBS) analysis, which includes prediction and visualization tools.\n2. ChIPseek is an R/Bioconductor package for analyzing ChIP-seq data to identify TFBSs and analyze peak shape and intensity.\n3. HISAT2 is an aligner for RNA-seq data that includes tools for TFBS analysis and is available in R/Bioconductor.\n4. STAR is an R/Bioconductor aligner for RNA-seq data that can be used for TFBS analysis, including identification and visualization tools.\n5. DeepTools, available in R/Bioconductor, is a package for analyzing ChIP-seq data, identifying TFBSs, and includes 3D visualization tools.",
    "llama-2-7b-chat-hf_fact": [
      "TFBStools is a package in R/Bioconductor used for transcription factor binding site (TFBS) analysis, which includes prediction and visualization tools.",
      "ChIPseek is an R/Bioconductor package for analyzing ChIP-seq data to identify TFBSs and analyze peak shape and intensity.",
      "HISAT2 is an aligner for RNA-seq data that includes tools for TFBS analysis and is available in R/Bioconductor.",
      "STAR is an R/Bioconductor aligner for RNA-seq data that can be used for TFBS analysis, including identification and visualization tools.",
      "DeepTools, available in R/Bioconductor, is a package for analyzing ChIP-seq data, identifying TFBSs, and includes 3D visualization tools."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: ChIPseeker is an R/Bioconductor package designed for ChIP-seq data analysis which includes functions for annotating peaks and more, but not specifically for TFBS analysis or peak shape and intensity analysis.\n3. FALSE [correction]: HISAT2 is an aligner for aligning RNA-seq reads to a reference genome, and is not available in R/Bioconductor, nor does it include tools for TFBS analysis.\n4. FALSE [correction]: STAR is a fast RNA-seq aligner, but it is not part of R/Bioconductor and it is not typically used for TFBS analysis, although the aligned data could be further analyzed for TFBSs with other tools.\n5. FALSE [correction]: DeepTools is a suite of Python tools particularly for the exploration of deep-sequencing data such as ChIP-seq. While it provides various analysis capabilities, it is not an R/Bioconductor package and does not include 3D visualization tools within it.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-2-7b-chat-hf_response": "Here are some clinical trials related to the prevention of sarcopenia:\n1. A randomized controlled trial published in the Journal of the American Medical Directors Association in 2018 found that a 12-month exercise program consisting of resistance training and aerobic exercise improved muscle mass and strength in older adults at risk for sarcopenia.\n2. A systematic review and meta-analysis published in the Journal of the American Geriatrics Society in 2019 found that resistance training and aerobic exercise were effective in preventing sarcopenia in older adults.\n3. A randomized controlled trial published in the Journal of Gerontology: Medical Sciences in 2017 found that a 6-month exercise program consisting of resistance training and aerobic exercise improved muscle mass and strength in older adults with mild sarcopenia.\n4. A randomized controlled trial published in the Journal of the American Geriatrics Society in 2016 found that a 12-month exercise program consisting of resistance training and aerobic exercise improved muscle mass and strength in older adults with sarcopenia.\n5. A systematic review and meta-analysis published in the Journal of the American Geriatrics Society in 2018 found that nutritional interventions, including protein supplementation and fortification of foods with bioactive compounds, were effective in preventing sarcopenia in older adults.\n6. A randomized controlled trial published in the Journal of Nutrition in 2019 found that a 12-month intervention with a protein-fortified yogurt improved muscle mass and strength in older adults with sarcopenia.\n7. A randomized controlled trial published in the Journal of the American Geriatrics Society in 2017 found that a 12-month intervention with a combination of protein supplementation and resistance training improved muscle mass and strength in older adults with sarcopenia.\n8. A systematic review and meta-analysis published in the Journal of the American Geriatrics Society in 2019 found that hormone replacement therapy, including testosterone and growth hormone, was effective in preventing sarcopenia in older adults.\n9. A randomized controlled trial published in",
    "llama-2-7b-chat-hf_fact_raw": "1. A randomized controlled trial published in the Journal of the American Medical Directors Association in 2018 studied a 12-month exercise program that improved muscle mass and strength in older adults at risk for sarcopenia.\n2. A systematic review and meta-analysis published in the Journal of the American Geriatrics Society in 2019 concluded that resistance training and aerobic exercise were effective in preventing sarcopenia in older adults.\n3. A randomized controlled trial published in the Journal of Gerontology: Medical Sciences in 2017 showed that a 6-month exercise program improved muscle mass and strength in older adults with mild sarcopenia.\n4. A 12-month exercise program consisting of resistance training and aerobic exercise was found to improve muscle mass and strength in older adults with sarcopenia, as per a study published in the Journal of the American Geriatrics Society in 2016.\n5. A study published in the Journal of Nutrition in 2019 found that a 12-month intervention involving protein-fortified yogurt improved muscle mass and strength in older adults with sarcopenia.",
    "llama-2-7b-chat-hf_fact": [
      "A randomized controlled trial published in the Journal of the American Medical Directors Association in 2018 studied a 12-month exercise program that improved muscle mass and strength in older adults at risk for sarcopenia.",
      "A systematic review and meta-analysis published in the Journal of the American Geriatrics Society in 2019 concluded that resistance training and aerobic exercise were effective in preventing sarcopenia in older adults.",
      "A randomized controlled trial published in the Journal of Gerontology: Medical Sciences in 2017 showed that a 6-month exercise program improved muscle mass and strength in older adults with mild sarcopenia.",
      "A 12-month exercise program consisting of resistance training and aerobic exercise was found to improve muscle mass and strength in older adults with sarcopenia, as per a study published in the Journal of the American Geriatrics Society in 2016.",
      "A study published in the Journal of Nutrition in 2019 found that a 12-month intervention involving protein-fortified yogurt improved muscle mass and strength in older adults with sarcopenia."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout access to specific articles and data from the Journals mentioned, it's not possible to determine the truth of these statements. They would need to be cross-referenced with the actual studies published in those respective years and journals to verify their accuracy.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-2-7b-chat-hf_response": "The database of molecular recognition features in membrane proteins is called the Membrane Protein Databases (MPD).",
    "llama-2-7b-chat-hf_fact_raw": "1. The Membrane Protein Databases (MPD) is a database of molecular recognition features in membrane proteins.",
    "llama-2-7b-chat-hf_fact": [
      "The Membrane Protein Databases (MPD) is a database of molecular recognition features in membrane proteins."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Membrane Protein Databases (MPD) is a database that provides structural and functional information on proteins embedded in membranes, not specifically on molecular recognition features.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-2-7b-chat-hf_response": "Yes, rivaroxaban is metabolized in the kidneys.",
    "llama-2-7b-chat-hf_fact_raw": "1. Rivaroxaban is metabolized in the kidneys.",
    "llama-2-7b-chat-hf_fact": [
      "Rivaroxaban is metabolized in the kidneys."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Rivaroxaban is primarily metabolized in the liver. Renal excretion accounts for only a portion of the elimination of rivaroxaban.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-2-7b-chat-hf_response": "TRalpha2 regulates the expression of genes involved in cardiac contractility, ion channels, and cell signaling pathways in the heart. Some specific examples of genes regulated by TRalpha2 in the heart include:\n* Troponin I\n* Tropomyosin\n* Calmodulin\n* Calcium handling proteins (e.g. CaMKKβ, CaMKIIα)\n* RyR2\n* KCNQ1\n* KCNE1\n* KCNE3\n* ATPase pump genes (e.g. ATP1A1, ATP1B1)\n* G-protein coupled receptor genes (e.g. β-AR, β-adrenergic receptor)\n* Signal transduction genes (e.g. PKA, PKG, MAPK/ERK)\n* Transcription factors (e.g. NFAT, NFATc3)\n* Genes involved in cardiac hypertrophy and fibrosis (e.g. ATF4, C/EBPβ)\nPlease note that this is not an exhaustive list and there may be other genes regulated by TRalpha2 in the heart.",
    "llama-2-7b-chat-hf_fact_raw": "1. TRalpha2 regulates genes involved in cardiac contractility.\n2. TRalpha2 affects the expression of ion channel genes in the heart.\n3. TRalpha2 influences cell signaling pathways by regulating genes in the heart.\n4. The gene Troponin I is an example of one regulated by TRalpha2 in the heart.\n5. TRalpha2 also regulates the gene RyR2 in the heart.",
    "llama-2-7b-chat-hf_fact": [
      "TRalpha2 regulates genes involved in cardiac contractility.",
      "TRalpha2 affects the expression of ion channel genes in the heart.",
      "TRalpha2 influences cell signaling pathways by regulating genes in the heart.",
      "The gene Troponin I is an example of one regulated by TRalpha2 in the heart.",
      "TRalpha2 also regulates the gene RyR2 in the heart."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-2-7b-chat-hf_response": "There are several biomedical question answering systems available, including:\n1. PubMed Central's Queries: This system allows users to search for answers to biomedical questions using a natural language interface.\n2. Biomedical Information Retrieval System (BIRS): This system provides a comprehensive search engine for biomedical literature, including articles, abstracts, and full-text documents.\n3. Biomedical Question Answering System (BQAS): This system uses natural language processing techniques to answer biomedical questions based on a large corpus of biomedical text.\n4. BioCreative II: This system is a collection of biomedical text and question answering resources, including a question answering system, a text classification system, and a named entity recognition system.\n5. Biomedical Natural Language Processing (BioNLP) System: This system provides a comprehensive set of tools for biomedical natural language processing, including question answering, named entity recognition, and sentiment analysis.\n6. Biomedical Information Retrieval and Question Answering System (BIRQ): This system provides a comprehensive search engine for biomedical literature, as well as a question answering system that can answer both general and domain-specific questions.\n7. Biomedical Question Answering System using Deep Learning (BQA-Deep): This system uses deep learning techniques to answer biomedical questions based on a large corpus of biomedical text.\n8. Biomedical Question Answering System based on Word Embeddings (BQA-WE): This system uses word embeddings to represent biomedical concepts and answer questions based on their semantic similarity.\n9. Biomedical Question Answering System based on Graph Convolutional Networks (BQA-GCN): This system uses graph convolutional networks to model the relationships between biomedical concepts and answer questions based on their structural similarity.\n10. Biomedical Question Answering System based on Attention-based Neural Networks (BQA-Attn): This system uses attention-based neural networks to focus on relevant parts of the input when answering biomedical questions.\nThese are just a few examples of the many biomedical question answering systems available. Each system has its own strengths and limitations, and the choice of which system to use will depend on the specific needs of the user.",
    "llama-2-7b-chat-hf_fact_raw": "1. PubMed Central's Queries is a biomedical question answering system that uses a natural language interface.\n2. The Biomedical Information Retrieval System (BIRS) provides a search engine for biomedical literature.\n3. The Biomedical Question Answering System (BQAS) employs natural language processing techniques to answer questions from biomedical texts.\n4. BioCreative II includes a collection of resources such as a question answering system and text classification system within the biomedical field.\n5. The Biomedical Information Retrieval and Question Answering System (BIRQ) offers a search engine for biomedical literature and a question answering system.",
    "llama-2-7b-chat-hf_fact": [
      "PubMed Central's Queries is a biomedical question answering system that uses a natural language interface.",
      "The Biomedical Information Retrieval System (BIRS) provides a search engine for biomedical literature.",
      "The Biomedical Question Answering System (BQAS) employs natural language processing techniques to answer questions from biomedical texts.",
      "BioCreative II includes a collection of resources such as a question answering system and text classification system within the biomedical field.",
      "The Biomedical Information Retrieval and Question Answering System (BIRQ) offers a search engine for biomedical literature and a question answering system."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: PubMed Central is a free full-text archive of biomedical and life sciences journal literature, but it is not specifically described as a question answering system with a natural language interface.\n2. TRUE\n3. TRUE\n4. TRUE – BioCreative II does include various resources for tasks in biomedical text mining, including text classification and information extraction, which may be used in systems for question answering.\n5. UNKNOWN – Without specific information about a system named Biomedical Information Retrieval and Question Answering System (BIRQ), it's impossible to determine the accuracy of this statement.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-2-7b-chat-hf_response": "The transcription factor that activates the betalain pathway is ABSCISIC ACID INSENSITIVE 3 (ABI3).",
    "llama-2-7b-chat-hf_fact_raw": "1. The transcription factor ABSCISIC ACID INSENSITIVE 3 (ABI3) activates the betalain pathway.",
    "llama-2-7b-chat-hf_fact": [
      "The transcription factor ABSCISIC ACID INSENSITIVE 3 (ABI3) activates the betalain pathway."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nThe available information is insufficient to accurately assess the statement regarding the role of the transcription factor ABSCISIC ACID INSENSITIVE 3 (ABI3) in activating the betalain pathway. ABI3 is generally known for its role in plant development, particularly in seed dormancy and germination. However, without specific scientific references to the role of ABI3 in the betalain biosynthesis pathway, it is not possible to confirm or deny the statement with certainty.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-2-7b-chat-hf_response": "Global quantitative phosphoproteomic analyses typically involve the use of various technologies for the enrichment of phosphorylated peptides. Some of the preferred technologies for phosphoproteome analysis include:\n1. TiO2-based enrichment: This method uses titanium dioxide (TiO2) to selectively bind phosphorylated peptides based on their charged and hydrophilic properties.\n2. IMAC (Immobilized Metal Affinity Chromatography): This method uses metal ions (e.g., copper or nickel) to selectively bind phosphorylated peptides based on their charge and hydrophilic properties.\n3. RESOURCE (Reversible Electrostatic Separation of Ubiquitin and Relevant Proteins): This method uses a reversible electrostatic interaction between the phosphorylated peptides and a stationary phase to enrich for phosphorylated peptides.\n4. Hydrophilic interaction liquid chromatography (HILIC): This method uses a hydrophilic stationary phase to separate phosphorylated peptides based on their hydrophilic properties.\n5. Reversed-phase HPLC: This method uses a reversed-phase stationary phase to separate phosphorylated peptides based on their hydrophobic properties.\n6. Microfluidic-based enrichment: This method uses microfluidics to enrich for phosphorylated peptides based on their size and charge.\n7. Enrichment using metal-organic frameworks (MOFs): This method uses MOFs as a stationary phase to selectively bind phosphorylated peptides based on their charge and hydrophilic properties.\n8. Enrichment using graphene-based materials: This method uses graphene-based materials as a stationary phase to selectively bind phosphorylated peptides based on their charge and hydrophilic properties.\n9. Enrichment using nanofabricated surfaces: This method uses nanofabricated surfaces as a stationary phase to selectively bind phosphorylated peptides based on their charge and hydrophilic properties.\n10. Enrichment using bio",
    "llama-2-7b-chat-hf_fact_raw": "1. TiO2-based enrichment is used in phosphoproteome analysis to bind phosphorylated peptides.\n2. Immobilized Metal Affinity Chromatography (IMAC) employs metal ions to bind phosphorylated peptides.\n3. Hydrophilic interaction liquid chromatography (HILIC) separates phosphorylated peptides based on their hydrophilic properties.\n4. Reversed-phase HPLC separates phosphorylated peptides using a reversed-phase stationary phase based on hydrophobic properties.\n5. Microfluidics can be used to enrich phosphorylated peptides by utilizing differences in size and charge.",
    "llama-2-7b-chat-hf_fact": [
      "TiO2-based enrichment is used in phosphoproteome analysis to bind phosphorylated peptides.",
      "Immobilized Metal Affinity Chromatography (IMAC) employs metal ions to bind phosphorylated peptides.",
      "Hydrophilic interaction liquid chromatography (HILIC) separates phosphorylated peptides based on their hydrophilic properties.",
      "Reversed-phase HPLC separates phosphorylated peptides using a reversed-phase stationary phase based on hydrophobic properties.",
      "Microfluidics can be used to enrich phosphorylated peptides by utilizing differences in size and charge."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: Titanium dioxide (TiO2) enrichment is a common method used in phosphoproteomics for binding phosphorylated peptides due to the affinity of the phosphate group for the metal oxide.\n2. TRUE: Immobilized Metal Affinity Chromatography (IMAC) utilizes metal ions (such as Fe3+, Ga3+, and others) to selectively bind and enrich phosphorylated peptides through interactions with the phosphate groups.\n3. TRUE: Hydrophilic interaction liquid chromatography (HILIC) separates molecules based on their hydrophilicity; phosphorylated peptides can be separated in this technique due to the highly polar nature of the phosphate group.\n4. TRUE: Reversed-phase high-performance liquid chromatography (HPLC) indeed separates peptides based on their hydrophobic properties using a hydrophobic stationary phase, and phosphorylated peptides can be included in such separations.\n5. TRUE: Microfluidic devices can be designed to enrich phosphorylated peptides by exploiting differences in size and charge, among other properties, for selective retention and separation.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-2-7b-chat-hf_response": "The Palmini classification is used to rate the severity of osteoarthritis of the knee.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Palmini classification is used to rate the severity of osteoarthritis.\n2. The Palmini classification is specifically applied to the knee.",
    "llama-2-7b-chat-hf_fact": [
      "The Palmini classification is used to rate the severity of osteoarthritis.",
      "The Palmini classification is specifically applied to the knee."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Kellgren-Lawrence classification is used to rate the severity of osteoarthritis.\n2. FALSE [correction]: The Kellgren-Lawrence classification, not the Palmini classification, is commonly used specifically for grading the severity of arthritis in the knee.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-2-7b-chat-hf_response": "Yes, viruses have been implicated in the etiology of human subacute thyroiditis.",
    "llama-2-7b-chat-hf_fact_raw": "1. Viruses have been implicated in the etiology of human subacute thyroiditis.",
    "llama-2-7b-chat-hf_fact": [
      "Viruses have been implicated in the etiology of human subacute thyroiditis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-2-7b-chat-hf_response": "Yes, STAT3 is involved in EIF2AK2-dependent suppression of autophagy.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-2-7b-chat-hf_response": "Theater is a software tool specifically designed for the analysis of genomic data, particularly for the analysis of gene expression data. It is a widely used tool in the field of bioinformatics and computational biology, and is particularly useful for the analysis of large-scale genomic datasets. Here are some of the key features and usage of the Theater software tool:\n1. Data Import: Theater can import various types of genomic data formats such as RNA-seq, ChIP-seq, and DNA methylation data.\n2. Data Preprocessing: Theater provides a range of tools for preprocessing genomic data, including trimming adapters, filtering low-quality reads, and mapping reads to a reference genome.\n3. Clustering Analysis: Theater can perform clustering analysis on genomic data to identify groups of genes or samples that are co-regulated or co-expressed.\n4. Pathway Analysis: Theater can identify pathways and biological processes that are enriched with differentially expressed genes.\n5. Network Analysis: Theater can construct gene regulatory networks and identify key regulators and target genes.\n6. Visualization: Theater provides a range of visualization tools for exploring and visualizing genomic data, including heat maps, scatter plots, and network diagrams.\n7. Integration with Other Tools: Theater can be integrated with other bioinformatics tools and databases, such as Gene Ontology, KEGG, and Reactome, to provide a comprehensive view of genomic data.\n8. User-Friendly Interface: Theater has a user-friendly interface that allows researchers to easily import and analyze genomic data without requiring extensive computational expertise.\n9. Scalability: Theater is designed to handle large-scale genomic datasets and can perform analysis on datasets of any size.\n10. Community Support: Theater has a large and active community of users and developers, which provides a wealth of resources and support for users.\nOverall, Theater is a powerful tool for the analysis of genomic data, particularly for the analysis of gene expression data. Its ability to perform clustering, pathway, network, and visualization analysis makes it a valuable tool for researchers in the field of bioinformatics and computational biology.",
    "llama-2-7b-chat-hf_fact_raw": "1. Theater is a software tool designed for the analysis of genomic data.\n2. It can import various types of genomic data formats including RNA-seq, ChIP-seq, and DNA methylation data.\n3. Theater provides tools for preprocessing genomic data like trimming adapters and mapping reads to a reference genome.\n4. The software can perform clustering analysis and identify pathways enriched with differentially expressed genes.\n5. Theater offers visualization tools such as heat maps, scatter plots, and network diagrams for genomic data.",
    "llama-2-7b-chat-hf_fact": [
      "Theater is a software tool designed for the analysis of genomic data.",
      "It can import various types of genomic data formats including RNA-seq, ChIP-seq, and DNA methylation data.",
      "Theater provides tools for preprocessing genomic data like trimming adapters and mapping reads to a reference genome.",
      "The software can perform clustering analysis and identify pathways enriched with differentially expressed genes.",
      "Theater offers visualization tools such as heat maps, scatter plots, and network diagrams for genomic data."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Theater (as it is not specifically known as a software tool in the broader scientific community) may not refer to a genomic data analysis software unless there is a specific tool by that name which is not well-known or is hypothetical in this context. Without additional context, this statement is likely false.\n2. UNKNOWN: Without confirmation that \"Theater\" is indeed a genomic data analysis software, the ability to import various types of genomic data formats cannot be determined.\n3. UNKNOWN: Similar to statement 2, without more context about \"Theater\" being a genomic data analysis software, the claim about providing tools for preprocessing cannot be assessed.\n4. UNKNOWN: The ability of the software to perform clustering analysis and identify pathways cannot be determined without confirming what \"Theater\" is.\n5. UNKNOWN: Similar to the previous statements, without confirming the nature of \"Theater\" as a genomic data analysis tool, the availability of visualization tools such as heat maps, scatter plots, and network diagrams cannot be determined.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-2-7b-chat-hf_response": "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2), where n is the length of the shorter sequence.\nIn the Smith-Waterman algorithm, the time complexity is determined by the number of comparisons made between the two sequences. The algorithm compares each element of the shorter sequence with every element of the longer sequence, resulting in a total of n^2 comparisons.\nTherefore, the execution time of the Smith-Waterman algorithm grows quadratically with the length of the shorter sequence, making it computationally expensive for longer sequences.",
    "llama-2-7b-chat-hf_fact_raw": "1. The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2).\n2. The time complexity is quadratically related to the length of the shorter sequence in the Smith-Waterman algorithm.\n3. The Smith-Waterman algorithm becomes computationally expensive for the alignment of longer sequences.",
    "llama-2-7b-chat-hf_fact": [
      "The execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences is O(n^2).",
      "The time complexity is quadratically related to the length of the shorter sequence in the Smith-Waterman algorithm.",
      "The Smith-Waterman algorithm becomes computationally expensive for the alignment of longer sequences."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The time complexity is quadratically related to the length of both sequences, not just the shorter sequence. The time complexity of the Smith-Waterman algorithm is O(n*m), where n and m are the lengths of the two sequences being aligned.\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-2-7b-chat-hf_response": "FLVCR1 is a member of the solute carrier family 2 (SLC2) subfamily. Specifically, it is a member of the SLC22A1 subfamily.",
    "llama-2-7b-chat-hf_fact_raw": "1. FLVCR1 is a member of the solute carrier family 2 (SLC2).\n2. FLVCR1 belongs to the SLC22A1 subfamily.",
    "llama-2-7b-chat-hf_fact": [
      "FLVCR1 is a member of the solute carrier family 2 (SLC2).",
      "FLVCR1 belongs to the SLC22A1 subfamily."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: FLVCR1 is a member of the solute carrier family 35 (SLC35), not the solute carrier family 2 (SLC2).\n2. FALSE [correction]: FLVCR1 does not belong to the SLC22A1 subfamily; it is part of the SLC35 family, specifically SLC35F2.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false"
    ]
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-2-7b-chat-hf_response": "GATA-1 is a transcription factor that plays a crucial role in regulating the expression of genes involved in erythroid cell development and maturation. The biotinylation tagging approach has been used to identify GATA-1 interacting partners. Here are some of the GATA-1 interacting partners that have been identified using this approach:\n1. HDAC1: GATA-1 was shown to interact with HDAC1, a histone deacetylase that plays a role in regulating chromatin structure and gene expression.\n2. H3K9me3: GATA-1 was found to interact with H3K9me3, a histone modification that is involved in the regulation of gene expression and cell fate determination.\n3. RBBP4: RBBP4, also known as ROC1, is a chromatin-remodeling complex subunit that was shown to interact with GATA-1.\n4. KAT2A: KAT2A is a histone acetyltransferase that was found to interact with GATA-1 and play a role in regulating erythroid gene expression.\n5. Brm: Brm is a transcriptional coactivator that was shown to interact with GATA-1 and play a role in regulating erythroid cell development.\n6. CTCF: CTCF is a chromatin-binding protein that was found to interact with GATA-1 and play a role in regulating the expression of erythroid genes.\n7. HMX1: HMX1 is a homeobox transcription factor that was shown to interact with GATA-1 and play a role in regulating erythroid cell development.\n8. NF-E2: NF-E2 is a transcription factor that was found to interact with GATA-1 and play a role in regulating erythroid gene expression.\n9. GATA2: GATA2 is another GATA-family transcription factor that was shown to interact with GATA-1 and play a role in regulating erythroid cell development.\n10. TFAP2A: TFAP2A is a transcription factor that was found to interact with GATA-1 and play a role in regulating erythroid gene expression.",
    "llama-2-7b-chat-hf_fact_raw": "1. GATA-1 was shown to interact with HDAC1, a histone deacetylase.\n2. GATA-1 was found to interact with the histone modification H3K9me3.\n3. RBBP4, also known as ROC1, interacts with GATA-1.\n4. GATA-1 interacts with KAT2A, a histone acetyltransferase.\n5. GATA-1 interacts with CTCF, a chromatin-binding protein.",
    "llama-2-7b-chat-hf_fact": [
      "GATA-1 was shown to interact with HDAC1, a histone deacetylase.",
      "GATA-1 was found to interact with the histone modification H3K9me3.",
      "RBBP4, also known as ROC1, interacts with GATA-1.",
      "GATA-1 interacts with KAT2A, a histone acetyltransferase.",
      "GATA-1 interacts with CTCF, a chromatin-binding protein."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: GATA-1 was found to interact with the histone modification H3K27me1.\n3. FALSE [correction]: RBBP4, also known as Retinoblastoma-binding protein 4, is not known as ROC1. ROC1 is actually an alias for the protein RBX1. There is no direct evidence provided for RBBP4's interaction with GATA-1, so unless it can be specifically substantiated, the interaction remains UNKNOWN.\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-2-7b-chat-hf_response": "The outcome of TAF10 interacting with the GATA1 transcription factor is the regulation of gene expression, specifically the activation of genes involved in erythropoiesis.",
    "llama-2-7b-chat-hf_fact_raw": "1. TAF10 interacts with the GATA1 transcription factor.\n2. The interaction between TAF10 and the GATA1 transcription factor regulates gene expression.\n3. The genes activated through this interaction are involved in erythropoiesis.",
    "llama-2-7b-chat-hf_fact": [
      "TAF10 interacts with the GATA1 transcription factor.",
      "The interaction between TAF10 and the GATA1 transcription factor regulates gene expression.",
      "The genes activated through this interaction are involved in erythropoiesis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n\nIf these statements are indeed extracted from a passage that discusses the specifics of the interaction between TAF10 and the GATA1 transcription factor and its involvement in the regulation of gene expression relevant to erythropoiesis, then the statements would seem valid based on the understanding of their biological functions. However, without specific reference to the passage, the response assumes the statements are accurate as presented.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-2-7b-chat-hf_response": "Yes, there are several decision support systems (DSS) available for chronic pain management. A DSS is a computer-based system that provides healthcare professionals with clinical decision-making support and helps them make informed decisions based on patient-specific data and clinical guidelines.\nSome examples of DSS for chronic pain management include:\n1. PainCare: This DSS is designed to help primary care physicians manage chronic pain in adults. It provides clinical decision support, pain assessment tools, and treatment recommendations based on clinical guidelines.\n2. Chronic Pain Management System (CPMS): This DSS is designed for use in primary care settings and provides clinical decision support for managing chronic pain. It includes a pain assessment tool, treatment recommendations, and a database of patient information.\n3. Pain-Q: This DSS is designed for use in primary care and specialty pain clinics. It provides clinical decision support, pain assessment tools, and treatment recommendations based on clinical guidelines.\n4. Pain Management Decision Support System (PMDSS): This DSS is designed for use in a variety of healthcare settings and provides clinical decision support for managing chronic pain. It includes a pain assessment tool, treatment recommendations, and a database of patient information.\n5. Chronic Pain Management (CPM) System: This DSS is designed for use in primary care and specialty pain clinics. It provides clinical decision support, pain assessment tools, and treatment recommendations based on clinical guidelines.\n6. Pain Management Decision Support (PMDS): This DSS is designed for use in primary care and specialty pain clinics. It provides clinical decision support, pain assessment tools, and treatment recommendations based on clinical guidelines.\n7. Chronic Pain Management (CPM) System: This DSS is designed for use in primary care and specialty pain clinics. It provides clinical decision support, pain assessment tools, and treatment recommendations based on clinical guidelines.\n8. Pain Management Decision Support (PMDS): This DSS is designed for use in primary care and specialty pain clinics. It provides clinical decision support, pain assessment tools, and treatment recommendations based on clinical guidelines.",
    "llama-2-7b-chat-hf_fact_raw": "1. Decision support systems (DSS) for chronic pain management are available to provide clinical decision-making support to healthcare professionals.\n2. PainCare is a decision support system designed to aid primary care physicians in managing chronic pain in adults.\n3. The Chronic Pain Management System (CPMS) is a DSS intended for use in primary care for managing chronic pain.\n4. Pain-Q is a decision support system designed for use in primary care and specialty pain clinics.\n5. The Pain Management Decision Support System (PMDSS) is a DSS designed for use in various healthcare settings for managing chronic pain.",
    "llama-2-7b-chat-hf_fact": [
      "Decision support systems (DSS) for chronic pain management are available to provide clinical decision-making support to healthcare professionals.",
      "PainCare is a decision support system designed to aid primary care physicians in managing chronic pain in adults.",
      "The Chronic Pain Management System (CPMS) is a DSS intended for use in primary care for managing chronic pain.",
      "Pain-Q is a decision support system designed for use in primary care and specialty pain clinics.",
      "The Pain Management Decision Support System (PMDSS) is a DSS designed for use in various healthcare settings for managing chronic pain."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE (Assuming PainCare exists and is as described, but the specific name \"PainCare\" is not well-known and cannot be verified without additional context)\n3. UNKNOWN (The existence and purpose of the Chronic Pain Management System (CPMS) as a DSS cannot be confirmed without additional context)\n4. UNKNOWN (The existence and specific design purpose of Pain-Q cannot be confirmed without additional context)\n5. TRUE (Assuming the Pain Management Decision Support System (PMDSS) exists and is as described, but similar to the previous statements, it cannot be verified without additional details)",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-2-7b-chat-hf_response": "The subcellular localization of the protein angiogenin is primarily in the endoplasmic reticulum (ER) and the Golgi apparatus.",
    "llama-2-7b-chat-hf_fact_raw": "1. Angiogenin is primarily localized in the endoplasmic reticulum (ER).\n2. Angiogenin is also localized in the Golgi apparatus.",
    "llama-2-7b-chat-hf_fact": [
      "Angiogenin is primarily localized in the endoplasmic reticulum (ER).",
      "Angiogenin is also localized in the Golgi apparatus."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Angiogenin is primarily localized in the nucleus and the cytoplasm, not the endoplasmic reticulum (ER).\n2. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-2-7b-chat-hf_response": "Ranolazine inhibits the activation of kinase signaling in the heart by blocking the activity of the enzyme ATP-dependent protein kinase C (PKC).",
    "llama-2-7b-chat-hf_fact_raw": "1. Ranolazine inhibits the activation of kinase signaling in the heart.\n2. Ranolazine blocks the activity of the enzyme ATP-dependent protein kinase C (PKC).",
    "llama-2-7b-chat-hf_fact": [
      "Ranolazine inhibits the activation of kinase signaling in the heart.",
      "Ranolazine blocks the activity of the enzyme ATP-dependent protein kinase C (PKC)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Ranolazine is known primarily for its inhibition of the late sodium current in the heart, not for the direct inhibition of kinase signaling.\n2. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-2-7b-chat-hf_response": "Yes, the regulation of Vsr endonuclease is independent of the growth phase of bacteria. Vsr endonuclease is a restriction enzyme that is involved in the defense against foreign DNA in bacteria, and its activity is regulated by a variety of mechanisms, including the binding of small molecules and the expression of regulatory genes. While the growth phase of bacteria can affect the expression of certain regulatory genes, the activity of Vsr endonuclease is not directly linked to the growth phase. Instead, it is primarily regulated by the availability of the small molecules that bind to the enzyme and modulate its activity.",
    "llama-2-7b-chat-hf_fact_raw": "1. Vsr endonuclease is a restriction enzyme involved in the defense against foreign DNA in bacteria.\n2. The regulation of Vsr endonuclease's activity is influenced by the binding of small molecules.\n3. The regulation of Vsr endonuclease's activity involves the expression of regulatory genes.\n4. The activity of Vsr endonuclease is not directly linked to the growth phase of bacteria.\n5. The availability of small molecules that bind to Vsr endonuclease is a primary factor in its regulation.",
    "llama-2-7b-chat-hf_fact": [
      "Vsr endonuclease is a restriction enzyme involved in the defense against foreign DNA in bacteria.",
      "The regulation of Vsr endonuclease's activity is influenced by the binding of small molecules.",
      "The regulation of Vsr endonuclease's activity involves the expression of regulatory genes.",
      "The activity of Vsr endonuclease is not directly linked to the growth phase of bacteria.",
      "The availability of small molecules that bind to Vsr endonuclease is a primary factor in its regulation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Vsr endonuclease is not a restriction enzyme; it is a very short patch repair endonuclease that is involved in DNA repair, not in the defense against foreign DNA in bacteria.\n2. UNKNOWN\n3. TRUE: The regulation of Vsr endonuclease and other enzymes involved in DNA repair mechanisms could be influenced by the expression of regulatory genes as part of the cell's response to DNA damage.\n4. UNKNOWN\n5. UNKNOWN\n\nRegulatory mechanisms of specific enzymes such as the Vsr endonuclease can be complex and may involve various factors, including but not limited to small molecules, protein-protein interactions, and regulatory genes. Without specific information from the provided passage or wider context, it is difficult to ascertain the exact mechanisms for the regulation of Vsr endonuclease's activity, particularly with respect to the influence of small molecules and the bacteria's growth phase.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-2-7b-chat-hf_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Here are some of the commonly used tools:\n1. TMHMM: TMHMM is a widely used tool for predicting transmembrane helices in proteins. It uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transmembrane domains.\n2. PredictProteinTm: PredictProteinTm is a web server that uses a combination of sequence and structure-based methods to predict the transmembrane topology of proteins. It can predict both the number and orientation of transmembrane helices.\n3. Topo-Predict: Topo-Predict is a web server that predicts the transmembrane topology of proteins based on their sequence. It uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transmembrane domains.\n4. Transmembrane Predictor: Transmembrane Predictor is a web server that predicts the transmembrane topology of proteins based on their sequence. It uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transmembrane domains.\n5. BepiPred: BepiPred is a web server that predicts the transmembrane topology of proteins based on their sequence. It uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transmembrane domains.\n6. TM-Align: TM-Align is a web server that predicts the transmembrane topology of proteins based on their sequence. It uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transmembrane domains.\n7. PHD-TOPO: PHD-TOPO is a web server that predicts the transmembrane topology of proteins based on their sequence. It uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transmembrane domains.\n8. TM-Coffee: TM-Coffee is a web server that predicts the transmembrane topology of proteins based on their sequence. It uses a combination of sequence analysis and structure-based methods to predict the presence of beta-barrel transm",
    "llama-2-7b-chat-hf_fact_raw": "1. TMHMM is a tool used for predicting transmembrane helices in proteins.\n2. PredictProteinTm is a web server designed to predict the transmembrane topology of proteins, including the number and orientation of transmembrane helices.\n3. Topo-Predict is a web server that predicts the transmembrane topology of proteins using sequence analysis and structure-based methods.\n4. BepiPred is a web server that predicts the transmembrane topology of proteins, with a focus on the presence of beta-barrel transmembrane domains.\n5. PHD-TOPO is a web server that predicts the transmembrane topology of proteins through a combination of sequence analysis and structure-based methods.",
    "llama-2-7b-chat-hf_fact": [
      "TMHMM is a tool used for predicting transmembrane helices in proteins.",
      "PredictProteinTm is a web server designed to predict the transmembrane topology of proteins, including the number and orientation of transmembrane helices.",
      "Topo-Predict is a web server that predicts the transmembrane topology of proteins using sequence analysis and structure-based methods.",
      "BepiPred is a web server that predicts the transmembrane topology of proteins, with a focus on the presence of beta-barrel transmembrane domains.",
      "PHD-TOPO is a web server that predicts the transmembrane topology of proteins through a combination of sequence analysis and structure-based methods."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: BepiPred is a web server that predicts the locations of linear B-cell epitopes.\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-2-7b-chat-hf_response": "Galassi classification is used for classifying the severity of chronic pancreatitis.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-2-7b-chat-hf_response": "Shapiro syndrome, also known as Shapiro-Omenn syndrome, is a rare genetic disorder characterized by the following common features:\n1. Intellectual disability: Individuals with Shapiro syndrome typically have mild to severe intellectual disability, which can range from mild cognitive impairment to profound intellectual disability.\n2. Distinctive facial features: People with Shapiro syndrome often have distinctive facial features, including a small head, narrow eyes, a short nose, and a thin upper lip.\n3. Short stature: Individuals with Shapiro syndrome tend to be short in stature, with an average height of around 4 feet 6 inches (137 cm) in adulthood.\n4. Delayed speech and language development: Children with Shapiro syndrome may experience delayed speech and language development, which can lead to difficulties with communication.\n5. Vision problems: Some individuals with Shapiro syndrome may experience vision problems, including nearsightedness, astigmatism, or cataracts.\n6. Skeletal abnormalities: Shapiro syndrome can cause various skeletal abnormalities, such as short limbs, joint deformities, and scoliosis.\n7. Hearing loss: Some individuals with Shapiro syndrome may experience hearing loss, which can range from mild to severe.\n8. Increased risk of infections: People with Shapiro syndrome may be at an increased risk of infections, particularly respiratory infections, due to their immune system dysfunction.\n9. Autoimmune disorders: Shapiro syndrome can increase the risk of developing autoimmune disorders, such as type 1 diabetes, thyroiditis, and autoimmune hepatitis.\n10. Male infertility: Some males with Shapiro syndrome may experience infertility due to hypogonadism, a condition where the testes do not produce enough testosterone.\nIt's important to note that the severity and range of symptoms can vary greatly among individuals with Shapiro syndrome, and some individuals may experience a milder or more severe form of the disorder.",
    "llama-2-7b-chat-hf_fact_raw": "1. Individuals with Shapiro syndrome typically have mild to severe intellectual disability.\n2. People with Shapiro syndrome often have distinctive facial features, including a small head, narrow eyes, a short nose, and a thin upper lip.\n3. Individuals with Shapiro syndrome tend to have an average adult height of around 4 feet 6 inches (137 cm).\n4. Children with Shapiro syndrome may experience delayed speech and language development.\n5. Some individuals with Shapiro syndrome may have vision problems such as nearsightedness, astigmatism, or cataracts.",
    "llama-2-7b-chat-hf_fact": [
      "Individuals with Shapiro syndrome typically have mild to severe intellectual disability.",
      "People with Shapiro syndrome often have distinctive facial features, including a small head, narrow eyes, a short nose, and a thin upper lip.",
      "Individuals with Shapiro syndrome tend to have an average adult height of around 4 feet 6 inches (137 cm).",
      "Children with Shapiro syndrome may experience delayed speech and language development.",
      "Some individuals with Shapiro syndrome may have vision problems such as nearsightedness, astigmatism, or cataracts."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Shapiro syndrome is characterized by the triad of recurrent episodes of spontaneous hypothermia, hyperhidrosis, and agenesis of the corpus callosum, not typically intellectual disability.\n2. FALSE [correction]: The distinctive facial features described are not characteristic of Shapiro syndrome; these features may point to a different condition or syndrome.\n3. FALSE [correction]: There are no specific average adult height criteria associated with Shapiro syndrome. Height can vary and is not a defining feature of the syndrome.\n4. UNKNOWN: While individuals with malformations of the brain such as agenesis of the corpus callosum can have language and speech delays, this is not a defining characteristic of Shapiro syndrome, and there is limited information on whether this occurs specifically in individuals with Shapiro syndrome.\n5. UNKNOWN: While vision problems can occur in individuals with various medical conditions, there is no specific association of vision problems like nearsightedness, astigmatism, or cataracts with Shapiro syndrome, and this would need to be referenced with more context about the condition.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-2-7b-chat-hf_response": "BRAG1 mutations have been linked to Charcot-Marie-Tooth disease (CMT), a group of genetic disorders that affect the peripheral nervous system.",
    "llama-2-7b-chat-hf_fact_raw": "1. Mutations within BRAG1 are linked to Charcot-Marie-Tooth disease (CMT).\n2. Charcot-Marie-Tooth disease affects the peripheral nervous system.",
    "llama-2-7b-chat-hf_fact": [
      "Mutations within BRAG1 are linked to Charcot-Marie-Tooth disease (CMT).",
      "Charcot-Marie-Tooth disease affects the peripheral nervous system."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Mutations within the gene PMP22 (among others) are linked to Charcot-Marie-Tooth disease (CMT), not BRAG1.\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 1362,
    "user_query": "Which protein is the main inhibitor of protein phosphatase 1 (PP1)?",
    "llama-2-7b-chat-hf_response": "The main inhibitor of protein phosphatase 1 (PP1) is called protein phosphatase 2A (PP2A).",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-2-7b-chat-hf_response": "In Bacillus subtilis, adaptive mutagenesis (also known as stationary-phase mutagenesis) is mediated by several mechanisms, including:\n1. DNA damage response: The bacterium's DNA damage response system, which includes the SOS response, can induce mutations in response to environmental stress, such as exposure to UV light.\n2. MutY gene silencing: The mutY gene, which encodes a DNA mutase, is silenced during stationary phase, leading to increased mutation rates.\n3. Telomere shortening: Telomeres, the protective repetitive DNA sequences at the ends of chromosomes, shorten during stationary phase, which can lead to chromosomal rearrangements and mutations.\n4. RecA-mediated recombination: The RecA recombinase enzyme can introduce mutations during homologous recombination events that occur during stationary phase.\n5. Rho-independent recombination: This type of recombination, which does not involve the RecA recombinase, can also introduce mutations during stationary phase.\n6. Mobile genetic elements: Mobile genetic elements, such as transposons, can also introduce mutations during stationary phase by inserting into the bacterial genome.\nThese mechanisms allow Bacillus subtilis to adapt to changing environmental conditions by generating genetic diversity, which can lead to the selection of mutants with beneficial traits.",
    "llama-2-7b-chat-hf_fact_raw": "1. The SOS response in Bacillus subtilis can induce mutations in response to environmental stress like UV light exposure.\n2. The mutY gene, associated with DNA repair, is silenced during the stationary phase in Bacillus subtilis.\n3. Telomere shortening occurs in Bacillus subtilis during the stationary phase, potentially causing chromosomal rearrangements and mutations.\n4. RecA-mediated recombination can introduce mutations in Bacillus subtilis during the stationary phase.\n5. Rho-independent recombination can introduce mutations during the stationary phase in Bacillus subtilis.",
    "llama-2-7b-chat-hf_fact": [
      "The SOS response in Bacillus subtilis can induce mutations in response to environmental stress like UV light exposure.",
      "The mutY gene, associated with DNA repair, is silenced during the stationary phase in Bacillus subtilis.",
      "Telomere shortening occurs in Bacillus subtilis during the stationary phase, potentially causing chromosomal rearrangements and mutations.",
      "RecA-mediated recombination can introduce mutations in Bacillus subtilis during the stationary phase.",
      "Rho-independent recombination can introduce mutations during the stationary phase in Bacillus subtilis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: The SOS response is a global response to DNA damage in bacteria such as Bacillus subtilis, and it can result in mutations due to error-prone repair mechanisms like those induced by UV light exposure.\n2. UNKNOWN: Without specific information about the regulation of the mutY gene in Bacillus subtilis, it is difficult to confirm if it is silenced during the stationary phase.\n3. FALSE [correction]: Telomere shortening is a process that typically occurs in eukaryotic organisms. Bacillus subtilis, being a prokaryote, does not have telomeres; therefore, telomere shortening does not occur in this bacterium.\n4. TRUE: RecA-mediated recombination is an important mechanism in bacteria like Bacillus subtilis, particularly during the SOS response, and can result in genetic variations due to the incorporation of mutations during repair processes.\n5. FALSE [correction]: Rho-independent termination is a mechanism for terminating transcription in prokaryotes. It is not directly involved in recombination; thus, it does not introduce mutations during the stationary phase in Bacillus subtilis. However, other mechanisms, not named 'Rho-independent recombination,' could introduce mutations during the stationary phase.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-2-7b-chat-hf_response": "Erucism, also known as erythromelalgia, is a rare disorder that causes burning pain in the hands and feet. The exact cause of erucism is not known, but it is believed to be related to abnormalities in the nerves that control temperature regulation in the body. Some potential causes and contributing factors include:\n1. Genetic mutations: Erucism is thought to be inherited in some cases, with certain genetic mutations affecting the functioning of the nerves involved in temperature regulation.\n2. Nerve damage: Trauma or injury to the nerves that control temperature regulation can lead to erucism.\n3. Neurological disorders: Certain neurological conditions, such as multiple sclerosis or peripheral neuropathy, can cause erucism.\n4. Inflammation: Inflammation in the nerves or surrounding tissues can contribute to erucism.\n5. Other medical conditions: Certain medical conditions, such as hypothyroidism or Raynaud's disease, can also contribute to erucism.\n6. Medications: Certain medications, such as beta-blockers, can cause erucism as a side effect.\n7. Hormonal changes: Hormonal changes during pregnancy or menopause can also contribute to erucism.\n8. Environmental factors: Exposure to cold temperatures or certain chemicals can also trigger erucism in some people.\nIt's important to note that erucism is a relatively rare disorder, and the exact cause may not be the same for every individual. A healthcare professional can help determine the underlying cause of erucism and develop an appropriate treatment plan.",
    "llama-2-7b-chat-hf_fact_raw": "1. Erucism, also known as erythromelalgia, is a rare disorder that causes burning pain in the hands and feet.\n2. The exact cause of erucism is not known, but it is believed to be related to abnormalities in the nerves that control temperature regulation in the body.\n3. Genetic mutations are thought to be a potential cause of erucism, with certain mutations affecting nerve function related to temperature regulation.\n4. Trauma or injury to nerves that control temperature regulation can lead to erucism.\n5. Certain neurological conditions, such as multiple sclerosis or peripheral neuropathy, can cause erucism.",
    "llama-2-7b-chat-hf_fact": [
      "Erucism, also known as erythromelalgia, is a rare disorder that causes burning pain in the hands and feet.",
      "The exact cause of erucism is not known, but it is believed to be related to abnormalities in the nerves that control temperature regulation in the body.",
      "Genetic mutations are thought to be a potential cause of erucism, with certain mutations affecting nerve function related to temperature regulation.",
      "Trauma or injury to nerves that control temperature regulation can lead to erucism.",
      "Certain neurological conditions, such as multiple sclerosis or peripheral neuropathy, can cause erucism."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Erucism is not the same as erythromelalgia; erucism refers to a toxic reaction caused by caterpillar hairs or spines, whereas erythromelalgia is a rare disorder characterized by burning pain in the extremities.\n2. TRUE, regarding erythromelalgia—but the mention of erucism is incorrect as it relates to caterpillar-induced reactions. If referring to erythromelalgia, it is thought to be related to abnormalities in the nerves, involving the control of blood vessel dilation and temperature regulation.\n3. TRUE, regarding erythromelalgia—but again, the use of the term erucism is incorrect. Certain genetic mutations can contribute to the development of erythromelalgia.\n4. UNKNOWN: In the context of erythromelalgia, trauma may exacerbate symptoms but is not a widely recognized primary cause. For erucism, trauma isn't relevant as it is not caused by injury but by toxins from caterpillars.\n5. FALSE [correction]: While neurological conditions like multiple sclerosis or peripheral neuropathy may cause symptoms similar to erythromelalgia (burning pain, changes in skin color, or temperature in the extremities), these conditions themselves do not cause erucism. Erucism is specifically the result of contact with certain types of caterpillars.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-2-7b-chat-hf_response": "Hydrochlorothiazide is a diuretic medication that is commonly used to treat hypertension (high blood pressure) and edema (excess fluid retention) associated with conditions such as heart failure, liver disease, and kidney disease. It is also sometimes used to treat hypokalemia (low potassium levels) and to reduce the risk of stroke in certain patients.",
    "llama-2-7b-chat-hf_fact_raw": "1. Hydrochlorothiazide is a diuretic medication.\n2. Hydrochlorothiazide is used to treat hypertension (high blood pressure).\n3. The medication is also used to treat edema associated with heart failure, liver disease, and kidney disease.\n4. It is sometimes used to treat hypokalemia (low potassium levels).\n5. Hydrochlorothiazide can be used to reduce the risk of stroke in certain patients.",
    "llama-2-7b-chat-hf_fact": [
      "Hydrochlorothiazide is a diuretic medication.",
      "Hydrochlorothiazide is used to treat hypertension (high blood pressure).",
      "The medication is also used to treat edema associated with heart failure, liver disease, and kidney disease.",
      "It is sometimes used to treat hypokalemia (low potassium levels).",
      "Hydrochlorothiazide can be used to reduce the risk of stroke in certain patients."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hydrochlorothiazide can actually lead to hypokalemia (low levels of potassium) as a side effect. It is not used to treat hypokalemia, but may be used in combination with potassium-sparing diuretics to reduce the risk of hypokalemia.\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-2-7b-chat-hf_response": "Yes, silicon has been used in the treatment of urinary incontinence. Silicon-based materials, such as meshes and implants, have been used to support the urethra and bladder neck, helping to prevent leakage of urine.",
    "llama-2-7b-chat-hf_fact_raw": "1. Silicon has been used in the treatment of urinary incontinence.\n2. Silicon-based materials include meshes and implants.\n3. These silicon-based materials are used to support the urethra and bladder neck.\n4. The purpose of supporting the urethra and bladder neck with silicon-based materials is to help prevent urine leakage.",
    "llama-2-7b-chat-hf_fact": [
      "Silicon has been used in the treatment of urinary incontinence.",
      "Silicon-based materials include meshes and implants.",
      "These silicon-based materials are used to support the urethra and bladder neck.",
      "The purpose of supporting the urethra and bladder neck with silicon-based materials is to help prevent urine leakage."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Silicone, not silicon, has been used in the treatment of urinary incontinence. Silicon is a chemical element, while silicone is a polymer used in medical devices.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-2-7b-chat-hf_response": "There is no established association between the moon cycle and the risk of rupture of intracranial aneurysms. Some studies have suggested that the incidence of rupture of intracranial aneurysms may be higher during certain phases of the menstrual cycle, but these findings are not consistent and the evidence is limited. Further research is needed to determine if there is any association between the moon cycle and the risk of rupture of intracranial aneurysms.",
    "llama-2-7b-chat-hf_fact_raw": "1. There is no established association between the moon cycle and the risk of rupture of intracranial aneurysms.\n2. Some studies have suggested that the incidence of rupture of intracranial aneurysms may be higher during certain phases of the menstrual cycle.\n3. The evidence regarding the association between the moon cycle and the rupture risk of intracranial aneurysms is limited.\n4. Further research is needed to determine if there is any association between the moon cycle and the risk of rupture of intracranial aneurysms.",
    "llama-2-7b-chat-hf_fact": [
      "There is no established association between the moon cycle and the risk of rupture of intracranial aneurysms.",
      "Some studies have suggested that the incidence of rupture of intracranial aneurysms may be higher during certain phases of the menstrual cycle.",
      "The evidence regarding the association between the moon cycle and the rupture risk of intracranial aneurysms is limited.",
      "Further research is needed to determine if there is any association between the moon cycle and the risk of rupture of intracranial aneurysms."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-2-7b-chat-hf_response": "Yes, the HuR protein has been shown to regulate the splicing process in various cell types and tissues. HuR is a member of the embryonic lethal abnormal vision, homolog (ELAVL1) family of RNA-binding proteins and plays a critical role in the regulation of mRNA splicing, particularly in the nervous system. HuR has been shown to bind to specific splice sites and enhance the splicing efficiency of certain pre-mRNAs, leading to the production of alternative splice variants. Additionally, HuR has been implicated in the regulation of mRNA stability and transport, which can also impact the splicing process. Dysregulation of HuR has been implicated in a variety of diseases, including cancer and neurodegenerative disorders, and altered HuR expression has been observed in these diseases.",
    "llama-2-7b-chat-hf_fact_raw": "1. The HuR protein regulates the splicing process in various cell types and tissues.\n2. HuR is a member of the embryonic lethal abnormal vision, homolog (ELAVL1) family of RNA-binding proteins.\n3. The HuR protein plays a role in the regulation of mRNA splicing, particularly in the nervous system.\n4. HuR binds to specific splice sites and enhances the splicing efficiency of certain pre-mRNAs.\n5. Dysregulation of HuR has been implicated in diseases such as cancer and neurodegenerative disorders.",
    "llama-2-7b-chat-hf_fact": [
      "The HuR protein regulates the splicing process in various cell types and tissues.",
      "HuR is a member of the embryonic lethal abnormal vision, homolog (ELAVL1) family of RNA-binding proteins.",
      "The HuR protein plays a role in the regulation of mRNA splicing, particularly in the nervous system.",
      "HuR binds to specific splice sites and enhances the splicing efficiency of certain pre-mRNAs.",
      "Dysregulation of HuR has been implicated in diseases such as cancer and neurodegenerative disorders."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The HuR protein does not regulate the splicing process; it is primarily involved in the stabilization and regulation of messenger RNA (mRNA) lifespan.\n2. TRUE\n3. FALSE [correction]: While HuR does play a role in the regulation of mRNA stability and translation, particularly in the nervous system, it does not specifically regulate mRNA splicing.\n4. FALSE [correction]: HuR generally binds to AU-rich elements in the 3' untranslated region of mRNAs and does not directly enhance the efficiency of splicing at specific splice sites.\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-2-7b-chat-hf_response": "Prothymosin alpha (Pa) is a small protein that plays a crucial role in the regulation of various cellular processes, including cell proliferation, differentiation, and survival. The c-terminal peptide of prothymosin alpha (Pac-CT) is a 16-amino acid peptide derived from the C-terminus of Pa. Known functions of Pac-CT include:\n1. Cell cycle regulation: Pac-CT has been shown to inhibit cell cycle progression and induce cell cycle arrest in G1 phase, suggesting a role in regulating cell proliferation.\n2. Apoptosis: Pac-CT has been shown to induce apoptosis (programmed cell death) in some cell types, suggesting a role in regulating cell survival.\n3. Neuroprotection: Pac-CT has been shown to have neuroprotective effects in various animal models of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.\n4. Anti-inflammatory effects: Pac-CT has been shown to have anti-inflammatory effects in various animal models of inflammation, suggesting a role in regulating inflammation.\n5. Regulation of angiogenesis: Pac-CT has been shown to regulate angiogenesis, the formation of new blood vessels, in various tissues, including the brain and tumors.\n6. Regulation of immune response: Pac-CT has been shown to regulate the immune response in various animal models, including the regulation of T cell activation and cytokine production.\n7. Regulation of metabolism: Pac-CT has been shown to regulate metabolic processes, including glucose metabolism and lipid metabolism, in various tissues.\n8. Regulation of stress response: Pac-CT has been shown to regulate the stress response in various tissues, including the regulation of heat shock protein expression and the response to oxidative stress.\nOverall, the functions of Pac-CT are complex and involve the regulation of multiple cellular processes, including cell cycle progression, apoptosis, neuroprotection, inflammation, angiogenesis, immune response, metabolism, and stress response.",
    "llama-2-7b-chat-hf_fact_raw": "1. The c-terminal peptide of prothymosin alpha (Pac-CT) is derived from the C-terminus of prothymosin alpha and is a 16-amino acid peptide.\n2. Pac-CT has been shown to inhibit cell cycle progression and induce cell cycle arrest in the G1 phase.\n3. Pac-CT has been demonstrated to induce apoptosis in some cell types.\n4. Pac-CT has neuroprotective effects in animal models of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.\n5. Pac-CT has been shown to have anti-inflammatory effects in various animal models of inflammation.",
    "llama-2-7b-chat-hf_fact": [
      "The c-terminal peptide of prothymosin alpha (Pac-CT) is derived from the C-terminus of prothymosin alpha and is a 16-amino acid peptide.",
      "Pac-CT has been shown to inhibit cell cycle progression and induce cell cycle arrest in the G1 phase.",
      "Pac-CT has been demonstrated to induce apoptosis in some cell types.",
      "Pac-CT has neuroprotective effects in animal models of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.",
      "Pac-CT has been shown to have anti-inflammatory effects in various animal models of inflammation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe first statement is a specific claim that could be verified by scientific data on the peptide in question. However, statements 2 through 5 relate to the biological activity of Pac-CT and its effects in various models or conditions. Without additional context or specific scientific references to verify these claims, it is not possible for me to confirm their accuracy. Such statements require specialized knowledge and access to current scientific research.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-2-7b-chat-hf_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the amino acid sequence RRQRRR.",
    "llama-2-7b-chat-hf_fact_raw": "1. The amino acid sequence RRQRRR plays a pivotal role in human cystatin C fibrillization.",
    "llama-2-7b-chat-hf_fact": [
      "The amino acid sequence RRQRRR plays a pivotal role in human cystatin C fibrillization."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nNote: The statement about the amino acid sequence RRQRRR playing a pivotal role in human cystatin C fibrillization is highly specific, and without access to the latest scientific journals or specific research papers, I cannot verify the accuracy of this statement. Cystatin C is known to be involved in amyloidosis processes, where abnormal fibrillization can occur, but the role of a specific amino acid sequence would need to be confirmed by a scientific source.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-2-7b-chat-hf_response": "Yes, administration of amifostine (ethyol) has been shown to increase the concentration of the protein HIF-1α in certain cells or tissues. HIF-1α is a transcription factor that plays a critical role in response to hypoxia and is involved in the regulation of various cellular processes, including glucose metabolism, angiogenesis, and cell survival. Amifostine is a cytoprotective prodrug that has been shown to have antioxidant and anti-inflammatory effects, and it has been used to protect against various forms of tissue damage, including radiation-induced injury. Studies have shown that amifostine can increase the expression of HIF-1α in various cell types, including cancer cells, and may play a role in the protective effects of amifostine against oxidative stress and cell death.",
    "llama-2-7b-chat-hf_fact_raw": "1. Amifostine administration increases the concentration of the protein HIF-1α in certain cells or tissues.\n2. HIF-1α is a transcription factor involved in the response to hypoxia.\n3. HIF-1α regulates various cellular processes, including glucose metabolism, angiogenesis, and cell survival.\n4. Amifostine is a cytoprotective prodrug with antioxidant and anti-inflammatory effects.\n5. Amifostine has been used to protect against tissue damage such as radiation-induced injury.",
    "llama-2-7b-chat-hf_fact": [
      "Amifostine administration increases the concentration of the protein HIF-1α in certain cells or tissues.",
      "HIF-1α is a transcription factor involved in the response to hypoxia.",
      "HIF-1α regulates various cellular processes, including glucose metabolism, angiogenesis, and cell survival.",
      "Amifostine is a cytoprotective prodrug with antioxidant and anti-inflammatory effects.",
      "Amifostine has been used to protect against tissue damage such as radiation-induced injury."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-2-7b-chat-hf_response": "Set7 deposits histone H3 lysine 4 trimethylation (H3K4me3) marks.",
    "llama-2-7b-chat-hf_fact_raw": "1. Set7 is responsible for depositing histone H3 lysine 4 trimethylation marks.",
    "llama-2-7b-chat-hf_fact": [
      "Set7 is responsible for depositing histone H3 lysine 4 trimethylation marks."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Set7 (also known as SETD7) is known to deposit histone H3 lysine 4 monomethylation marks (H3K4me1), not trimethylation (H3K4me3) marks. It is primarily a histone methyltransferase for lysine 4 on histone H3 with a specificity for monomethylation.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-2-7b-chat-hf_response": "The protein hepcidin has 4 disulfide bridges.",
    "llama-2-7b-chat-hf_fact_raw": "1. Hepcidin has 4 disulfide bridges.",
    "llama-2-7b-chat-hf_fact": [
      "Hepcidin has 4 disulfide bridges."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-2-7b-chat-hf_response": "The protein encoded by the gene DNAJC11 is localized in the cytoplasm.",
    "llama-2-7b-chat-hf_fact_raw": "1. The protein encoded by the gene DNAJC11 is localized in the cytoplasm.",
    "llama-2-7b-chat-hf_fact": [
      "The protein encoded by the gene DNAJC11 is localized in the cytoplasm."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nThe subcellular localization of the protein encoded by the gene DNAJC11 requires specific scientific knowledge or reliable sources to verify. Without further context or reference, I cannot provide an accurate answer about the localization of this particular protein.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-2-7b-chat-hf_response": "Yes, ultraconserved elements are depleted among copy number variants (CNVs).",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-2-7b-chat-hf_response": "The substrate of the Haspin kinase during mitosis is the protein Cdc20.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-2-7b-chat-hf_response": "Viroid replication is a unique mechanism of replication that occurs in the absence of a host cell's machinery. Viroids replicate by creating multiple copies of themselves through a process called \"rolling circle replication,\" where they continuously amplify their genetic material by adding new nucleotides to the end of the existing RNA molecule. This results in the production of many identical copies of the viroid, which can then go on to infect other cells.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-2-7b-chat-hf_response": "Yes, fibronectin has been identified as a potential serum biomarker for Duchenne muscular dystrophy (DMD). Studies have shown that levels of fibronectin in the blood are significantly reduced in individuals with DMD compared to healthy controls, and this reduction can be detected as early as 6 months of age. This reduction in fibronectin levels may serve as an early marker for the diagnosis of DMD and may also provide a useful tool for monitoring disease progression and response to treatment.",
    "llama-2-7b-chat-hf_fact_raw": "1. Fibronectin is identified as a potential serum biomarker for Duchenne muscular dystrophy (DMD).\n2. Studies indicate that levels of fibronectin are significantly reduced in the blood of individuals with DMD compared to healthy controls.\n3. The reduction of fibronectin levels can be detected as early as 6 months of age in individuals with DMD.\n4. The reduction in fibronectin levels may be used as an early marker for the diagnosis of DMD.\n5. Reduced fibronectin levels can provide a tool for monitoring the progression of DMD and the response to treatment.",
    "llama-2-7b-chat-hf_fact": [
      "Fibronectin is identified as a potential serum biomarker for Duchenne muscular dystrophy (DMD).",
      "Studies indicate that levels of fibronectin are significantly reduced in the blood of individuals with DMD compared to healthy controls.",
      "The reduction of fibronectin levels can be detected as early as 6 months of age in individuals with DMD.",
      "The reduction in fibronectin levels may be used as an early marker for the diagnosis of DMD.",
      "Reduced fibronectin levels can provide a tool for monitoring the progression of DMD and the response to treatment."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific sources or scientific studies to confirm these statements, I cannot verify whether they are true or false. These statements would require reference to current medical research on biomarkers for Duchenne muscular dystrophy (DMD) to establish their veracity.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-2-7b-chat-hf_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. The Human Epigenome Project: This project aims to generate comprehensive epigenetic profiles of human tissues and cells, including DNA methylation, histone modifications, and chromatin structure.\n2. The ENCODE (ENCyclopedia Of DNA Elements) Project: This project aims to create a comprehensive catalog of all functional elements in the human genome, including promoters, enhancers, and other regulatory elements.\n3. The Roadmap Epigenomics Project: This project aims to generate comprehensive epigenetic profiles of multiple tissues and cell types from multiple species, including humans, mice, and fruit flies.\n4. The Mouse Epigenome Project: This project aims to generate comprehensive epigenetic profiles of multiple tissues and cell types from mice, including DNA methylation, histone modifications, and chromatin structure.\n5. The Epigenomics of Human Disease Project: This project aims to investigate the role of epigenetic changes in human disease, including cancer, diabetes, and neurological disorders.\n6. The Epigenetic Regulation of Stem Cell Pluripotency Project: This project aims to investigate the epigenetic mechanisms that regulate stem cell pluripotency and differentiation.\n7. The Epigenetic Control of Gene Expression Project: This project aims to investigate the epigenetic mechanisms that control gene expression, including DNA methylation, histone modifications, and non-coding RNAs.\n8. The Epigenetic Landscape of Aging Project: This project aims to investigate the epigenetic changes that occur with aging and their impact on gene expression and cellular function.\n9. The Epigenetic Basis of Cancer Project: This project aims to investigate the epigenetic changes that occur in cancer and their impact on cellular function and tumor progression.\n10. The Epigenetic Regulation of Immune Cell Function Project: This project aims to investigate the epigenetic mechanisms that regulate immune cell function, including T cell and B cell differentiation and activation.\nThese are some of the major epigenome projects that have contributed data to the DeepBlue epigenomic",
    "llama-2-7b-chat-hf_fact_raw": "1. The DeepBlue epigenomic data server contains data from the Human Epigenome Project.\n2. Data from the ENCODE (ENCyclopedia Of DNA Elements) Project is included in the DeepBlue epigenomic data server.\n3. The Roadmap Epigenomics Project has contributed data to the DeepBlue epigenomic data server.\n4. The Mouse Epigenome Project is one of the epigenome projects whose data is available on the DeepBlue epigenomic data server.\n5. The Epigenomics of Human Disease Project aims to explore the role of epigenetic changes in diseases such as cancer, diabetes, and neurological disorders, and its data is contained within the DeepBlue server.",
    "llama-2-7b-chat-hf_fact": [
      "The DeepBlue epigenomic data server contains data from the Human Epigenome Project.",
      "Data from the ENCODE (ENCyclopedia Of DNA Elements) Project is included in the DeepBlue epigenomic data server.",
      "The Roadmap Epigenomics Project has contributed data to the DeepBlue epigenomic data server.",
      "The Mouse Epigenome Project is one of the epigenome projects whose data is available on the DeepBlue epigenomic data server.",
      "The Epigenomics of Human Disease Project aims to explore the role of epigenetic changes in diseases such as cancer, diabetes, and neurological disorders, and its data is contained within the DeepBlue server."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nRationale:\n1. The Human Epigenome Project is a collaborative effort to map the human epigenome, and it is reasonable that the DeepBlue epigenomic data server would contain data from significant projects like this.\n2. The ENCODE Project is a well-known project that aims to elucidate all functional elements in the human genome, and its datasets are commonly used and shared in genomic databases.\n3. Similar to ENCODE, the Roadmap Epigenomics Project is a significant endeavor aimed at understanding the epigenome, and its data tends to be available widely for research purposes which may include being available on servers like DeepBlue.\n4. The existence of a \"Mouse Epigenome Project\" could be plausible since model organisms are frequently studied, but without specific knowledge about whether DeepBlue includes this data, we cannot definitively confirm or deny it without further information.\n5. The aims of the \"Epigenomics of Human Disease Project\" falls in line with typical objectives of such research initiatives, and its data might be found on comprehensive databases like DeepBlue. However, without specific information confirming its inclusion in DeepBlue, this statement remains unknown.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-2-7b-chat-hf_response": "The tool that employs self-organizing maps for analyzing synonymous codon usage is called \"CodonMaps.\"",
    "llama-2-7b-chat-hf_fact_raw": "1. CodonMaps is a tool that employs self-organizing maps for analyzing synonymous codon usage.",
    "llama-2-7b-chat-hf_fact": [
      "CodonMaps is a tool that employs self-organizing maps for analyzing synonymous codon usage."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\nWithout additional context on a specific tool called CodonMaps, it is not possible to verify the accuracy of this statement. Codon usage analysis can be performed using various computational tools and methods, including self-organizing maps, but without more precise information or a reliable source confirming the existence and function of a tool named \"CodonMaps,\" the truth of this statement remains uncertain.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-2-7b-chat-hf_response": "MINDY-1 is a clinical trial for a potential treatment for COVID-19. The acronym MINDY-1 stands for \"Medicine INhiBiTorY-1\", and it is a phase 1 clinical trial for a drug called INhiBiTorY-1, which is being developed by the biotechnology company Moderna Therapeutics. The trial is investigating the safety and efficacy of INhiBiTorY-1 as a potential treatment for COVID-19, with the goal of preventing or reducing the severity of symptoms in patients infected with the virus.",
    "llama-2-7b-chat-hf_fact_raw": "1. MINDY-1 is a clinical trial for a potential treatment for COVID-19.\n2. MINDY-1 stands for \"Medicine INhiBiTorY-1\".\n3. INhiBiTorY-1 is a drug being developed by Moderna Therapeutics.\n4. The trial is a phase 1 clinical trial.\n5. The goal of the trial is to prevent or reduce the severity of COVID-19 symptoms in infected patients.",
    "llama-2-7b-chat-hf_fact": [
      "MINDY-1 is a clinical trial for a potential treatment for COVID-19.",
      "MINDY-1 stands for \"Medicine INhiBiTorY-1\".",
      "INhiBiTorY-1 is a drug being developed by Moderna Therapeutics.",
      "The trial is a phase 1 clinical trial.",
      "The goal of the trial is to prevent or reduce the severity of COVID-19 symptoms in infected patients."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: The acronym MINDY-1 does not stand for \"Medicine INhiBiTorY-1\". Without additional context, the true meaning of MINDY-1 cannot be determined.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout additional context or specific information about the MINDY-1 clinical trial, it is challenging to determine the accuracy of these statements besides the apparent incorrect definition provided for the acronym in statement 2.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-2-7b-chat-hf_response": "The software package available for the analysis of conserved genomic loci is called \"PhyloWGS\".",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-2-7b-chat-hf_response": "The PIEZO2 gene has been associated with several diseases, including:\n1. PIEZO2-related disorder: This is a rare genetic disorder caused by mutations in the PIEZO2 gene. It is characterized by developmental delays, intellectual disability, seizures, and distinctive facial features.\n2. Hypohidrotic ectodermal dysplasia (HED): HED is a group of rare genetic disorders that affect the development of the skin, sweat glands, and hair. Some mutations in the PIEZO2 gene have been found to cause HED.\n3. Ectodermal dysplasia with craniofacial and limb abnormalities: This is a rare genetic disorder that affects the development of the skin, sweat glands, and hair, as well as the face and limbs. Some mutations in the PIEZO2 gene have been found to cause this condition.",
    "llama-2-7b-chat-hf_fact_raw": "1. PIEZO2-related disorder is a rare genetic disorder caused by mutations in the PIEZO2 gene.\n2. Hypohidrotic ectodermal dysplasia is a group of disorders that can be caused by some mutations in the PIEZO2 gene.\n3. Ectodermal dysplasia with craniofacial and limb abnormalities is a genetic disorder associated with mutations in the PIEZO2 gene.",
    "llama-2-7b-chat-hf_fact": [
      "PIEZO2-related disorder is a rare genetic disorder caused by mutations in the PIEZO2 gene.",
      "Hypohidrotic ectodermal dysplasia is a group of disorders that can be caused by some mutations in the PIEZO2 gene.",
      "Ectodermal dysplasia with craniofacial and limb abnormalities is a genetic disorder associated with mutations in the PIEZO2 gene."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Hypohidrotic ectodermal dysplasia is typically not associated with mutations in the PIEZO2 gene. It is often caused by mutations in different genes, such as the EDA, EDAR, and EDARADD genes.\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-2-7b-chat-hf_response": "ERAP1-ERAP2 dimerization promotes the degradation of misfolded proteins in the endoplasmic reticulum (ER).",
    "llama-2-7b-chat-hf_fact_raw": "1. ERAP1-ERAP2 dimerization promotes the degradation of misfolded proteins.\n2. The degradation of misfolded proteins occurs in the endoplasmic reticulum (ER).",
    "llama-2-7b-chat-hf_fact": [
      "ERAP1-ERAP2 dimerization promotes the degradation of misfolded proteins.",
      "The degradation of misfolded proteins occurs in the endoplasmic reticulum (ER)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-2-7b-chat-hf_response": "R-spondin 1 and Noggin are two proteins that have been implicated in the regulation of gallbladder development and function. In non-damaged gallbladders, R-spondin 1 and Noggin play a role in the maintenance of gallbladder epithelial cell proliferation and differentiation, and in the regulation of bile acid metabolism.",
    "llama-2-7b-chat-hf_fact_raw": "1. R-spondin 1 is a protein involved in the regulation of gallbladder development and function.\n2. Noggin is a protein involved in the regulation of gallbladder development and function.\n3. In non-damaged gallbladders, R-spondin 1 plays a role in the maintenance of gallbladder epithelial cell proliferation and differentiation.\n4. In non-damaged gallbladders, Noggin plays a role in the maintenance of gallbladder epithelial cell proliferation and differentiation.\n5. R-spondin 1 and Noggin are implicated in the regulation of bile acid metabolism in non-damaged gallbladders.",
    "llama-2-7b-chat-hf_fact": [
      "R-spondin 1 is a protein involved in the regulation of gallbladder development and function.",
      "Noggin is a protein involved in the regulation of gallbladder development and function.",
      "In non-damaged gallbladders, R-spondin 1 plays a role in the maintenance of gallbladder epithelial cell proliferation and differentiation.",
      "In non-damaged gallbladders, Noggin plays a role in the maintenance of gallbladder epithelial cell proliferation and differentiation.",
      "R-spondin 1 and Noggin are implicated in the regulation of bile acid metabolism in non-damaged gallbladders."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Noggin is a protein that is involved in the regulation of many developmental processes, such as neural tube formation, but it is not specifically associated with the regulation of gallbladder development and function.\n3. UNKNOWN\n4. FALSE [correction]: While Noggin does play a role in various cellular processes during development, it is not known for maintaining gallbladder epithelial cell proliferation and differentiation.\n5. UNKNOWN\n\nR-spondin 1 is generally associated with Wnt signaling and has roles in various developmental processes, but its specific role in gallbladder development and function, as well as bile acid metabolism in non-damaged gallbladders, requires more context or scholarly references to confirm. Similarly, while Noggin is known to modulate developmental pathways, particularly those involving bone morphogenetic proteins, its role in bile acid metabolism in the gallbladder is not well-established in common scientific knowledge.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-2-7b-chat-hf_response": "Yes, NADPH oxidase 5 requires the subunit PORC for its function.",
    "llama-2-7b-chat-hf_fact_raw": "1. NADPH oxidase 5 requires the subunit PORC for its function.",
    "llama-2-7b-chat-hf_fact": [
      "NADPH oxidase 5 requires the subunit PORC for its function."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: NADPH oxidase 5 is considered a standalone enzyme that does not require cytosolic subunits, like p22phox (also known as CYBA) which is typically required by other NADPH oxidase family members for their function. \"PORC\" is not recognized as a standard subunit or cofactor for NADPH oxidases.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-2-7b-chat-hf_response": "Furin and hepcidin are both involved in the regulation of iron metabolism in the body. Furin is a protease enzyme that cleaves a variety of proteins, including some involved in iron metabolism, such as transferrin and lactoferrin. Hepcidin, on the other hand, is a hormone produced in the liver that regulates iron absorption and distribution in the body by binding to ferroportin, a protein that mediates iron efflux from cells. Hepcidin levels are increased in response to iron excess or inflammation, leading to decreased iron absorption and increased iron recycling, which helps to maintain iron homeostasis in the body.",
    "llama-2-7b-chat-hf_fact_raw": "1. Furin is a protease enzyme involved in the regulation of iron metabolism.\n2. Hepcidin is a hormone that regulates iron absorption and distribution in the body.\n3. Hepcidin is produced in the liver.\n4. Hepcidin binds to ferroportin, a protein that mediates iron efflux from cells.\n5. Hepcidin levels increase in response to iron excess or inflammation.",
    "llama-2-7b-chat-hf_fact": [
      "Furin is a protease enzyme involved in the regulation of iron metabolism.",
      "Hepcidin is a hormone that regulates iron absorption and distribution in the body.",
      "Hepcidin is produced in the liver.",
      "Hepcidin binds to ferroportin, a protein that mediates iron efflux from cells.",
      "Hepcidin levels increase in response to iron excess or inflammation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Furin is a protease enzyme involved in activating precursor proteins into their mature form, not directly in the regulation of iron metabolism.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-2-7b-chat-hf_response": "The largest metabolic gene cluster in yeast is the glycolytic pathway, also known as the pentose phosphate pathway.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-2-7b-chat-hf_response": "The role of LIMT lncRNA is to regulate the expression of genes involved in cellular processes such as cell proliferation, differentiation, and survival.",
    "llama-2-7b-chat-hf_fact_raw": "1. LIMT lncRNA regulates the expression of genes.\n2. The genes regulated by LIMT lncRNA are involved in cell proliferation.\n3. The genes regulated by LIMT lncRNA are involved in cell differentiation.\n4. The genes regulated by LIMT lncRNA are involved in cell survival.",
    "llama-2-7b-chat-hf_fact": [
      "LIMT lncRNA regulates the expression of genes.",
      "The genes regulated by LIMT lncRNA are involved in cell proliferation.",
      "The genes regulated by LIMT lncRNA are involved in cell differentiation.",
      "The genes regulated by LIMT lncRNA are involved in cell survival."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\n[Please note that these answers are based on general knowledge about lncRNAs (long non-coding RNAs) such as LIMT, which are known to be involved in various cellular processes including gene expression, cell proliferation, differentiation, and survival. However, given the specific nature of these statements, more detailed information from the original passage or a scientific source would be necessary to verify the accuracy of these statements definitively.]",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-2-7b-chat-hf_response": "The R/Bioconductor package commonly used for performing SNP (Single Nucleotide Polymorphism) enrichment analysis is called \"SNPtest.\"",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-2-7b-chat-hf_response": "The key players in radial glial specification to ependymal cells include:\n1. Notch signaling: Notch is a critical regulator of radial glial cell fate specification and differentiation to ependymal cells.\n2. Wnt/β-catenin signaling: Wnt/β-catenin signaling also plays a crucial role in regulating radial glial cell fate and differentiation to ependymal cells.\n3. Shh signaling: Shh signaling is involved in the regulation of radial glial cell fate and differentiation to ependymal cells, particularly during early embryonic development.\n4. PDGFRA signaling: Platelet-derived growth factor receptor alpha (PDGFRA) signaling is also involved in the regulation of radial glial cell fate and differentiation to ependymal cells.\n5. EGFR signaling: Epidermal growth factor receptor (EGFR) signaling is also important in regulating radial glial cell fate and differentiation to ependymal cells.\n6. FGF signaling: Fibroblast growth factor (FGF) signaling is involved in the regulation of radial glial cell fate and differentiation to ependymal cells, particularly during later stages of embryonic development.\n7. BMP signaling: Bone morphogenetic protein (BMP) signaling is also involved in the regulation of radial glial cell fate and differentiation to ependymal cells.\n8. Retinoic acid signaling: Retinoic acid, a derivative of vitamin A, is involved in the regulation of radial glial cell fate and differentiation to ependymal cells.\nThese signaling pathways interact and coordinate to regulate the specification and differentiation of radial glial cells to ependymal cells in the developing nervous system.",
    "llama-2-7b-chat-hf_fact_raw": "1. Notch signaling is a critical regulator of radial glial cell fate specification and differentiation to ependymal cells.\n2. Wnt/β-catenin signaling plays a role in regulating radial glial cell fate and differentiation to ependymal cells.\n3. Shh signaling is involved in the regulation of radial glial cell fate during early embryonic development.\n4. PDGFRA signaling is involved in the regulation of radial glial cell fate and differentiation to ependymal cells.\n5. Retinoic acid signaling is involved in the regulation of radial glial cell fate and differentiation to ependymal cells.",
    "llama-2-7b-chat-hf_fact": [
      "Notch signaling is a critical regulator of radial glial cell fate specification and differentiation to ependymal cells.",
      "Wnt/β-catenin signaling plays a role in regulating radial glial cell fate and differentiation to ependymal cells.",
      "Shh signaling is involved in the regulation of radial glial cell fate during early embryonic development.",
      "PDGFRA signaling is involved in the regulation of radial glial cell fate and differentiation to ependymal cells.",
      "Retinoic acid signaling is involved in the regulation of radial glial cell fate and differentiation to ependymal cells."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE - Notch signaling is indeed a critical regulator in the development of the central nervous system, including the regulation of radial glial cell fate and their differentiation into various cell types, such as ependymal cells.\n2. TRUE - Wnt/β-catenin signaling is known to play a role in the regulation of various aspects of neural development, including the fate specification of radial glial cells.\n3. TRUE - Sonic hedgehog (Shh) signaling is a key pathway in the regulation of neural development and radial glial cell differentiation during embryogenesis.\n4. UNKNOWN - PDGFRA (platelet-derived growth factor receptor alpha) signaling does play roles in the development of the brain and radial glia, but whether it specifically regulates differentiation to ependymal cells is not as well established in the literature as for the other pathways mentioned. This requires more specific information or current scientific evidence to confirm.\n5. TRUE - Retinoic acid signaling is involved in neuronal development and has been implicated in the regulation of radial glial cell fate and differentiation into various cell types, including ependymal cells.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-2-7b-chat-hf_response": "Triple negative gliomas are characterized by the lack of expression of the following proteins:\n* Tumor suppressor proteins (p53, p16, p21)\n* Markers of astrocyte differentiation (GFAP, A2B5)\n* Markers of neuronal differentiation ( NeuN, MAP2)\nThese tumors are also often associated with mutations in genes involved in DNA repair and cell cycle regulation, such as TP53 and BRCA1/2.",
    "llama-2-7b-chat-hf_fact_raw": "1. Triple negative gliomas lack the expression of tumor suppressor proteins such as p53, p16, and p21.\n2. Triple negative gliomas also lack the expression of markers of astrocyte differentiation like GFAP and A2B5.\n3. Markers of neuronal differentiation such as NeuN and MAP2 are not expressed in triple negative gliomas.\n4. These tumors are often associated with mutations in genes involved in DNA repair, including TP53.\n5. Mutations in cell cycle regulation genes like BRCA1/2 are also associated with triple negative gliomas.",
    "llama-2-7b-chat-hf_fact": [
      "Triple negative gliomas lack the expression of tumor suppressor proteins such as p53, p16, and p21.",
      "Triple negative gliomas also lack the expression of markers of astrocyte differentiation like GFAP and A2B5.",
      "Markers of neuronal differentiation such as NeuN and MAP2 are not expressed in triple negative gliomas.",
      "These tumors are often associated with mutations in genes involved in DNA repair, including TP53.",
      "Mutations in cell cycle regulation genes like BRCA1/2 are also associated with triple negative gliomas."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Triple negative gliomas are characterized by the lack of expression of IDH1, TP53, and ATRX, rather than p53, p16, and p21.\n2. TRUE\n3. UNKNOWN: Without specific literature or research data, it’s unclear if markers of neuronal differentiation such as NeuN and MAP2 are not expressed in triple negative gliomas. This might depend on the specific traits of the triple negative glioma in question.\n4. TRUE: TP53 is a gene involved in DNA repair, and its mutations are often associated with various types of tumors, including gliomas.\n5. UNKNOWN: While mutations in BRCA1/2 are more commonly associated with breast and ovarian cancers, without specific data or research evidence, it is uncertain whether these mutations are also associated with triple negative gliomas.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-2-7b-chat-hf_response": "TOPAZ1 is a gene that has been associated with cancer, specifically with the development of acute myeloid leukemia (AML).",
    "llama-2-7b-chat-hf_fact_raw": "1. TOPAZ1 is a gene.\n2. TOPAZ1 has been associated with cancer.\n3. TOPAZ1 is specifically linked with the development of acute myeloid leukemia (AML).",
    "llama-2-7b-chat-hf_fact": [
      "TOPAZ1 is a gene.",
      "TOPAZ1 has been associated with cancer.",
      "TOPAZ1 is specifically linked with the development of acute myeloid leukemia (AML)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: There is no widely recognized gene named TOPAZ1. The closest match could be TOP1, which stands for topoisomerase (DNA) I, a known gene relevant to cancer research. However, without further context, the claim about TOPAZ1 cannot be validated.\n2. UNKNOWN: Without correct identification of the gene in question, it's unclear whether it is associated with cancer. However, if TOPAZ1 was a misspelling or misunderstanding for TOP1, then it could be considered true since TOP1 has been associated with cancer.\n3. UNKNOWN: The link between the gene mentioned as TOPAZ1 and acute myeloid leukemia (AML) cannot be determined. If it's referring to TOP1 and there is evidence of such a link, then it might be true. However, that specific association would need to be verified with reliable scientific literature.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-2-7b-chat-hf_response": "The gene that controls the expression of GATA-1 isoforms is the GATA-1 gene itself. GATA-1 is a transcription factor that is involved in the regulation of gene expression in hematopoietic cells, and it exists in multiple isoforms, each with distinct functions. The expression of these isoforms is controlled by various factors, including the GATA-1 gene itself, and the expression of other transcription factors and regulatory elements.",
    "llama-2-7b-chat-hf_fact_raw": "1. The GATA-1 gene controls the expression of its own isoforms.\n2. GATA-1 is a transcription factor involved in the regulation of gene expression in hematopoietic cells.\n3. GATA-1 exists in multiple isoforms with distinct functions.",
    "llama-2-7b-chat-hf_fact": [
      "The GATA-1 gene controls the expression of its own isoforms.",
      "GATA-1 is a transcription factor involved in the regulation of gene expression in hematopoietic cells.",
      "GATA-1 exists in multiple isoforms with distinct functions."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-2-7b-chat-hf_response": "MIRA-seq is a sequencing-based method used to identify and characterize the regulatory elements in a genome, particularly those involved in the regulation of gene expression. The term \"MIRA\" stands for \"Microarray-based Identification of Regulatory Elements.\"",
    "llama-2-7b-chat-hf_fact_raw": "1. MIRA-seq is a method used in genomics.\n2. MIRA-seq is used to identify and characterize regulatory elements in a genome.\n3. MIRA-seq focuses on elements involved in the regulation of gene expression.\n4. MIRA stands for \"Microarray-based Identification of Regulatory Elements.\"",
    "llama-2-7b-chat-hf_fact": [
      "MIRA-seq is a method used in genomics.",
      "MIRA-seq is used to identify and characterize regulatory elements in a genome.",
      "MIRA-seq focuses on elements involved in the regulation of gene expression.",
      "MIRA stands for \"Microarray-based Identification of Regulatory Elements.\""
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: MIRA stands for \"Methylated CpG Island Recovery Assay.\"",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-2-7b-chat-hf_response": "ARCALYST is indicated for the treatment of cryopyrin-associated periodic syndrome (CAPS) in adults and pediatric patients aged 12 years and older.",
    "llama-2-7b-chat-hf_fact_raw": "1. ARCALYST is a treatment for cryopyrin-associated periodic syndrome (CAPS).\n2. ARCALYST is indicated for use in adults.\n3. ARCALYST is also indicated for use in pediatric patients aged 12 years and older.",
    "llama-2-7b-chat-hf_fact": [
      "ARCALYST is a treatment for cryopyrin-associated periodic syndrome (CAPS).",
      "ARCALYST is indicated for use in adults.",
      "ARCALYST is also indicated for use in pediatric patients aged 12 years and older."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ARCALYST is indicated for use in pediatric patients aged 4 years and older.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-2-7b-chat-hf_response": "The human acrocentric chromosomes that are involved in Robertsonian translocation are chromosomes 13, 14, 15, and 21. These chromosomes are designated as acrocentric because they have a short arm that is much smaller than their long arm, and they are typically involved in translocations that result in a change in the number or structure of the chromosomes.",
    "llama-2-7b-chat-hf_fact_raw": "1. Chromosomes 13, 14, 15, and 21 are involved in Robertsonian translocation.\n2. Human acrocentric chromosomes have a short arm that is much smaller than their long arm.\n3. Robertsonian translocation results in a change in the number or structure of chromosomes.",
    "llama-2-7b-chat-hf_fact": [
      "Chromosomes 13, 14, 15, and 21 are involved in Robertsonian translocation.",
      "Human acrocentric chromosomes have a short arm that is much smaller than their long arm.",
      "Robertsonian translocation results in a change in the number or structure of chromosomes."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-2-7b-chat-hf_response": "The R package \"brainTumor\" has been developed for the identification of pediatric brain tumors.",
    "llama-2-7b-chat-hf_fact_raw": "1. The R package \"brainTumor\" is developed for the identification of pediatric brain tumors.",
    "llama-2-7b-chat-hf_fact": [
      "The R package \"brainTumor\" is developed for the identification of pediatric brain tumors."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nI cannot verify the statement as no specific \"brainTumor\" R package details are provided, and to the best of my knowledge, there is no widely recognized R package specifically named \"brainTumor\" developed for the identification of pediatric brain tumors as of my last update in 2023. Without additional details or updates, the existence and purpose of such a package cannot be confirmed.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-2-7b-chat-hf_response": "Yes, NEMO (Nuclear Envelope-Associated Protein 1, also known as IκBα) is a zinc finger protein.",
    "llama-2-7b-chat-hf_fact_raw": "1. NEMO is also known as Nuclear Envelope-Associated Protein 1.\n2. NEMO is a zinc finger protein.",
    "llama-2-7b-chat-hf_fact": [
      "NEMO is also known as Nuclear Envelope-Associated Protein 1.",
      "NEMO is a zinc finger protein."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: NEMO (NF-kappa-B essential modulator) is not classified as a zinc finger protein; it is involved with the regulation of the NF-kappa-B pathway, which is crucial for immune response. Zinc finger proteins are a different family of proteins characterized by their use of zinc ions to stabilize their folds.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-2-7b-chat-hf_response": "Yes, TFIIS (Transcription Factor IIS) can affect nucleosome positioning. TFIIS is a transcription factor that plays a role in the initiation of transcription in eukaryotic cells, and it has been shown to influence the positioning of nucleosomes on the DNA. Specifically, TFIIS has been shown to displace nucleosomes from the promoter region of actively transcribed genes, allowing RNA polymerase to access the DNA and initiate transcription.",
    "llama-2-7b-chat-hf_fact_raw": "1. TFIIS can affect nucleosome positioning.\n2. TFIIS is a transcription factor that plays a role in the initiation of transcription in eukaryotic cells.\n3. TFIIS has been shown to displace nucleosomes from the promoter region of actively transcribed genes.\n4. The displacement of nucleosomes by TFIIS allows RNA polymerase to access the DNA to initiate transcription.",
    "llama-2-7b-chat-hf_fact": [
      "TFIIS can affect nucleosome positioning.",
      "TFIIS is a transcription factor that plays a role in the initiation of transcription in eukaryotic cells.",
      "TFIIS has been shown to displace nucleosomes from the promoter region of actively transcribed genes.",
      "The displacement of nucleosomes by TFIIS allows RNA polymerase to access the DNA to initiate transcription."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: TFIIS is not a transcription factor that directly plays a role in the initiation of transcription, it is a transcription elongation factor that helps RNA polymerase II overcome blocks to transcription elongation.\n3. UNKNOWN (While TFIIS can influence transcription elongation and indirectly affect nucleosome positioning, there is not enough context provided to confirm this specific statement.)\n4. UNKNOWN (This statement is proposing a specific mechanism by which TFIIS might affect transcription initiation by displacing nucleosomes, but without additional context it is not possible to confirm the accuracy of the mechanism described.)",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-2-7b-chat-hf_response": "Origins of replication close to yeast centromeres fire late.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-2-7b-chat-hf_response": "Mammalian GA-sequences are characterized by the following properties:\n1. High conservation: GA-sequences are highly conserved across different mammalian species, indicating their importance in the regulation of gene expression.\n2. Short length: GA-sequences are typically short, ranging from 10 to 20 nucleotides in length.\n3. A/T-rich: GA-sequences are rich in A/T base pairs, which are less flexible than G/C base pairs and may contribute to their specificity in protein-DNA interactions.\n4. High affinity for histone H3 lysine 4 trimethylation: GA-sequences have been shown to be enriched in histone H3 lysine 4 trimethylation (H3K4me3), which is a mark of active gene transcription.\n5. Enhancer-like activity: GA-sequences have been shown to act as enhancers, binding to transcription factors and other proteins to regulate gene expression.\n6. Repression of gene expression: GA-sequences can also repress gene expression by blocking the binding of transcription factors to their target sites.\n7. Tissue-specific expression: GA-sequences are tissue-specific, with different sequences being enriched in specific tissues or cell types.\n8. Developmental stage-specific expression: GA-sequences are also developmental stage-specific, with different sequences being expressed at different stages of development.\n9. Regulation of stem cell self-renewal: GA-sequences have been implicated in the regulation of stem cell self-renewal and differentiation.\n10. Cancer-associated mutations: GA-sequences have been found to be mutated in various types of cancer, suggesting a role in cancer development and progression.",
    "llama-2-7b-chat-hf_fact_raw": "1. GA-sequences are highly conserved across different mammalian species.\n2. GA-sequences range from 10 to 20 nucleotides in length.\n3. GA-sequences are rich in A/T base pairs.\n4. GA-sequences are enriched in histone H3 lysine 4 trimethylation (H3K4me3).\n5. GA-sequences can act as enhancers and have been shown to regulate gene expression.",
    "llama-2-7b-chat-hf_fact": [
      "GA-sequences are highly conserved across different mammalian species.",
      "GA-sequences range from 10 to 20 nucleotides in length.",
      "GA-sequences are rich in A/T base pairs.",
      "GA-sequences are enriched in histone H3 lysine 4 trimethylation (H3K4me3).",
      "GA-sequences can act as enhancers and have been shown to regulate gene expression."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN: There is not enough context to determine whether GA-sequences are highly conserved across different mammalian species. \"GA-sequences\" is a vague term and could refer to a specific type of sequence pattern that is either well-conserved or not, depending on the exact sequences in question.\n2. FALSE [correction]: Without specific context, we cannot accurately determine the length of \"GA-sequences\" as this term is not standard and could refer to various different kinds of sequences.\n3. TRUE: Generally, GA-sequences would be considered rich in adenine (A) and thymine (T) base pairs, as these are the bases represented by the letters \"A\" and \"T\".\n4. UNKNOWN: Without context, we cannot determine if GA-sequences are specifically enriched in histone H3 lysine 4 trimethylation (H3K4me3), as this is a specific type of epigenetic mark that may or may not be associated with any given DNA sequence.\n5. UNKNOWN: Whether GA-sequences can act as enhancers and regulate gene expression would depend on the specific sequences and context. Enhancers are regulatory DNA sequences that can increase the transcription of genes, but without specific information, we cannot confirm this statement.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-2-7b-chat-hf_response": "There are 7 Groucho-related genes (GRG) contained in the mouse genome.",
    "llama-2-7b-chat-hf_fact_raw": "1. The mouse genome contains 7 Groucho-related genes (GRG).",
    "llama-2-7b-chat-hf_fact": [
      "The mouse genome contains 7 Groucho-related genes (GRG)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-2-7b-chat-hf_response": "RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) carries RNA cleavage activity.",
    "llama-2-7b-chat-hf_fact_raw": "1. The RNA polymerase II subunit RPB1 carries RNA cleavage activity.",
    "llama-2-7b-chat-hf_fact": [
      "The RNA polymerase II subunit RPB1 carries RNA cleavage activity."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The RNA polymerase II subunit RPB1 does not carry RNA cleavage activity. RNA cleavage activity during transcription is typically associated with specific cleavage and polyadenylation factors, not with the RNA polymerase II complex itself. The RNA polymerase II enzyme is responsible for synthesizing RNA from a DNA template.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-2-7b-chat-hf_response": "Ohdo syndrome is caused by mutations in the gene encoding the protein MAPRE1.",
    "llama-2-7b-chat-hf_fact_raw": "1. Ohdo syndrome is caused by mutations in the gene. \n2. The gene involved in Ohdo syndrome encodes the protein MAPRE1.",
    "llama-2-7b-chat-hf_fact": [
      "Ohdo syndrome is caused by mutations in the gene.",
      "The gene involved in Ohdo syndrome encodes the protein MAPRE1."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The gene involved in Ohdo syndrome, SALL1, encodes the protein spalt-like transcription factor 1.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-2-7b-chat-hf_response": "The R/Bioconductor package developed for the analysis of psychiatric disease genes is called \"PsychGen\".",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-2-7b-chat-hf_response": "The swirl sign is a radiologic sign that is often seen in patients with intracerebral hemorrhage (ICH). It is characterized by a spiral or swirling pattern of blood within the hemisphere, typically in the setting of a subarachnoid hemorrhage.\nThe swirl sign is caused by the rotation of the blood within the hemisphere due to the movement of the brain during the hemorrhage. This rotation creates a spiral or swirling pattern of blood that can be seen on a CT or MRI scan. The sign is thought to be more pronounced in patients with a larger hemorrhage and may be more visible on T2-weighted MRI sequences.\nThe swirl sign is often used as a marker of the severity of the hemorrhage and can be an indicator of the risk of further neurological deterioration. It is also used to monitor the response to treatment and to predict the likelihood of a favorable outcome.\nIt is important to note that the swirl sign is not specific to ICH and can also be seen in other conditions such as subdural hematoma or cerebral edema. Therefore, it is important to interpret the sign in the context of the patient's clinical presentation and other diagnostic findings.",
    "llama-2-7b-chat-hf_fact_raw": "1. The swirl sign is a radiologic sign often seen in patients with intracerebral hemorrhage (ICH).\n2. It is characterized by a spiral or swirling pattern of blood within the brain hemisphere.\n3. The swirl sign can be seen on CT or MRI scans.\n4. The sign is thought to be more pronounced in patients with a larger hemorrhage.\n5. The swirl sign can also be seen in conditions such as subdural hematoma or cerebral edema.",
    "llama-2-7b-chat-hf_fact": [
      "The swirl sign is a radiologic sign often seen in patients with intracerebral hemorrhage (ICH).",
      "It is characterized by a spiral or swirling pattern of blood within the brain hemisphere.",
      "The swirl sign can be seen on CT or MRI scans.",
      "The sign is thought to be more pronounced in patients with a larger hemorrhage.",
      "The swirl sign can also be seen in conditions such as subdural hematoma or cerebral edema."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The swirl sign is characterized by a mix of hypoattenuating and hyperattenuating areas within a hematoma, suggesting active bleeding, not necessarily a spiral or swirling pattern of blood.\n3. TRUE\n4. UNKNOWN: The relationship between the swirl sign's pronounced appearance and the size of the hemorrhage would depend on various factors and is not an established fact; thus, this statement is difficult to conclusively determine as true or false without specific context or sources.\n5. FALSE [correction]: The swirl sign is specifically associated with intracerebral hemorrhage (ICH) due to active bleeding within the hematoma and is not typically used to describe findings in conditions such as subdural hematoma or cerebral edema.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-2-7b-chat-hf_response": "Arabidopsis ROF1 expression is induced by various factors, including:\n1. Abiotic stressors: ROF1 expression is increased in response to abiotic stressors such as drought, salt, and high temperature.\n2. Hormonal regulation: ROF1 expression is regulated by plant hormones, including ethylene, auxin, and cytokinin.\n3. Developmental cues: ROF1 expression is developmentally regulated, with higher expression levels in young tissues and during the reproductive phase.\n4. Pathogen infection: ROF1 expression is induced in response to infection by certain pathogens, such as the bacterial pathogen Pseudomonas syringae.\n5. Signaling pathways: ROF1 expression can be induced by signaling pathways, such as the MAPK and JA signaling pathways, which are activated in response to various stimuli, including stress and pathogen infection.",
    "llama-2-7b-chat-hf_fact_raw": "1. Abiotic stressors such as drought, salt, and high temperature can induce Arabidopsis ROF1 expression.\n2. Plant hormones including ethylene, auxin, and cytokinin regulate the expression of Arabidopsis ROF1.\n3. Arabidopsis ROF1 expression is higher in young tissues and during the reproductive phase, indicating developmental regulation.\n4. Infection by certain pathogens, like the bacterial pathogen Pseudomonas syringae, can induce Arabidopsis ROF1 expression.\n5. Signaling pathways such as the MAPK and JA signaling pathways can induce Arabidopsis ROF1 expression.",
    "llama-2-7b-chat-hf_fact": [
      "Abiotic stressors such as drought, salt, and high temperature can induce Arabidopsis ROF1 expression.",
      "Plant hormones including ethylene, auxin, and cytokinin regulate the expression of Arabidopsis ROF1.",
      "Arabidopsis ROF1 expression is higher in young tissues and during the reproductive phase, indicating developmental regulation.",
      "Infection by certain pathogens, like the bacterial pathogen Pseudomonas syringae, can induce Arabidopsis ROF1 expression.",
      "Signaling pathways such as the MAPK and JA signaling pathways can induce Arabidopsis ROF1 expression."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with general knowledge of plant biology and stress responses in plants, including Arabidopsis thaliana (commonly studied as a model organism). Each of the statements relates to known factors that affect the expression of stress-related genes - abiotic stress, hormone signaling, developmental stages, pathogen infection, and signaling pathways (MAPK and JA represent mitogen-activated protein kinase and jasmonic acid signaling, respectively). However, without specific experimental data or references to confirm these claims for the particular gene mentioned, 'ROF1', these are assumed to be true based on general patterns observed within the field of plant science. If experimental evidence specific to Arabidopsis ROF1 contradicts these statements, the responses would change accordingly.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-2-7b-chat-hf_response": "The most common protein associated with hereditary renal amyloidosis is alpha-2-macroglobulin (A2M).",
    "llama-2-7b-chat-hf_fact_raw": "1. Alpha-2-macroglobulin (A2M) is the protein most commonly associated with hereditary renal amyloidosis.",
    "llama-2-7b-chat-hf_fact": [
      "Alpha-2-macroglobulin (A2M) is the protein most commonly associated with hereditary renal amyloidosis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Transthyretin (TTR) is the protein most commonly associated with hereditary renal amyloidosis, not alpha-2-macroglobulin (A2M). A2M is a proteinase inhibitor and not typically associated with hereditary renal amyloidosis.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-2-7b-chat-hf_response": "Yes, the proteome of the mouse hippocampus has been analyzed.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-2-7b-chat-hf_response": "Yes, mouse chromosomes are acrocentric. Acrocentric chromosomes are characterized by a short arm that is much smaller than the long arm, and mouse chromosomes are a classic example of this type of chromosome structure.",
    "llama-2-7b-chat-hf_fact_raw": "1. Mouse chromosomes are acrocentric.\n2. Acrocentric chromosomes have a short arm that is much smaller than the long arm.",
    "llama-2-7b-chat-hf_fact": [
      "Mouse chromosomes are acrocentric.",
      "Acrocentric chromosomes have a short arm that is much smaller than the long arm."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-2-7b-chat-hf_response": "The siRNA-based drug in clinical trials for the treatment of pancreatic cancer is ONC201.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-2-7b-chat-hf_response": "The HPG (Hydrogen Peroxide-Gap Junction) pore is a type of ion channel that is found in the plasma membrane of certain cells, including neurons and muscle cells. The HPG pore is a small, non-selective ion channel that allows the passage of small molecules, including hydrogen peroxide (H2O2), calcium ions (Ca2+), and other signaling molecules.\nThe HPG pore is named after its ability to allow the passage of hydrogen peroxide, which is a signaling molecule that plays a role in a variety of cellular processes, including cell signaling, inflammation, and oxidative stress. The HPG pore is also known as the \"gap junction pore\" because it forms a direct connection between adjacent cells, allowing the passage of ions and small molecules between them.\nThe HPG pore is important for a variety of physiological processes, including the regulation of muscle contraction, the control of heart rate, and the coordination of neural activity. Dysfunction of the HPG pore has been implicated in a variety of diseases, including muscle disorders, neurological disorders, and cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. The HPG pore is found in the plasma membrane of certain cells, such as neurons and muscle cells.\n2. The HPG pore allows the passage of small molecules including hydrogen peroxide, calcium ions, and other signaling molecules.\n3. Hydrogen peroxide's passage through the HPG pore plays a role in cellular processes like cell signaling, inflammation, and oxidative stress.\n4. The HPG pore forms a direct connection between adjacent cells, which is why it is also called the \"gap junction pore.\"\n5. Dysfunctions of the HPG pore have been implicated in diseases such as muscle disorders, neurological disorders, and cancer.",
    "llama-2-7b-chat-hf_fact": [
      "The HPG pore is found in the plasma membrane of certain cells, such as neurons and muscle cells.",
      "The HPG pore allows the passage of small molecules including hydrogen peroxide, calcium ions, and other signaling molecules.",
      "Hydrogen peroxide's passage through the HPG pore plays a role in cellular processes like cell signaling, inflammation, and oxidative stress.",
      "The HPG pore forms a direct connection between adjacent cells, which is why it is also called the \"gap junction pore.\"",
      "Dysfunctions of the HPG pore have been implicated in diseases such as muscle disorders, neurological disorders, and cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. FALSE [correction]: The term \"HPG pore\" is not standard terminology for cell biology. It might be a confusion with \"gap junctions.\" Gap junctions, not \"HPG pores,\" form direct connections between adjacent cells that allow the passage of ions and small signaling molecules.\n5. UNKNOWN\n\nThe term \"HPG pore\" is not a recognized term in cellular biology. If by \"HPG pore\" it is meant to describe a type of cellular structure such as ion channels or pores, the statements would require specific correct terminology to accurately assess their validity. For instance, hydrogen peroxide can pass through certain channels in cell membranes, and dysfunctions in cellular structures similar to what might be suggested by \"HPG pore\" are implicated in various diseases. However, without the correct terminology or more context, it's challenging to provide accurate answers.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-2-7b-chat-hf_response": "The 959 Nematode Genomes initiative is a large-scale effort to sequence the genomes of 959 species of nematodes, which are a group of microscopic worms that are found in a wide range of environments, including soil, plants, and animals. The goal of the initiative is to generate a comprehensive understanding of the evolution, diversity, and function of nematodes, and to identify new targets for pest management and drug discovery. The initiative is being led by the University of California, Davis, in collaboration with other institutions around the world.",
    "llama-2-7b-chat-hf_fact_raw": "1. The 959 Nematode Genomes initiative aims to sequence the genomes of 959 species of nematodes.\n2. Nematodes, targeted by the initiative, are microscopic worms found in environments like soil, plants, and animals.\n3. The initiative's goals include understanding nematode evolution, diversity, and function.\n4. The initiative intends to identify new targets for pest management and drug discovery.\n5. The University of California, Davis is leading the initiative, in collaboration with other global institutions.",
    "llama-2-7b-chat-hf_fact": [
      "The 959 Nematode Genomes initiative aims to sequence the genomes of 959 species of nematodes.",
      "Nematodes, targeted by the initiative, are microscopic worms found in environments like soil, plants, and animals.",
      "The initiative's goals include understanding nematode evolution, diversity, and function.",
      "The initiative intends to identify new targets for pest management and drug discovery.",
      "The University of California, Davis is leading the initiative, in collaboration with other global institutions."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-2-7b-chat-hf_response": "The R package \"NIPT\" has been developed specifically for analyzing Non-invasive prenatal testing (NIPT) data.",
    "llama-2-7b-chat-hf_fact_raw": "1. The R package named \"NIPT\" is developed for analyzing Non-invasive prenatal testing data.",
    "llama-2-7b-chat-hf_fact": [
      "The R package named \"NIPT\" is developed for analyzing Non-invasive prenatal testing data."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\n[Note: Unless provided with specific and current information about the existence and purpose of the R package \"NIPT,\" the truth of this statement cannot be ascertained. While it is plausible that an R package called \"NIPT\" could exist for this purpose, without further details or a reliable source, the statement's accuracy remains unknown.]",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "llama-2-7b-chat-hf_response": "Achenbach's syndrome is a rare medical condition characterized by the association of two distinct clinical features:\n1. Hyperhidrosis (excessive sweating): Achenbach's patients experience excessive sweating, particularly on the palms of the hands and soles of the feet, which can be severe and debilitating.\n2. Erythromelalgia (redness and warmth of the skin): The skin of the affected areas, typically the hands and feet, becomes red and warm to the touch, often accompanied by a burning sensation.\nAchenbach's syndrome is believed to be caused by a dysfunction in the nervous system, specifically in the pathways that control sweating and temperature regulation. The exact cause is still unknown, but it is thought to involve a combination of genetic and environmental factors. There is currently no cure for Achenbach's syndrome, and treatment is focused on managing the symptoms.",
    "llama-2-7b-chat-hf_fact_raw": "1. Achenbach's syndrome is characterized by hyperhidrosis, specifically on the palms of the hands and soles of the feet.\n2. Patients with Achenbach's syndrome experience erythromelalgia, which involves redness and warmth of the skin, often with a burning sensation.\n3. Affecting typically the hands and feet, the skin becomes red and warm to the touch in Achenbach's syndrome.\n4. Achenbach's syndrome is believed to be caused by a dysfunction in the nervous system related to sweating and temperature regulation.\n5. There is no known cure for Achenbach's syndrome, and treatment aims at managing symptoms.",
    "llama-2-7b-chat-hf_fact": [
      "Achenbach's syndrome is characterized by hyperhidrosis, specifically on the palms of the hands and soles of the feet.",
      "Patients with Achenbach's syndrome experience erythromelalgia, which involves redness and warmth of the skin, often with a burning sensation.",
      "Affecting typically the hands and feet, the skin becomes red and warm to the touch in Achenbach's syndrome.",
      "Achenbach's syndrome is believed to be caused by a dysfunction in the nervous system related to sweating and temperature regulation.",
      "There is no known cure for Achenbach's syndrome, and treatment aims at managing symptoms."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is characterized by spontaneous bruising in the hands or fingers. Hyperhidrosis is not a characteristic of this syndrome.\n2. FALSE [correction]: Erythromelalgia is a different condition that involves redness and warmth of the skin, often with a burning sensation, but it is not related to Achenbach's syndrome, which involves bruising.\n3. TRUE (with clarification): Affecting typically the hands, Achenbach's syndrome includes sudden bruising, although it is not specified as red and warm to the touch in the definition of the syndrome.\n4. FALSE [correction]: The exact cause of Achenbach's syndrome is not well understood, but it is not typically described as being related to dysfunction in the nervous system specifically concerning sweating and temperature regulation.\n5. TRUE (with clarification): There is no known cure for Achenbach's syndrome, and treatment is generally supportive, focusing on managing any discomfort and reassuring patients due to the benign nature of the syndrome.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-2-7b-chat-hf_response": "The algorithm used for detection of long repeat expansions is called Long Repeat Finder (LRF).",
    "llama-2-7b-chat-hf_fact_raw": "1. The Long Repeat Finder (LRF) algorithm is used for detection of long repeat expansions.",
    "llama-2-7b-chat-hf_fact": [
      "The Long Repeat Finder (LRF) algorithm is used for detection of long repeat expansions."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-2-7b-chat-hf_response": "Neuroligin-3 has been shown to promote the growth and proliferation of certain types of brain tumors, including:\n* Medulloblastoma: A type of pediatric brain cancer that originates in the cerebellum.\n* Glioblastoma: The most common and aggressive form of brain cancer in adults.\n* Brain stem glioma: A type of brain cancer that originates in the brain stem.\nIt is important to note that the exact mechanisms by which neuroligin-3 promotes the growth and proliferation of these tumors are not yet fully understood, and more research is needed to determine the specific ways in which it contributes to the development and progression of these diseases.",
    "llama-2-7b-chat-hf_fact_raw": "1. Neuroligin-3 promotes the growth and proliferation of medulloblastoma, which is a pediatric brain cancer.\n2. Neuroligin-3 also promotes the growth and proliferation of glioblastoma, the most common and aggressive form of brain cancer in adults.\n3. Neuroligin-3 is associated with the promotion of brain stem glioma, a type of brain cancer originating in the brain stem.\n4. Medulloblastoma originates in the cerebellum.\n5. The exact mechanisms by which neuroligin-3 promotes tumor growth are not yet fully understood.",
    "llama-2-7b-chat-hf_fact": [
      "Neuroligin-3 promotes the growth and proliferation of medulloblastoma, which is a pediatric brain cancer.",
      "Neuroligin-3 also promotes the growth and proliferation of glioblastoma, the most common and aggressive form of brain cancer in adults.",
      "Neuroligin-3 is associated with the promotion of brain stem glioma, a type of brain cancer originating in the brain stem.",
      "Medulloblastoma originates in the cerebellum.",
      "The exact mechanisms by which neuroligin-3 promotes tumor growth are not yet fully understood."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: Neuroligin-3 has been indicated in research to promote the growth and proliferation of medulloblastoma, which is indeed a type of pediatric brain cancer.\n2. TRUE: Studies have shown that neuroligin-3 can also promote the growth and proliferation of glioblastoma, which is the most common and aggressive form of brain cancer in adults.\n3. UNKNOWN: The statement does not provide sufficient context to verify the specific role of neuroligin-3 in brain stem glioma. Research is ongoing, and the relationship between neuroligin-3 and various types of brain cancers including brain stem glioma can be complex.\n4. TRUE: Medulloblastoma indeed originates in the cerebellum, the part of the brain that is located at the back of the skull.\n5. TRUE: It is acknowledged in the scientific community that while some roles of neuroligin-3 in tumor growth have been identified, the exact mechanisms are complex and not yet fully understood.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-2-7b-chat-hf_response": "Gas vesicles in Mycobacterium tuberculosis are approximately 5-10 nanometers in diameter.",
    "llama-2-7b-chat-hf_fact_raw": "1. Gas vesicles in Mycobacterium tuberculosis have a diameter of approximately 5-10 nanometers.",
    "llama-2-7b-chat-hf_fact": [
      "Gas vesicles in Mycobacterium tuberculosis have a diameter of approximately 5-10 nanometers."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\n[Note: While Mycobacterium tuberculosis is a well-known bacterium causing tuberculosis, standard scientific literature does not commonly recognize gas vesicles as a feature of this bacterium. Gas vesicles are more typically associated with aquatic, photosynthetic organisms and some halophilic archaea. Without specific literature or context confirming the statement about gas vesicles in M. tuberculosis, the truth of this statement cannot be ascertained.]",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-2-7b-chat-hf_response": "There are three BET (Bromodomain and Extra-Terminal) proteins:\n1. BRD2 (Bromodomain-Containing Protein 2)\n2. BRD3 (Bromodomain-Containing Protein 3)\n3. BRDT (Bromodomain-Containing Protein T)\nThese proteins are involved in regulating gene expression by recognizing and binding to acetylated histone proteins, and play a role in various cellular processes including cell proliferation, differentiation, and survival.",
    "llama-2-7b-chat-hf_fact_raw": "1. BRD2 is known as Bromodomain-Containing Protein 2.\n2. BRD3 is known as Bromodomain-Containing Protein 3.\n3. BRDT is known as Bromodomain-Containing Protein T.\n4. BET proteins are involved in regulating gene expression by recognizing and binding to acetylated histone proteins.\n5. BET proteins play a role in cellular processes such as cell proliferation, differentiation, and survival.",
    "llama-2-7b-chat-hf_fact": [
      "BRD2 is known as Bromodomain-Containing Protein 2.",
      "BRD3 is known as Bromodomain-Containing Protein 3.",
      "BRDT is known as Bromodomain-Containing Protein T.",
      "BET proteins are involved in regulating gene expression by recognizing and binding to acetylated histone proteins.",
      "BET proteins play a role in cellular processes such as cell proliferation, differentiation, and survival."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: BRDT is known as Bromodomain Testis-Specific Protein.\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-2-7b-chat-hf_response": "The algorithm developed for prediction of protein subcellular localization using deep learning is called DeepLoc.",
    "llama-2-7b-chat-hf_fact_raw": "1. DeepLoc is an algorithm developed for prediction of protein subcellular localization. \n2. DeepLoc utilizes deep learning techniques.",
    "llama-2-7b-chat-hf_fact": [
      "DeepLoc is an algorithm developed for prediction of protein subcellular localization.",
      "DeepLoc utilizes deep learning techniques."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-2-7b-chat-hf_response": "I apologize, but I'm not familiar with the term \"MULTOVL\". Could you please provide more context or information about what MULTOVL is?",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-2-7b-chat-hf_response": "Yes, GDF15 can be used as a biomarker for metformin treatment.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-2-7b-chat-hf_response": "Yes, recursive splicing is more common in short introns.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-2-7b-chat-hf_response": "TALE-iD is a method used for identifying the functional elements in the genome, such as enhancers, silencers, and promoters, by mapping the interactions between transcription factors and their target DNA sequences.",
    "llama-2-7b-chat-hf_fact_raw": "1. TALE-iD is a method used for identifying functional elements in the genome.\n2. The functional elements identified by TALE-iD include enhancers, silencers, and promoters.\n3. TALE-iD maps the interactions between transcription factors and their target DNA sequences.",
    "llama-2-7b-chat-hf_fact": [
      "TALE-iD is a method used for identifying functional elements in the genome.",
      "The functional elements identified by TALE-iD include enhancers, silencers, and promoters.",
      "TALE-iD maps the interactions between transcription factors and their target DNA sequences."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: TALE-iD stands for \"transcription activator-like effector nuclease-mediated chromatin immunoprecipitation (ChIP)-seq,\" which is a technique that combines the DNA-binding specificity of TALENs with ChIP-seq to identify the binding sites of transcription factors. It does not directly map interactions between transcription factors and their target DNA sequences; rather, it identifies the binding sites which are indicative of potential interactions.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-2-7b-chat-hf_response": "One Lisp framework that has been developed for image processing is CL-Imaging.",
    "llama-2-7b-chat-hf_fact_raw": "1. CL-Imaging is a Lisp framework developed for image processing.",
    "llama-2-7b-chat-hf_fact": [
      "CL-Imaging is a Lisp framework developed for image processing."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-2-7b-chat-hf_response": "Approximately 800 genes in S. cerevisiae are the result of an ancient whole genome duplication.",
    "llama-2-7b-chat-hf_fact_raw": "1. Approximately 800 genes in S. cerevisiae are the result of an ancient whole genome duplication.",
    "llama-2-7b-chat-hf_fact": [
      "Approximately 800 genes in S. cerevisiae are the result of an ancient whole genome duplication."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "llama-2-7b-chat-hf_response": "Estrogen-related receptor β (Esrrb) is bound by the complex of estrogen and its cognate ligand.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-2-7b-chat-hf_response": "ZCCHC17, also known as zinc finger CCHC-type zinc finger protein 17, is a protein that plays a role in regulating gene expression, particularly in the context of stem cells and development. It is involved in the maintenance of pluripotency and self-renewal of stem cells, and has been implicated in the regulation of cell fate decisions and differentiation.",
    "llama-2-7b-chat-hf_fact_raw": "1. ZCCHC17 is a protein.\n2. ZCCHC17 plays a role in regulating gene expression.\n3. ZCCHC17 is involved in the maintenance of pluripotency and self-renewal of stem cells.\n4. ZCCHC17 has been implicated in the regulation of cell fate decisions and differentiation.",
    "llama-2-7b-chat-hf_fact": [
      "ZCCHC17 is a protein.",
      "ZCCHC17 plays a role in regulating gene expression.",
      "ZCCHC17 is involved in the maintenance of pluripotency and self-renewal of stem cells.",
      "ZCCHC17 has been implicated in the regulation of cell fate decisions and differentiation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n\nExplanation:\nZCCHC17, also known as zinc finger CCHC domain-containing protein 17, is indeed a protein. It is known to be involved in RNA binding and has a role in the regulation of gene expression, often linked with mRNA processing or stability. The specifics of its functions in pluripotency, stem cell self-renewal, cell fate decisions, and differentiation are less commonly discussed and require detailed scientific research references to confirm. Without specific context or citations, it is difficult to confirm the third and fourth statements, which are more detailed and would require specialist knowledge or current research data to verify.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-2-7b-chat-hf_response": "The proteins that form the nuclear pore basket in human cells are called nucleoporins.",
    "llama-2-7b-chat-hf_fact_raw": "1. Nucleoporins are the proteins that form the nuclear pore basket in human cells.",
    "llama-2-7b-chat-hf_fact": [
      "Nucleoporins are the proteins that form the nuclear pore basket in human cells."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Nucleoporins are the proteins that comprise the nuclear pore complex, which includes but is not limited to the nuclear pore basket in human cells. They play a role in the transport of molecules across the nuclear envelope.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-2-7b-chat-hf_response": "Gepotidacin is a topoisomerase II inhibitor.",
    "llama-2-7b-chat-hf_fact_raw": "1. Gepotidacin is a topoisomerase II inhibitor.",
    "llama-2-7b-chat-hf_fact": [
      "Gepotidacin is a topoisomerase II inhibitor."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Gepotidacin is a topoisomerase inhibitor, but it specifically targets bacterial type II topoisomerases known as DNA gyrase and topoisomerase IV, not human topoisomerase II.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-2-7b-chat-hf_response": "Canvas SPW (Semiconductor Process Window) is a software tool used in the semiconductor industry for process window management. It is designed to help manufacturers optimize their manufacturing processes by identifying and controlling the parameters that impact the yield and quality of their products.\nCanvas SPW provides a comprehensive view of the manufacturing process, allowing users to visualize and analyze the various steps involved in the production of semiconductors. It uses advanced algorithms and machine learning techniques to identify patterns and trends in the data, and to make predictions about future performance.\nSome of the key features of Canvas SPW include:\n1. Process monitoring: Canvas SPW provides real-time monitoring of the manufacturing process, allowing users to track the performance of their equipment and materials.\n2. Data analysis: The tool uses advanced data analysis techniques to identify patterns and trends in the data, and to make predictions about future performance.\n3. Yield prediction: Canvas SPW can predict the yield of the production process, allowing manufacturers to identify potential issues before they occur.\n4. Process optimization: The tool provides recommendations for optimizing the manufacturing process, based on the data analysis and yield predictions.\n5. Machine learning: Canvas SPW uses machine learning algorithms to learn from the data and improve its predictions over time.\n6. Integration: Canvas SPW can integrate with other software tools and systems, such as manufacturing execution systems (MES) and enterprise resource planning (ERP) systems.\nBy using Canvas SPW, manufacturers can improve the efficiency and effectiveness of their manufacturing processes, reduce costs, and increase the yield and quality of their products.",
    "llama-2-7b-chat-hf_fact_raw": "1. Canvas SPW is a software tool used for process window management in the semiconductor industry.\n2. The purpose of Canvas SPW is to optimize manufacturing processes by identifying and controlling parameters impacting yield and quality.\n3. Canvas SPW provides real-time monitoring of the semiconductor manufacturing process.\n4. The software predicts the yield of the production process and identifies potential issues before they occur.\n5. Canvas SPW incorporates machine learning algorithms to learn from data and improve its predictions over time.",
    "llama-2-7b-chat-hf_fact": [
      "Canvas SPW is a software tool used for process window management in the semiconductor industry.",
      "The purpose of Canvas SPW is to optimize manufacturing processes by identifying and controlling parameters impacting yield and quality.",
      "Canvas SPW provides real-time monitoring of the semiconductor manufacturing process.",
      "The software predicts the yield of the production process and identifies potential issues before they occur.",
      "Canvas SPW incorporates machine learning algorithms to learn from data and improve its predictions over time."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN: The validity of this statement depends on the existence of a software tool named \"Canvas SPW\" with the described function within the semiconductor industry. Without additional information, the truthfulness of this statement cannot be verified.\n2. UNKNOWN: Assuming Canvas SPW is a software tool for the semiconductor industry as previously mentioned, this statement could very well be true as optimizing manufacturing processes could be a key functionality. But without specific information about the software, this remains unconfirmed.\n3. UNKNOWN: Assuming that Canvas SPW exists and performs the stated functions, real-time monitoring could be one of its features. However, this cannot be confirmed without additional context or knowledge about Canvas SPW.\n4. UNKNOWN: Predicting yield and identifying potential issues before they occur would be a logical feature for a process window management tool, but without further data on this specific software, Canvas SPW, the truthfulness of this statement remains undetermined.\n5. UNKNOWN: Machine learning is commonly used in software to enhance predictive capabilities over time. This claim about Canvas SPW utilizing machine learning is plausible but cannot be confirmed as true or false without more information about the software itself.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-2-7b-chat-hf_response": "STING (Stimulator of Interferon Genes) is a protein that plays a crucial role in the innate immune response. STING agonists are compounds that activate STING and trigger an immune response. Here are some examples of STING agonists:\n1. Poly IC: Poly IC is a synthetic analog of DNA that activates STING and induces the production of interferons and pro-inflammatory cytokines.\n2. CpG ODN: CpG oligonucleotides are synthetic DNA molecules that contain the characteristic CpG dinucleotide motif found in bacterial DNA. They are potent STING agonists that activate the immune system and induce the production of interferons and cytokines.\n3. MMK-11: MMK-11 is a small molecule STING agonist that is being developed as a potential therapy for cancer and infectious diseases.\n4. BX795: BX795 is a STING agonist that is being developed as a potential therapy for cancer and infectious diseases.\n5. VTX-2308: VTX-2308 is a STING agonist that is being developed as a potential therapy for cancer and infectious diseases.\n6. TGN-020: TGN-020 is a STING agonist that is being developed as a potential therapy for cancer and infectious diseases.\n7. GSK'872: GSK'872 is a STING agonist that is being developed as a potential therapy for cancer and infectious diseases.\n8. BMS-986177: BMS-986177 is a STING agonist that is being developed as a potential therapy for cancer and infectious diseases.\n9. LBH-0201: LBH-0201 is a STING agonist that is being developed as a potential therapy for cancer and infectious diseases.\n10. IT-101: IT-101 is a STING agonist that is being developed as a potential therapy for cancer and inf",
    "llama-2-7b-chat-hf_fact_raw": "1. Poly IC is a synthetic analog of DNA that activates STING.\n2. CpG oligonucleotides contain the CpG dinucleotide motif and are potent STING agonists.\n3. MMK-11 is a small molecule STING agonist under development for potential therapies for cancer and infectious diseases.\n4. BX795 is a STING agonist under development for potential therapies for cancer and infectious diseases.\n5. VTX-2308 is a STING agonist under development for potential therapies for cancer and infectious diseases.",
    "llama-2-7b-chat-hf_fact": [
      "Poly IC is a synthetic analog of DNA that activates STING.",
      "CpG oligonucleotides contain the CpG dinucleotide motif and are potent STING agonists.",
      "MMK-11 is a small molecule STING agonist under development for potential therapies for cancer and infectious diseases.",
      "BX795 is a STING agonist under development for potential therapies for cancer and infectious diseases.",
      "VTX-2308 is a STING agonist under development for potential therapies for cancer and infectious diseases."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Poly IC is a synthetic analog of double-stranded RNA (dsRNA), not DNA, that can activate immune responses but is not a direct agonist of STING (Stimulator of Interferon Genes).\n2. FALSE [correction]: CpG oligonucleotides contain the CpG dinucleotide motif and are recognized by Toll-like receptor 9 (TLR9), not STING.\n3. TRUE\n4. FALSE [correction]: BX795 is not a STING agonist. It is known as a kinase inhibitor that has been shown to have indirect effects on STING pathway activation.\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-2-7b-chat-hf_response": "SLIC-CAGE (Sparse Linear Independence of Cytosine-guided CApture of Gene Expression) is a computational method used to analyze gene expression data. It is a type of non-negative matrix factorization technique that is used to identify patterns of gene expression and to understand the underlying biological processes.\nThe basic idea behind SLIC-CAGE is to represent gene expression data as a mixture of a small number of underlying patterns, or \"themes,\" and to estimate the proportion of each theme present in each sample. The themes are represented as linear combinations of a set of basis vectors, which are learned from the data using a non-negative matrix factorization technique.\nSLIC-CAGE is similar to other non-negative matrix factorization techniques, such as NMF (Non-negative Matrix Factorization) and ICA (Independent Component Analysis), but it has some key differences. For example, SLIC-CAGE uses a sparse representation of the basis vectors, which allows it to identify a smaller number of underlying themes in the data. This can be useful when dealing with high-dimensional gene expression data, where a large number of themes might not be biologically meaningful.\nSLIC-CAGE has been used to analyze a variety of gene expression data sets, including those from microarray experiments and RNA-seq experiments. It has been used to identify novel biological pathways and processes, to understand the regulation of gene expression, and to identify potential drug targets.\nThe steps involved in SLIC-CAGE are as follows:\n1. Data preprocessing: The gene expression data is preprocessed to remove any unwanted variation and to normalize the data.\n2. Sparse representation: The basis vectors are represented as a sparse linear combination of the gene expression data.\n3. Non-negative matrix factorization: The gene expression data is represented as a linear combination of the basis vectors, and the coefficients of the linear combination are estimated.\n4. Theme identification: The basis vectors are used to identify the underlying themes in the data.\n5. Theme interpretation: The identified themes are interpreted in the context of the biological process or pathway of interest.\nThe advantages of SLIC-CAGE are:\n1. Identification of novel biological themes: SLIC-CAGE can identify novel biological themes that are not apparent from other analysis methods.",
    "llama-2-7b-chat-hf_fact_raw": "1. SLIC-CAGE stands for Sparse Linear Independence of Cytosine-guided CApture of Gene Expression.\n2. SLIC-CAGE is a computational method used to analyze gene expression data.\n3. The method uses non-negative matrix factorization to identify patterns of gene expression.\n4. SLIC-CAGE operates under the principle of representing gene expression data as a mixture of a small number of underlying themes or patterns.\n5. SLIC-CAGE has been applied in the analysis of various gene expression data sets, including microarray and RNA-seq experiments.",
    "llama-2-7b-chat-hf_fact": [
      "SLIC-CAGE stands for Sparse Linear Independence of Cytosine-guided CApture of Gene Expression.",
      "SLIC-CAGE is a computational method used to analyze gene expression data.",
      "The method uses non-negative matrix factorization to identify patterns of gene expression.",
      "SLIC-CAGE operates under the principle of representing gene expression data as a mixture of a small number of underlying themes or patterns.",
      "SLIC-CAGE has been applied in the analysis of various gene expression data sets, including microarray and RNA-seq experiments."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: SLIC-CAGE is not a computational method, but rather a technology used for capturing the transcription start sites of genes.\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE\n\nThe correction for statement 2 is based on the fact that SLIC-CAGE (single-molecule linked-read capture and long-read sequencing) is a laboratory technique used for capturing and sequencing the start sites of gene transcripts, rather than being a computational method for analyzing data. The validity of statements 1, 3, and 4 cannot be judged without information on what \"SLIC-CAGE\" refers to in the context given, but the description does not match that of the known SLIC-CAGE laboratory method. Statement 5 is true if we assume SLIC-CAGE is indeed a method related to analyzing gene expression, as it has been applied to various gene expression data sets such as microarray and RNA-seq experiments.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-2-7b-chat-hf_response": "LEM-3 (Lethal giant larvae 3) is a protein that plays a role in the regulation of cellular processes, including cell signaling, cytoskeleton organization, and membrane trafficking. It is involved in the following functions:\n1. Regulation of G-protein coupled receptor (GPCR) signaling: LEM-3 regulates the activity of GPCRs, which are important for signaling pathways involved in various physiological processes, including vision, smell, and taste.\n2. Cytoskeleton organization: LEM-3 is involved in the regulation of cytoskeleton organization, particularly in the formation of the actin cytoskeleton.\n3. Membrane trafficking: LEM-3 is involved in the regulation of membrane trafficking, particularly in the transport of proteins and lipids between the endoplasmic reticulum (ER) and the Golgi apparatus.\n4. Cell adhesion and migration: LEM-3 is involved in the regulation of cell adhesion and migration, which are important for cellular processes such as wound healing and tissue development.\n5. Cancer: LEM-3 has been implicated in cancer development and progression, particularly in the regulation of GPCR signaling and cytoskeleton organization.\nOverall, LEM-3 plays a multifaceted role in cellular processes, and its dysregulation can lead to various diseases, including cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. LEM-3 is a protein that regulates cellular processes such as cell signaling and cytoskeleton organization.\n2. LEM-3 regulates the activity of G-protein coupled receptors (GPCRs), which are important for signaling pathways.\n3. LEM-3 is involved in cytoskeleton organization, particularly in the formation of the actin cytoskeleton.\n4. LEM-3 plays a role in membrane trafficking, specifically in the transport between the endoplasmic reticulum (ER) and the Golgi apparatus.\n5. LEM-3 is implicated in the development and progression of cancer.",
    "llama-2-7b-chat-hf_fact": [
      "LEM-3 is a protein that regulates cellular processes such as cell signaling and cytoskeleton organization.",
      "LEM-3 regulates the activity of G-protein coupled receptors (GPCRs), which are important for signaling pathways.",
      "LEM-3 is involved in cytoskeleton organization, particularly in the formation of the actin cytoskeleton.",
      "LEM-3 plays a role in membrane trafficking, specifically in the transport between the endoplasmic reticulum (ER) and the Golgi apparatus.",
      "LEM-3 is implicated in the development and progression of cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: LEM-3 is not specifically known to regulate the activity of G-protein coupled receptors (GPCRs); it's generally involved in maintaining genome stability and DNA repair processes.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nNote: The specificity regarding LEM-3's roles in cellular processes can be highly technical and context-dependent. The LEM domain-containing proteins are generally known for their role in chromatin organization and nuclear integrity, not necessarily for direct involvement in signaling pathways like those mediated by GPCRs. Furthermore, while it's possible that malfunction of such processes could be implicated in cancer progression, a statement about LEM-3's involvement in cancer requires specific evidence that was not provided in the context. Lastly, membrane trafficking is a broad term and without specific evidence tying LEM-3 to ER-Golgi transport, the truth of that statement remains undetermined.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-2-7b-chat-hf_response": "I'm not familiar with a software or tool called \"tmVar\". Could you please provide more context or clarify the question? I want to make sure I give you an accurate answer.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-2-7b-chat-hf_response": "There are several databases that contain information on somatic mutations in normal cells, including:\n1. The Cancer Genome Atlas (TCGA): TCGA is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) that aims to catalogue the genomic changes in various types of cancer. The database contains RNA sequencing data from thousands of normal tissues, as well as from tumors, and can be used to identify somatic mutations in normal cells.\n2. The ExAC (Exome Aggregation Consortium) database: The ExAC database is a collection of exome sequencing data from over 60,000 individuals, including both normal and cancer tissues. The database can be used to identify somatic mutations in normal cells.\n3. The GTEx (Genotype-Tissue Expression) database: GTEx is a database of genotype and expression data from over 500 tissues from normal individuals. The database can be used to identify somatic mutations in normal cells.\n4. The Roadmap Epigenomics Project: The Roadmap Epigenomics Project is a collaborative effort to map the epigenetic landscape of human tissues. The database contains epigenetic data from thousands of normal tissues, as well as from tumors, and can be used to identify somatic mutations in normal cells.\n5. The Cancer Epigenome Atlas (CEA): CEA is a database of epigenetic data from over 8,000 normal tissues and over 9,000 tumors from various cancer types. The database can be used to identify somatic mutations in normal cells.\n6. The Epigenome-Wide Association Study (EWAS): EWAS is a database of epigenetic data from thousands of normal tissues and tumors, and can be used to identify somatic mutations in normal cells.\n7. The Human Epigenome Atlas (HEA): HEA is a database of epigenetic data from thousands of normal tissues and tumors, and can be used to identify somatic mutations in normal cells.\n8. The Epigenomics of Human Disease (EHD): EHD is a database of epigenetic data from thousands of normal tissues and tumors, and can be",
    "llama-2-7b-chat-hf_fact_raw": "1. The Cancer Genome Atlas (TCGA) is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).\n2. The Exome Aggregation Consortium (ExAC) database contains exome sequencing data from over 60,000 individuals.\n3. The Genotype-Tissue Expression (GTEx) database includes genotype and expression data from over 500 tissues from normal individuals.\n4. The Roadmap Epigenomics Project is a collaborative project aimed at mapping the epigenetic landscape of human tissues.\n5. The Cancer Epigenome Atlas (CEA) contains epigenetic data from over 8,000 normal tissues and over 9,000 tumors from various cancer types.",
    "llama-2-7b-chat-hf_fact": [
      "The Cancer Genome Atlas (TCGA) is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).",
      "The Exome Aggregation Consortium (ExAC) database contains exome sequencing data from over 60,000 individuals.",
      "The Genotype-Tissue Expression (GTEx) database includes genotype and expression data from over 500 tissues from normal individuals.",
      "The Roadmap Epigenomics Project is a collaborative project aimed at mapping the epigenetic landscape of human tissues.",
      "The Cancer Epigenome Atlas (CEA) contains epigenetic data from over 8,000 normal tissues and over 9,000 tumors from various cancer types."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The GTEx database includes genotype and expression data from a range of tissues, but not over 500 tissues. As of my knowledge cutoff in 2023, GTEx includes data from up to 54 non-diseased tissue sites from nearly 1,000 individuals.\n4. TRUE\n5. FALSE [correction]: There is no well-known and recognized database specifically called \"The Cancer Epigenome Atlas (CEA)\" that fits this description. The well-known project related to cancer epigenomics would be The Cancer Genome Atlas (TCGA), which includes epigenetic data along with other types of genomic and clinical data from various cancer types, but not specifically from over 8,000 normal tissues.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-2-7b-chat-hf_response": "Yes, there are graph kernel libraries available that have been implemented in Java. Here are a few examples:\n1. JUNG (Java Universal Network/Graph): JUNG is a Java library for graph processing and visualization. It provides a comprehensive set of graph algorithms and data structures, as well as tools for graph visualization and layout.\n2. GraphMol: GraphMol is a Java library for molecular graph processing. It provides a wide range of algorithms and data structures for working with molecular graphs, including graph traversal, graph matching, and graph optimization.\n3. Weave: Weave is a Java library for graph processing and analysis. It provides a simple and flexible API for working with graphs, as well as a range of algorithms and data structures for graph processing.\n4. GraphSAGE: GraphSAGE is a Java library for graph-based machine learning. It provides a range of algorithms and data structures for working with graph-structured data, including graph neural networks and graph-based clustering.\n5. GraphX: GraphX is a Java library for graph processing and analysis. It provides a range of algorithms and data structures for working with graphs, as well as tools for graph visualization and layout.\nThese are just a few examples of graph kernel libraries available in Java. There are many other libraries available, each with their own strengths and weaknesses, so it's worth exploring the options to find the one that best fits your needs.",
    "llama-2-7b-chat-hf_fact_raw": "1. JUNG is a Java library designed for graph processing and visualization.\n2. GraphMol is a Java library for molecular graph processing.\n3. Weave is a Java library that offers graph processing and analysis capabilities.\n4. GraphSAGE is a Java library used for graph-based machine learning.\n5. GraphX is a Java library that provides tools for graph processing, analysis, and visualization.",
    "llama-2-7b-chat-hf_fact": [
      "JUNG is a Java library designed for graph processing and visualization.",
      "GraphMol is a Java library for molecular graph processing.",
      "Weave is a Java library that offers graph processing and analysis capabilities.",
      "GraphSAGE is a Java library used for graph-based machine learning.",
      "GraphX is a Java library that provides tools for graph processing, analysis, and visualization."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: GraphMol is not a Java library. RDKit, which is a collection of cheminformatics and machine learning tools, has a component called GraphMol for molecule manipulation, and it is typically used with Python, not Java.\n3. UNKNOWN (Without additional context, it is unclear whether \"Weave\" refers to a specific Java library or something else. There is a web-based visualization platform called Weave, but without more information, the Java aspect cannot be confirmed.)\n4. FALSE [correction]: GraphSAGE is an algorithm for inductive representation learning on large graphs, but it is not specifically a Java library. It can be implemented in various programming languages and is commonly associated with Python in the context of machine learning frameworks like PyTorch or TensorFlow.\n5. FALSE [correction]: GraphX is part of the Apache Spark ecosystem and is a distributed graph processing framework. While Apache Spark mainly uses Scala, it supports multiple languages including Java, but GraphX itself is not a Java library.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-2-7b-chat-hf_response": "SHERLOCK (Specific High-Sensitivity Enzyme-Linked ImmunoSorbent Assay) is a diagnostic platform that can detect a wide range of pathogens, including viruses, bacteria, and fungi, in a single test. SHERLOCKv2 is the latest version of the platform, which includes four advances:\n1. Multiplexing: SHERLOCKv2 allows for the detection of multiple pathogens in a single test, making it a more efficient and cost-effective diagnostic tool.\n2. Nucleic acid amplification: SHERLOCKv2 uses a nucleic acid amplification technique called loop-mediated isothermal amplification (LAMP) to amplify the targeted pathogen's genetic material, which improves the sensitivity and specificity of the test.\n3. Isothermal amplification: Unlike traditional PCR, which requires a series of temperature cycling steps, LAMP is an isothermal process, meaning that the reaction occurs at a constant temperature throughout the amplification process. This makes the test faster and more convenient to perform.\n4. Portability: SHERLOCKv2 is designed to be portable and easy to use in a variety of settings, including in the field or in resource-limited environments. This makes it a useful tool for rapid diagnostics in areas where access to laboratory facilities is limited.",
    "llama-2-7b-chat-hf_fact_raw": "1. SHERLOCKv2 is capable of multiplexing, allowing it to detect multiple pathogens in a single test.\n2. The platform uses loop-mediated isothermal amplification (LAMP) to amplify a pathogen's genetic material.\n3. The LAMP technique operates at a constant temperature throughout the amplification process.\n4. SHERLOCKv2 is designed to be portable for use in diverse settings, including those with limited resources.",
    "llama-2-7b-chat-hf_fact": [
      "SHERLOCKv2 is capable of multiplexing, allowing it to detect multiple pathogens in a single test.",
      "The platform uses loop-mediated isothermal amplification (LAMP) to amplify a pathogen's genetic material.",
      "The LAMP technique operates at a constant temperature throughout the amplification process.",
      "SHERLOCKv2 is designed to be portable for use in diverse settings, including those with limited resources."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-2-7b-chat-hf_response": "The Bartender algorithm is a heuristic search algorithm used in artificial intelligence and robotics to find the shortest path to a goal in a weighted graph or network. It is a type of admissible heuristic algorithm, meaning that the estimated distance to the goal is always less than or equal to the actual distance.\nThe algorithm works by maintaining a set of possible paths to the goal, called the \"bartender's list\". At each step, the algorithm selects the next node to expand based on a heuristic function that estimates the distance from the current node to the goal. The heuristic function is designed to be admissible, meaning that it never overestimates the actual distance to the goal.\nThe Bartender algorithm is often used in the context of pathfinding problems, such as finding the shortest path between two points in a graph or network. It is particularly useful in situations where the graph is too large to be searched exhaustively, or where the heuristic function can be used to prune the search space.\nThe basic steps of the Bartender algorithm are:\n1. Initialize the bartender's list with the starting node.\n2. At each step, select the next node to expand based on the heuristic function.\n3. Expand the selected node and add its successors to the bartender's list.\n4. Repeat step 2 until the goal node is reached or the bartender's list is empty.\n5. Output the shortest path from the starting node to the goal node.\nThe Bartender algorithm is a simple and efficient algorithm for finding the shortest path to a goal in a weighted graph or network. It is particularly useful in situations where the graph is too large to be searched exhaustively, or where the heuristic function can be used to prune the search space.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Bartender algorithm is a heuristic search algorithm used to find the shortest path to a goal in a weighted graph or network.\n2. It is an admissible heuristic algorithm, meaning that it does not overestimate the actual distance to the goal.\n3. The algorithm maintains a set of possible paths called the \"bartender's list\".\n4. The Bartender algorithm selects the next node to expand based on a heuristic function that estimates the distance to the goal.\n5. The algorithm is designed for pathfinding problems, such as finding the shortest path between two points in a graph or network.",
    "llama-2-7b-chat-hf_fact": [
      "The Bartender algorithm is a heuristic search algorithm used to find the shortest path to a goal in a weighted graph or network.",
      "It is an admissible heuristic algorithm, meaning that it does not overestimate the actual distance to the goal.",
      "The algorithm maintains a set of possible paths called the \"bartender's list\".",
      "The Bartender algorithm selects the next node to expand based on a heuristic function that estimates the distance to the goal.",
      "The algorithm is designed for pathfinding problems, such as finding the shortest path between two points in a graph or network."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: There is no widely recognized heuristic search algorithm known as the \"Bartender algorithm\". Commonly known algorithms for shortest path problems include Dijkstra's algorithm, A* algorithm, and Bellman-Ford algorithm.\n2. UNKNOWN (This statement refers to a non-existent Bartender algorithm. In general, an admissible heuristic is one that does not overestimate the distance to the goal. This property is relevant to algorithms like the A* search algorithm).\n3. FALSE [correction]: Since the Bartender algorithm does not exist, it does not maintain a \"bartender's list\" of possible paths. This statement might be confused with algorithms like A* that maintain a set of potential paths but without a list by that name.\n4. UNKNOWN (This statement would be true for the A* algorithm or other heuristic-based pathfinding algorithms but cannot be evaluated for the Bartender algorithm because it does not exist).\n5. UNKNOWN (While this statement is generally applicable to heuristic search algorithms for pathfinding problems, it cannot be specifically associated with a non-existent Bartender algorithm).",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-2-7b-chat-hf_response": "Some web-based pedigree editors available include Pedigree-Online, Family Tree Builder, and MyHeritage.",
    "llama-2-7b-chat-hf_fact_raw": "1. Pedigree-Online is a web-based pedigree editor.\n2. Family Tree Builder is a web-based pedigree editor.\n3. MyHeritage offers a web-based pedigree editor.",
    "llama-2-7b-chat-hf_fact": [
      "Pedigree-Online is a web-based pedigree editor.",
      "Family Tree Builder is a web-based pedigree editor.",
      "MyHeritage offers a web-based pedigree editor."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-2-7b-chat-hf_response": "There are several curated databases available for spider-venom toxins, including:\n1. ToxinDB: A comprehensive database of toxins from various sources, including spider venom.\n2. SpiderTox: A database of spider venom peptides and proteins, including their structures, functions, and pharmacological activities.\n3. Venom-DB: A database of venom peptides and proteins from various species, including spiders, snakes, and scorpions.\n4. ToxinSearch: A database of toxins from various sources, including spider venom, with information on their structures, functions, and pharmacological activities.\n5. AntTox: A database of antimicrobial peptides and toxins, including those found in spider venom.\n6. Natural Products API: A database of natural products, including spider venom toxins, with information on their structures, activities, and sources.\n7. Toxinology: A database of toxins from various sources, including spider venom, with information on their structures, functions, and pharmacological activities.\n8. Venom-Tox: A database of venom peptides and proteins from various species, including spiders, with information on their structures, functions, and pharmacological activities.\n9. ToxinTDB: A database of toxins from various sources, including spider venom, with information on their structures, functions, and pharmacological activities.\n10. ToxinNet: A database of toxins from various sources, including spider venom, with information on their structures, functions, and pharmacological activities.\nThese databases provide valuable information on the structure, function, and pharmacological activities of spider-venom toxins, and can be used for research and development of new drugs and therapies.",
    "llama-2-7b-chat-hf_fact_raw": "1. ToxinDB is a comprehensive database of toxins that includes information on spider venom.\n2. SpiderTox is a database that contains information on spider venom peptides and proteins.\n3. Venom-DB is a database that includes venom peptides and proteins from various species such as spiders, snakes, and scorpions.\n4. The Natural Products API is a database that contains information on natural products, including spider venom toxins.\n5. Toxinology is a database that provides information on the structures, functions, and pharmacological activities of toxins from various sources, including spider venom.",
    "llama-2-7b-chat-hf_fact": [
      "ToxinDB is a comprehensive database of toxins that includes information on spider venom.",
      "SpiderTox is a database that contains information on spider venom peptides and proteins.",
      "Venom-DB is a database that includes venom peptides and proteins from various species such as spiders, snakes, and scorpions.",
      "The Natural Products API is a database that contains information on natural products, including spider venom toxins.",
      "Toxinology is a database that provides information on the structures, functions, and pharmacological activities of toxins from various sources, including spider venom."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-2-7b-chat-hf_response": "No, Axitinib has not been shown to prolong survival of pancreatic cancer patients.",
    "llama-2-7b-chat-hf_fact_raw": "1. Axitinib has not been shown to prolong survival of pancreatic cancer patients.",
    "llama-2-7b-chat-hf_fact": [
      "Axitinib has not been shown to prolong survival of pancreatic cancer patients."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\nExplanation: There is no specific information provided in your statements that indicates whether axitinib has or has not shown to prolong the survival of pancreatic cancer patients. This is a statement that would require specific clinical trial data or a publication reference to confirm its validity. Without this information, it is not possible to determine the truthfulness of the statement.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-2-7b-chat-hf_response": "MLP regulates F-actin dynamics through its interaction with the actin-binding protein, Glued.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-2-7b-chat-hf_response": "There are approximately 200 pseudokinases in the human kinome.",
    "llama-2-7b-chat-hf_fact_raw": "1. There are approximately 200 pseudokinases in the human kinome.",
    "llama-2-7b-chat-hf_fact": [
      "There are approximately 200 pseudokinases in the human kinome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n\nWhile specifics can fluctuate with ongoing research and current scientific consensus, as of my last update, it is generally accepted that the human kinome comprises about 500-600 kinases, and among them, roughly 10% are considered pseudokinases. Therefore, the statement is approximately true based on the estimated number of pseudokinases.",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-2-7b-chat-hf_response": "ApoE mimetics are compounds that mimic the structure and function of apolipoprotein E (apoE), a protein that plays a key role in lipid metabolism and is involved in various diseases, including Alzheimer's disease, cardiovascular disease, and cancer. Here are three examples of apoE mimetics:\n1. ApoE-mimetic peptides: These are short peptides that mimic the structure of apoE and have been shown to have lipid-lowering and anti-inflammatory effects in preclinical studies. Examples of apoE-mimetic peptides include the peptide Gly-Thr-Gly-Arg-Gly-Gly-Ser-Gly-Gly-Leu-Gly-Gly-Ala-Gly-Ser-Gly-Gly-Gly-Gly-Gly (GQWAVSESPQGQWAVSESPQG) and the peptide Gly-Thr-Gly-Arg-Gly-Gly-Ser-Gly-Gly-Leu-Gly-Gly-Ala-Gly-Ser-Gly-Gly-Gly-Gly-Gly (GQWAVSESPQGQWAVSESPQG).\n2. ApoE-mimetic small molecules: These are small molecules that mimic the structure of apoE and have been shown to have lipid-lowering and anti-inflammatory effects in preclinical studies. Examples of apoE-mimetic small molecules include the compound GW3965 and the compound GW6453.\n3. ApoE-mimetic nanoparticles: These are nanoparticles that mimic the structure of apoE and have been shown to have lipid-lowering and anti-inflammatory effects in preclinical studies. Examples of apoE-mimetic nanoparticles include the nanoparticle Glyco-apoE and the nanoparticle ApoE-mimetic.\nIt's worth noting that while these apoE mimetics have shown promise in preclinical studies, further research is needed to",
    "llama-2-7b-chat-hf_fact_raw": "1. ApoE-mimetic peptides are designed to mimic the structure of apolipoprotein E.\n2. The apoE-mimetic peptide with the sequence \"Gly-Thr-Gly-Arg-Gly-Gly-Ser-Gly-Gly-Leu-Gly-Gly-Ala-Gly-Ser-Gly-Gly-Gly-Gly-Gly\" (GQWAVSESPQGQWAVSESPQG) is an example of an apoE-mimetic peptide.\n3. The compound GW3965 is an example of an apoE-mimetic small molecule.\n4. ApoE-mimetic nanoparticles are created to mimic the structure of apolipoprotein E.\n5. The nanoparticle Glyco-apoE is an example of an apoE-mimetic nanoparticle.",
    "llama-2-7b-chat-hf_fact": [
      "ApoE-mimetic peptides are designed to mimic the structure of apolipoprotein E.",
      "The apoE-mimetic peptide with the sequence \"Gly-Thr-Gly-Arg-Gly-Gly-Ser-Gly-Gly-Leu-Gly-Gly-Ala-Gly-Ser-Gly-Gly-Gly-Gly-Gly\" (GQWAVSESPQGQWAVSESPQG) is an example of an apoE-mimetic peptide.",
      "The compound GW3965 is an example of an apoE-mimetic small molecule.",
      "ApoE-mimetic nanoparticles are created to mimic the structure of apolipoprotein E.",
      "The nanoparticle Glyco-apoE is an example of an apoE-mimetic nanoparticle."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: ApoE-mimetic peptides are indeed designed to mimic the structure and function of apolipoprotein E (ApoE), which plays a key role in lipid metabolism and is involved in various physiological processes including cholesterol transport and neuronal repair.\n\n2. FALSE [correction]: The sequence given is repetitive and does not match a typical apoE-mimetic peptide sequence. An example of an apoE-mimetic peptide sequence would be much shorter and is typically designed to resemble a region of the apoE protein that interacts with lipoprotein receptors.\n\n3. UNKNOWN: Without specific context or confirmation from a reliable source, it cannot be determined if GW3965 is an apoE-mimetic small molecule. GW3965 is known as a Liver X Receptor (LXR) agonist, which is involved in cholesterol homeostasis, but not specifically stated as an apoE-mimetic.\n\n4. TRUE: ApoE-mimetic nanoparticles are designed to mimic the structure of apolipoprotein E. This approach harnesses the physiological functions of ApoE to create nanoparticles that can, for example, enhance drug delivery to the brain or target specific cells.\n\n5. UNKNOWN: Without additional context, it's unclear if \"Glyco-apoE\" refers to an actual apoE-mimetic nanoparticle in use or research. Glycosylation is a common post-translational modification in proteins, and a nanoparticle named Glyco-apoE could theoretically be designed to mimic the effects of glycosylated apolipoprotein E, but without specific information, this cannot be confirmed.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-2-7b-chat-hf_response": "SAMHD1 activity is higher in males than in females.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-2-7b-chat-hf_response": "Yes, RUNX2 has been shown to inhibit astrocyte differentiation.",
    "llama-2-7b-chat-hf_fact_raw": "1. RUNX2 inhibits astrocyte differentiation.",
    "llama-2-7b-chat-hf_fact": [
      "RUNX2 inhibits astrocyte differentiation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-2-7b-chat-hf_response": "Cobb-Stainsby excision arthroplasty is a surgical procedure that is performed to treat a condition called avascular necrosis of the femoral head, which is a condition where the blood supply to the femoral head is disrupted, leading to bone death. This procedure is typically performed on the hip joint, specifically on the femur (thighbone) of the affected leg.",
    "llama-2-7b-chat-hf_fact_raw": "1. Cobb-Stainsby excision arthroplasty is a surgical procedure used to treat avascular necrosis of the femoral head.\n2. Avascular necrosis of the femoral head is a condition characterized by the disruption of blood supply to the femoral head, resulting in bone death.\n3. The Cobb-Stainsby excision arthroplasty procedure is typically performed on the hip joint.\n4. The surgery is specifically performed on the femur of the affected leg.",
    "llama-2-7b-chat-hf_fact": [
      "Cobb-Stainsby excision arthroplasty is a surgical procedure used to treat avascular necrosis of the femoral head.",
      "Avascular necrosis of the femoral head is a condition characterized by the disruption of blood supply to the femoral head, resulting in bone death.",
      "The Cobb-Stainsby excision arthroplasty procedure is typically performed on the hip joint.",
      "The surgery is specifically performed on the femur of the affected leg."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Cobb-Stainsby excision arthroplasty is not a procedure for avascular necrosis of the femoral head; it is an older procedure used for disarticulation at the hip for disabling hip instability, especially in children with cerebral palsy.\n2. TRUE\n3. FALSE [correction]: The Cobb-Stainsby excision arthroplasty procedure is related to the hip joint but is not typically performed for treating avascular necrosis of the femoral head; it is more associated with addressing hip instability issues in specific populations.\n4. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-2-7b-chat-hf_response": "Yes, GRHL2 over-expression has been shown to promote epithelial-to-mesenchymal transition (EMT) in various cancer cell types.",
    "llama-2-7b-chat-hf_fact_raw": "1. GRHL2 over-expression promotes epithelial-to-mesenchymal transition (EMT).\n2. This promotion of EMT by GRHL2 has been observed in various cancer cell types.",
    "llama-2-7b-chat-hf_fact": [
      "GRHL2 over-expression promotes epithelial-to-mesenchymal transition (EMT).",
      "This promotion of EMT by GRHL2 has been observed in various cancer cell types."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-2-7b-chat-hf_response": "Several T-UCRs (transcribed ultraconserved regions) have been implicated in lung cancer, including:\n1. T-UCR1\n2. T-UCR2\n3. T-UCR3\n4. T-UCR4\n5. T-UCR5\nThese T-UCRs are known to be involved in the development and progression of lung cancer, and may serve as potential therapeutic targets for the treatment of the disease.",
    "llama-2-7b-chat-hf_fact_raw": "1. T-UCR1 has been implicated in lung cancer.\n2. T-UCR2 has been implicated in lung cancer.\n3. T-UCR3 has been implicated in lung cancer.\n4. T-UCR4 has been implicated in lung cancer.\n5. T-UCR5 has been implicated in lung cancer.",
    "llama-2-7b-chat-hf_fact": [
      "T-UCR1 has been implicated in lung cancer.",
      "T-UCR2 has been implicated in lung cancer.",
      "T-UCR3 has been implicated in lung cancer.",
      "T-UCR4 has been implicated in lung cancer.",
      "T-UCR5 has been implicated in lung cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nWithout additional context or information on what \"T-UCR\" refers to, it is not possible to determine the accuracy of these statements. \"T-UCR\" could potentially refer to a series of genes or genetic markers, but without specific details or a source to confirm the implications in lung cancer, the truthfulness of these statements cannot be established.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-2-7b-chat-hf_response": "GPR151, also known as the orphan receptor GPR151, is a G protein-coupled receptor that is primarily expressed in the brain and has been implicated in various physiological processes, including neurotransmission, inflammation, and immune response. The exact function of GPR151 is not fully understood, but it is thought to play a role in the regulation of synaptic plasticity and learning and memory. GPR151 has been shown to be involved in the modulation of glutamate and dopamine signaling, and it has been implicated in various neurological disorders, including epilepsy, Alzheimer's disease, and Parkinson's disease. GPR151 has also been shown to be involved in the regulation of immune responses, including the activation of immune cells and the production of cytokines. Overall, GPR151 is a complex and multifunctional receptor that is still being studied and characterized, and further research is needed to fully understand its role in health and disease.",
    "llama-2-7b-chat-hf_fact_raw": "1. GPR151 is a G protein-coupled receptor primarily expressed in the brain.\n2. GPR151 has been implicated in physiological processes such as neurotransmission, inflammation, and immune response.\n3. The receptor is thought to play a role in the regulation of synaptic plasticity and learning and memory.\n4. GPR151 is involved in the modulation of glutamate and dopamine signaling.\n5. GPR151 has been implicated in various neurological disorders, including epilepsy, Alzheimer's disease, and Parkinson’s disease.",
    "llama-2-7b-chat-hf_fact": [
      "GPR151 is a G protein-coupled receptor primarily expressed in the brain.",
      "GPR151 has been implicated in physiological processes such as neurotransmission, inflammation, and immune response.",
      "The receptor is thought to play a role in the regulation of synaptic plasticity and learning and memory.",
      "GPR151 is involved in the modulation of glutamate and dopamine signaling.",
      "GPR151 has been implicated in various neurological disorders, including epilepsy, Alzheimer's disease, and Parkinson’s disease."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: GPR151 is not directly implicated in general physiological processes such as inflammation and immune response; instead, it has a more specific role primarily related to the nervous system.\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-2-7b-chat-hf_response": "The Fluzone intradermal quadrivalent vaccine contains the following attenuated live viruses:\n* Influenza A/H1N1\n* Influenza A/H3N2\n* Influenza B/Victoria\n* Influenza B/Yamagata",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-2-7b-chat-hf_response": "The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE) in the promoter region, specifically in the -218G/C polymorphism. This polymorphism has been found to be associated with an increased risk of developing SLE in several studies.",
    "llama-2-7b-chat-hf_fact_raw": "1. The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE).\n2. The association between the TNFR2 gene and SLE is located in the promoter region of the gene.\n3. The specific polymorphism associated with an increased risk of SLE is the -218G/C polymorphism within the TNFR2 gene.",
    "llama-2-7b-chat-hf_fact": [
      "The TNFR2 gene is genetically associated with Systemic Lupus Erythematosus (SLE).",
      "The association between the TNFR2 gene and SLE is located in the promoter region of the gene.",
      "The specific polymorphism associated with an increased risk of SLE is the -218G/C polymorphism within the TNFR2 gene."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. UNKNOWN\n\nThe TNFR2 gene has been studied in relation to various autoimmune diseases, including Systemic Lupus Erythematosus (SLE), but without further context about recent scientific discoveries, it's challenging to confirm the current understanding of these associations, including specific locations like the promoter region or specific polymorphisms such as the -218G/C polymorphism within the TNFR2 gene. Scientific knowledge is constantly evolving, and the understanding of genetic associations can rapidly change with new research.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-2-7b-chat-hf_response": "Yes, there is a vaccine being developed for peanut allergy.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-2-7b-chat-hf_response": "The mouse Fxy gene is located on the X chromosome at position Xq28.",
    "llama-2-7b-chat-hf_fact_raw": "1. The mouse Fxy gene is located on the X chromosome.\n2. The mouse Fxy gene is positioned at Xq28.",
    "llama-2-7b-chat-hf_fact": [
      "The mouse Fxy gene is located on the X chromosome.",
      "The mouse Fxy gene is positioned at Xq28."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The mouse Fxy gene is not positioned at Xq28, which is a location reference for the human X chromosome. In mice, chromosomal locations are generally described differently, often by cytogenetic band or simply stating that it's on the X chromosome without a specific location akin to 'Xq28'.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-2-7b-chat-hf_response": "The basis of the MPE-seq method is the use of a chemical modification, methylation, to capture and isolate specific RNA molecules in order to determine their expression levels. The method involves treating the cells with a reagent called methylation propyl-EDTA (MPE), which adds a methyl group to the 5' end of the RNA molecule. This modified RNA is then captured using oligonucleotide probes, and the captured RNA is sequenced using Next-Generation Sequencing (NGS) technologies. The resulting data can be used to quantify the expression levels of specific genes by comparing the abundance of the modified RNA molecules to that of the unmodified RNA molecules.",
    "llama-2-7b-chat-hf_fact_raw": "1. The MPE-seq method uses chemical modification to capture and isolate specific RNA molecules.\n2. Methylation propyl-EDTA (MPE) is used to add a methyl group to the 5' end of RNA molecules in MPE-seq.\n3. MPE-seq involves the use of oligonucleotide probes to capture modified RNA.\n4. Next-Generation Sequencing (NGS) technologies are used to sequence the captured RNA in the MPE-seq method.\n5. The expression levels of specific genes can be quantified using MPE-seq by comparing the abundance of modified RNA molecules to that of unmodified RNA molecules.",
    "llama-2-7b-chat-hf_fact": [
      "The MPE-seq method uses chemical modification to capture and isolate specific RNA molecules.",
      "Methylation propyl-EDTA (MPE) is used to add a methyl group to the 5' end of RNA molecules in MPE-seq.",
      "MPE-seq involves the use of oligonucleotide probes to capture modified RNA.",
      "Next-Generation Sequencing (NGS) technologies are used to sequence the captured RNA in the MPE-seq method.",
      "The expression levels of specific genes can be quantified using MPE-seq by comparing the abundance of modified RNA molecules to that of unmodified RNA molecules."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Methylation propyl-EDTA (MPE) is not used to add a methyl group to the RNA molecules in MPE-seq; MPE stands for Methidiumpropyl-EDTA (a derivative of EDTA) which is a chemical used for RNA footprinting, not RNA methylation.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-2-7b-chat-hf_response": "The programming language used for implementing GWAR (Genome-Wide Association Study) is typically Python. GWAS is a popular computational approach used to identify genetic variants associated with complex diseases, and Python has become the de facto standard for GWAS analysis due to its simplicity, flexibility, and large number of available libraries and tools for genomics analysis.",
    "llama-2-7b-chat-hf_fact_raw": "1. Python is used for implementing GWAR (Genome-Wide Association Study).\n2. GWAS is used to identify genetic variants associated with complex diseases.\n3. Python is favored for GWAS analysis due to its simplicity, flexibility, and the availability of genomics analysis libraries and tools.",
    "llama-2-7b-chat-hf_fact": [
      "Python is used for implementing GWAR (Genome-Wide Association Study).",
      "GWAS is used to identify genetic variants associated with complex diseases.",
      "Python is favored for GWAS analysis due to its simplicity, flexibility, and the availability of genomics analysis libraries and tools."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-2-7b-chat-hf_response": "No, there is limited evidence to suggest that xaliproden (also known as masitinib) improves the prognosis of amyotrophic lateral sclerosis (ALS). While some studies have suggested that masitinib may slow the progression of ALS, the overall evidence is mixed and more research is needed to fully understand its effectiveness in treating this condition.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-2-7b-chat-hf_response": "The LiPS-A3S line is a transgenic line in which transgenes are inserted into chromosome 1.",
    "llama-2-7b-chat-hf_fact_raw": "1. Transgenes are inserted into chromosome 1 in the case of the LiPS-A3S line.",
    "llama-2-7b-chat-hf_fact": [
      "Transgenes are inserted into chromosome 1 in the case of the LiPS-A3S line."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n\nExplanation: Without specific information regarding the genetic engineering details of the LiPS-A3S line, it is impossible to determine the accuracy of this statement. The statement requires specialized knowledge of a particular genetic modification process, and without additional context or reference to relevant scientific literature, the veracity of the statement remains unknown.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-2-7b-chat-hf_response": "One tool that exists for predicting drug synergy with deep learning is DeepSynth.",
    "llama-2-7b-chat-hf_fact_raw": "1. DeepSynth is a tool for predicting drug synergy using deep learning.",
    "llama-2-7b-chat-hf_fact": [
      "DeepSynth is a tool for predicting drug synergy using deep learning."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-2-7b-chat-hf_response": "The cloud-based platform that has been developed for comparing GWAS is called \"GWAS Central.\"",
    "llama-2-7b-chat-hf_fact_raw": "1. GWAS Central is a cloud-based platform.\n2. GWAS Central has been developed for comparing GWAS (Genome-Wide Association Studies).",
    "llama-2-7b-chat-hf_fact": [
      "GWAS Central is a cloud-based platform.",
      "GWAS Central has been developed for comparing GWAS (Genome-Wide Association Studies)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: GWAS Central is not specifically described as a cloud-based platform, but as a database and online resource for genome-wide association studies.\n2. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-2-7b-chat-hf_response": "Yes, CMB305 has shown potential as a treatment for sarcomas, particularly those that are resistant to conventional chemotherapy.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-2-7b-chat-hf_response": "The manifestations of the Saint's Triad are:\n1. Horner's syndrome: This is characterized by a red eye (hypertrophy of the conjunctiva), droopy eyelid (ptosis), and a facial weakness or paralysis (facial nerve palsy).\n2. Cranial nerve palsies: These are abnormalities in the functioning of the cranial nerves, which can cause a range of symptoms including double vision, droopy eyelid, and difficulty moving the facial muscles.\n3. Oculomotor dysfunction: This refers to problems with the muscles that control eye movement, including the inability to move the eyes in different directions (oculogyric crisis).",
    "llama-2-7b-chat-hf_fact_raw": "1. Horner's syndrome includes symptoms such as red eye, droopy eyelid, and facial weakness or paralysis.\n2. Cranial nerve palsies can cause double vision, droopy eyelid, and difficulty moving facial muscles.\n3. Oculomotor dysfunction involves problems with the muscles that control eye movement.",
    "llama-2-7b-chat-hf_fact": [
      "Horner's syndrome includes symptoms such as red eye, droopy eyelid, and facial weakness or paralysis.",
      "Cranial nerve palsies can cause double vision, droopy eyelid, and difficulty moving facial muscles.",
      "Oculomotor dysfunction involves problems with the muscles that control eye movement."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Horner's syndrome typically includes symptoms such as a droopy eyelid (ptosis), constricted pupil (miosis), and lack of sweating (anhidrosis) on the affected side of the face, not red eye.\n2. TRUE\n3. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-2-7b-chat-hf_response": "Yes, overexpression of LY6K has been associated with a better prognosis for non-small cell lung cancer (NSCLC) patients.",
    "llama-2-7b-chat-hf_fact_raw": "1. Overexpression of LY6K is associated with a better prognosis for non-small cell lung cancer patients.",
    "llama-2-7b-chat-hf_fact": [
      "Overexpression of LY6K is associated with a better prognosis for non-small cell lung cancer patients."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Overexpression of LY6K is generally associated with a poorer prognosis for non-small cell lung cancer patients.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-2-7b-chat-hf_response": "Cytokinesis is the process by which a cell divides into two daughter cells. During this process, the following CDK (cyclin-dependent kinase) targets are dephosphorylated:\n1. Cyclin-dependent kinase 1 (CDK1): CDK1 is dephosphorylated by the protein phosphatase Cdc25A during cytokinesis.\n2. Cyclin-dependent kinase 2 (CDK2): CDK2 is also dephosphorylated by Cdc25A during cytokinesis.\n3. Cyclin-dependent kinase 5 (CDK5): CDK5 is involved in the regulation of microtubule dynamics and is dephosphorylated during cytokinesis.\n4. Cyclin-dependent kinase 6 (CDK6): CDK6 is a key regulator of the G1/S checkpoint and is dephosphorylated during cytokinesis.\n5. Cyclin-dependent kinase 7 (CDK7): CDK7 is involved in the regulation of transcription and is dephosphorylated during cytokinesis.\n6. Cyclin-dependent kinase 9 (CDK9): CDK9 is involved in the regulation of transcription and is dephosphorylated during cytokinesis.\nThese dephosphorylation events are important for the proper progression of cytokinesis and the formation of the cleavage furrow.",
    "llama-2-7b-chat-hf_fact_raw": "1. Cyclin-dependent kinase 1 (CDK1) is dephosphorylated by the protein phosphatase Cdc25A during cytokinesis.\n2. Cyclin-dependent kinase 2 (CDK2) is dephosphorylated by Cdc25A during cytokinesis.\n3. Cyclin-dependent kinase 5 (CDK5) is dephosphorylated during cytokinesis.\n4. Cyclin-dependent kinase 6 (CDK6) is dephosphorylated during cytokinesis.\n5. Cyclin-dependent kinase 7 (CDK7) is dephosphorylated during cytokinesis.",
    "llama-2-7b-chat-hf_fact": [
      "Cyclin-dependent kinase 1 (CDK1) is dephosphorylated by the protein phosphatase Cdc25A during cytokinesis.",
      "Cyclin-dependent kinase 2 (CDK2) is dephosphorylated by Cdc25A during cytokinesis.",
      "Cyclin-dependent kinase 5 (CDK5) is dephosphorylated during cytokinesis.",
      "Cyclin-dependent kinase 6 (CDK6) is dephosphorylated during cytokinesis.",
      "Cyclin-dependent kinase 7 (CDK7) is dephosphorylated during cytokinesis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: CDK1 is indeed dephosphorylated by the protein phosphatase Cdc25A during the cell cycle, particularly at the transition from G2 phase to mitosis, which is a step preceding cytokinesis.\n2. FALSE [correction]: CDK2 is not specifically known to be dephosphorylated by Cdc25A during cytokinesis. Cdc25A does activate CDK2, but this occurs earlier in the cell cycle, primarily regulating the transition from G1 phase to S phase.\n3. UNKNOWN: While CDK5 is a cyclin-dependent kinase, its role is more associated with neuronal development and function, not classical cell cycle regulation. Whether it is dephosphorylated during cytokinesis is unclear and not well established in mainstream scientific literature.\n4. UNKNOWN: CDK6 is involved in the cell cycle, acting in the G1 phase and the G1/S transition. However, there is limited information on its dephosphorylation specifically during cytokinesis, and it's not as well-characterized as CDK1 or CDK2 in this regard.\n5. UNKNOWN: CDK7 has a role as a CDK-activating kinase (CAK), which phosphorylates other CDKs to regulate the cell cycle. While it has roles throughout the cell cycle, including possible functions during cytokinesis, it is not traditionally highlighted for being dephosphorylated during cytokinesis. The precise timing and regulation of its dephosphorylation in the cell cycle are not clearly defined in the context provided.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-2-7b-chat-hf_response": "Xanamem is a brand name for the drug memantine, which is used to treat Alzheimer's disease and other dementias.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-2-7b-chat-hf_response": "The Hof1-Cyk3 interaction plays a role in regulating the activity of the Hog1 mitogen-activated protein kinase (MAPK) pathway in yeast.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-2-7b-chat-hf_response": "Several T-UCRs, including T-UCR uc003dqy.1, uc003dqx.1, and uc003dqw.1, have been implicated in gastric cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. T-UCRs such as uc003dqy.1, uc003dqx.1, and uc003dqw.1 have been implicated in gastric cancer.",
    "llama-2-7b-chat-hf_fact": [
      "T-UCRs such as uc003dqy.1, uc003dqx.1, and uc003dqw.1 have been implicated in gastric cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nExplanation: Without access to up-to-date and specific scientific literature or databases that can confirm the involvement of the T-UCRs (transcribed-ultraconserved regions) mentioned (uc003dqy.1, uc003dqx.1, and uc003dqw.1) in gastric cancer, it is impossible to determine the veracity of this statement. Ultraconserved regions are indeed a topic of research in cancer biology, but specifics would require expert knowledge or a reliable source.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-2-7b-chat-hf_response": "The Lupus Severity Index (LSI) is a clinical index used to assess the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease. The LSI is a composite score that takes into account various organ involvement, serological markers, and clinical manifestations of the disease. The score ranges from 0 to 100, with higher scores indicating more severe disease. The LSI has been shown to be a useful tool for evaluating the severity of SLE and monitoring the response to treatment.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).\n2. The LSI is a composite score that includes organ involvement, serological markers, and clinical manifestations of SLE.\n3. The LSI score ranges from 0 to 100.\n4. Higher scores on the LSI indicate more severe disease.\n5. The LSI is utilized to monitor response to treatment for SLE.",
    "llama-2-7b-chat-hf_fact": [
      "The Lupus Severity Index (LSI) is used to assess the severity of systemic lupus erythematosus (SLE).",
      "The LSI is a composite score that includes organ involvement, serological markers, and clinical manifestations of SLE.",
      "The LSI score ranges from 0 to 100.",
      "Higher scores on the LSI indicate more severe disease.",
      "The LSI is utilized to monitor response to treatment for SLE."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The Lupus Severity Index (LSI) does not have a specific scoring range from 0 to 100. The statement seems to be based on the concept of severity indices for diseases like SLE, but LSI is not a standardized or commonly recognized tool with a defined scoring range. Severity indices for SLE may vary in their scoring systems.\n4. TRUE (assuming that LSI follows the typical pattern of scoring systems where higher scores reflect greater severity)\n5. TRUE (assuming that LSI is a tool used for monitoring, which is consistent with how severity indices are generally used, even if it's not a widely recognized standard)",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-2-7b-chat-hf_response": "De novo mutations in the ZSWIM6 gene have been associated with several disorders, including:\n1. Neuronal ceroid lipofuscinosis 8 (NCL8), also known as Batten disease, a rare genetic disorder that affects the nervous system and causes progressive loss of vision, seizures, and developmental delays.\n2. Cerebral folate deficiency (CFD), a rare genetic disorder that affects the brain and nervous system and can cause developmental delays, seizures, and intellectual disability.\n3. Intellectual disability, autism spectrum disorder, and other neurodevelopmental disorders, although the frequency and severity of these conditions are not well-established.\nIt's important to note that the list of disorders associated with de novo mutations in ZSWIM6 is not exhaustive, and more research is needed to fully understand the role of this gene in human health and disease.",
    "llama-2-7b-chat-hf_fact_raw": "1. De novo mutations in the ZSWIM6 gene are associated with Neuronal ceroid lipofuscinosis 8 (NCL8), also known as Batten disease.\n2. De novo mutations in the ZSWIM6 gene can cause Cerebral folate deficiency (CFD).\n3. Intellectual disability and autism spectrum disorder may be associated with de novo mutations in the ZSWIM6 gene.\n4. De novo mutations in ZSWIM6 are implicated in various neurodevelopmental disorders.\n5. The frequency and severity of neurodevelopmental disorders caused by de novo mutations in the ZSWIM6 gene are not well-established.",
    "llama-2-7b-chat-hf_fact": [
      "De novo mutations in the ZSWIM6 gene are associated with Neuronal ceroid lipofuscinosis 8 (NCL8), also known as Batten disease.",
      "De novo mutations in the ZSWIM6 gene can cause Cerebral folate deficiency (CFD).",
      "Intellectual disability and autism spectrum disorder may be associated with de novo mutations in the ZSWIM6 gene.",
      "De novo mutations in ZSWIM6 are implicated in various neurodevelopmental disorders.",
      "The frequency and severity of neurodevelopmental disorders caused by de novo mutations in the ZSWIM6 gene are not well-established."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: De novo mutations in the CLN8 gene, not the ZSWIM6 gene, are associated with Neuronal ceroid lipofuscinosis 8 (NCL8), also known as Batten disease.\n2. UNKNOWN (as of my last update, there is no strong evidence linking ZSWIM6 to Cerebral folate deficiency (CFD), but scientific knowledge is always advancing, and this might require consultation with up-to-date specialist literature or databases).\n3. TRUE (some studies suggest an association between de novo mutations in the ZSWIM6 gene and these conditions, but the evidence may not be definitive for all cases).\n4. TRUE (ZSWIM6 has been implicated in playing a role in neurodevelopmental disorders, as indicated by studies identifying mutations in individuals with such disorders).\n5. TRUE (given the complexity and variability of genetic disorders, it's common that the exact frequency and severity of those caused by specific genetic mutations, such as de novo mutations in the ZSWIM6 gene, may not be fully established).",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-2-7b-chat-hf_response": "The Koos Classification is used to classify patients with stroke based on the severity of their neurological deficits. It categorizes stroke patients into four categories:\n1. Cerebral hemisphere (Koos I)\n2. Cerebral hemisphere and cerebellum (Koos II)\n3. Cerebral hemisphere, cerebellum, and brainstem (Koos III)\n4. Brainstem (Koos IV)\nEach category is further subdivided into subtypes based on the location and severity of the neurological deficits. The Koos Classification is widely used in clinical settings to assess and manage stroke patients.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Koos Classification is used to classify patients with stroke.\n2. The Koos Classification categorizes stroke patients into four categories.\n3. Koos I involves the cerebral hemisphere.\n4. Koos II involves the cerebral hemisphere and cerebellum.\n5. Koos III involves the cerebral hemisphere, cerebellum, and brainstem, while Koos IV is specific to the brainstem.",
    "llama-2-7b-chat-hf_fact": [
      "The Koos Classification is used to classify patients with stroke.",
      "The Koos Classification categorizes stroke patients into four categories.",
      "Koos I involves the cerebral hemisphere.",
      "Koos II involves the cerebral hemisphere and cerebellum.",
      "Koos III involves the cerebral hemisphere, cerebellum, and brainstem, while Koos IV is specific to the brainstem."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Koos Classification is used to classify vestibular schwannomas (also known as acoustic neuromas), not stroke patients.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Koos II involves the cerebral hemisphere and may extend into the cerebellopontine angle, not specifically the cerebellum.\n5. FALSE [correction]: Koos III involves the cerebral hemisphere, cerebellum, and may press on the brainstem, but not necessarily involve it, while Koos IV involves the entire cerebellopontine angle area and significantly compresses the brainstem.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-2-7b-chat-hf_response": "AZD8601 is an inhibitor of the enzyme Bruton's tyrosine kinase (BTK). In vivo, AZD8601 has been shown to:\n1. Inhibit B cells activation and proliferation: AZD8601 reduces the activation and proliferation of B cells, which are important in the immune response.\n2. Reduce autoantibody production: AZD8601 inhibits the production of autoantibodies, which are antibodies that are produced in response to the body's own tissues and can be harmful in autoimmune diseases.\n3. Modulate the immune response: AZD8601 can modulate the immune response by altering the balance between different immune cell populations, such as T cells and B cells.\n4. Exhibit anti-inflammatory effects: AZD8601 has been shown to have anti-inflammatory effects in various models of inflammation, including colitis and arthritis.\n5. Increase the expression of anti-inflammatory cytokines: AZD8601 has been shown to increase the expression of anti-inflammatory cytokines, such as interleukin-10 (IL-10), in various tissues, including the spleen, lymph nodes, and liver.\n6. Reduce the accumulation of immune cells in inflamed tissues: AZD8601 has been shown to reduce the accumulation of immune cells in inflamed tissues, such as the spleen and liver, in various models of inflammation.\n7. Exhibit antitumor effects: AZD8601 has been shown to have antitumor effects in various models of cancer, including breast cancer and lymphoma.\n8. Increase the expression of pro-apoptotic proteins: AZD8601 has been shown to increase the expression of pro-apoptotic proteins, such as BAX and BAK, in various cancer cell lines.\n9. Reduce the expression of anti-apoptotic proteins: AZD8601 has been shown to reduce",
    "llama-2-7b-chat-hf_fact_raw": "1. AZD8601 inhibits B cell activation and proliferation.\n2. AZD8601 reduces the production of autoantibodies.\n3. AZD8601 can modulate the immune response by altering the balance between different immune cell populations.\n4. AZD8601 has been shown to have anti-inflammatory effects in models of inflammation including colitis and arthritis.\n5. AZD8601 has been shown to have antitumor effects in various models of cancer, including breast cancer and lymphoma.",
    "llama-2-7b-chat-hf_fact": [
      "AZD8601 inhibits B cell activation and proliferation.",
      "AZD8601 reduces the production of autoantibodies.",
      "AZD8601 can modulate the immune response by altering the balance between different immune cell populations.",
      "AZD8601 has been shown to have anti-inflammatory effects in models of inflammation including colitis and arthritis.",
      "AZD8601 has been shown to have antitumor effects in various models of cancer, including breast cancer and lymphoma."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: AZD8601 does not inhibit B cell activation and proliferation; it is a drug designed to function as a messenger RNA therapy to produce the protein VEGF-A in cardiovascular disease treatment.\n2. FALSE [correction]: AZD8601 does not reduce the production of autoantibodies; it is targeted towards inducing the production of a specific protein for therapeutic effects in cardiovascular disease.\n3. FALSE [correction]: AZD8601 is intended to modulate cardiovascular tissue through the expression of VEGF-A and does not specifically alter the balance between different immune cell populations.\n4. FALSE [correction]: While AZD8601 is designed to have therapeutic benefits in the context of cardiovascular disease by promoting angiogenesis through VEGF-A production, there is no specific mention of anti-inflammatory effects in models of colitis and arthritis in the given statements.\n5. FALSE [correction]: AZD8601 has not been described in the given statements as having antitumor effects; rather, its purpose is related to cardiovascular applications.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-2-7b-chat-hf_response": "SAHFs (Spatially-Organized High-Fidelity Transcription Factors) are created through a process called \"spatially-organized chromatin assembly\". This process involves the recruitment of specific transcription factors to specific genomic regions, where they form complexes with other proteins and DNA to create SAHFs. These complexes are then stable for extended periods of time, allowing for the maintenance of specific gene expression patterns.",
    "llama-2-7b-chat-hf_fact_raw": "1. SAHFs are created through a process called \"spatially-organized chromatin assembly\".\n2. The process involves the recruitment of specific transcription factors to specific genomic regions.\n3. SAHFs form complexes with other proteins and DNA.\n4. Once formed, these complexes are stable for extended periods of time.\n5. The stability of SAHF complexes allows for the maintenance of specific gene expression patterns.",
    "llama-2-7b-chat-hf_fact": [
      "SAHFs are created through a process called \"spatially-organized chromatin assembly\".",
      "The process involves the recruitment of specific transcription factors to specific genomic regions.",
      "SAHFs form complexes with other proteins and DNA.",
      "Once formed, these complexes are stable for extended periods of time.",
      "The stability of SAHF complexes allows for the maintenance of specific gene expression patterns."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\n[Sidenote: Statements about SAHFs (Senescence-Associated Heterochromatin Foci) seem to be generally consistent with the underlying principles of heterochromatin formation and function. However, without specific literature or research studies to confirm the exact processes and stability of SAHF complexes, some statements may not fully capture the complexity and nuances. Hence, while the statements as presented align with general scientific understanding, the verification of each statement would require a more detailed examination of current research.]",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-2-7b-chat-hf_response": "The PDZ domain in SATB1 (Steroidogenic factor 1) is involved in the regulation of protein-protein interactions and the localization of SATB1 to specific subcellular regions. It allows SATB1 to bind to and modulate the activity of other proteins, and to localize to specific subcellular regions where it can regulate gene expression.",
    "llama-2-7b-chat-hf_fact_raw": "1. The PDZ domain in SATB1 is involved in the regulation of protein-protein interactions.\n2. The PDZ domain helps in the localization of SATB1 to specific subcellular regions.\n3. SATB1 can bind to and modulate the activity of other proteins through its PDZ domain.\n4. SATB1 with the help of its PDZ domain can regulate gene expression in specific subcellular regions.",
    "llama-2-7b-chat-hf_fact": [
      "The PDZ domain in SATB1 is involved in the regulation of protein-protein interactions.",
      "The PDZ domain helps in the localization of SATB1 to specific subcellular regions.",
      "SATB1 can bind to and modulate the activity of other proteins through its PDZ domain.",
      "SATB1 with the help of its PDZ domain can regulate gene expression in specific subcellular regions."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The PDZ domain is not a domain found in SATB1. SATB1 contains PDZ-like sequences but not an actual PDZ domain and it is known for its Cut domains and homeodomain that mediate its functions.\n2. FALSE [correction]: Since SATB1 does not have a PDZ domain, it does not utilize this domain for localization. SATB1 localizes to specific nuclear structures known as matrix attachment regions (MARs) through other domains.\n3. UNKNOWN: While SATB1 can indeed bind to and modulate the activity of other proteins, attributing this function specifically to a PDZ domain is incorrect because SATB1 does not contain an actual PDZ domain. The functions of SATB1 in modulating protein activity are mediated by other domains and regions of the protein.\n4. TRUE: SATB1 is known to regulate gene expression and can influence the expression of multiple genes in specific regions of the nucleus. However, this function is not mediated by a PDZ domain, but rather by its ability to bind to DNA at MARs and recruit chromatin remodeling factors.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-2-7b-chat-hf_response": "The basis of the BLISS technique is the use of Bayesian inference to estimate the parameters of a statistical model from observational data. BLISS stands for Bayesian Linear Inverse Problem for Structural Studies, and it is specifically designed for estimating the parameters of a linear regression model in the presence of missing data.",
    "llama-2-7b-chat-hf_fact_raw": "1. The BLISS technique is based on the use of Bayesian inference.\n2. BLISS is an acronym for Bayesian Linear Inverse Problem for Structural Studies.\n3. The BLISS technique is intended for estimating parameters of a linear regression model.\n4. The BLISS technique is designed to work in the presence of missing data.",
    "llama-2-7b-chat-hf_fact": [
      "The BLISS technique is based on the use of Bayesian inference.",
      "BLISS is an acronym for Bayesian Linear Inverse Problem for Structural Studies.",
      "The BLISS technique is intended for estimating parameters of a linear regression model.",
      "The BLISS technique is designed to work in the presence of missing data."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific information about the BLISS technique, such as a detailed description or an academic definition, it is not possible to accurately confirm or correct these statements. If the BLISS technique is a specific, established method with these characteristics in a field such as statistics, physics, or another domain, then detailed information would be necessary to evaluate the veracity of the statements.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-2-7b-chat-hf_response": "Here are three NK3R antagonists:\n1. A-83-01\n2. L-796,532\n3. VPC-10001",
    "llama-2-7b-chat-hf_fact_raw": "1. A-83-01 is an NK3R antagonist.\n2. L-796,532 is an NK3R antagonist.\n3. VPC-10001 is an NK3R antagonist.",
    "llama-2-7b-chat-hf_fact": [
      "A-83-01 is an NK3R antagonist.",
      "L-796,532 is an NK3R antagonist.",
      "VPC-10001 is an NK3R antagonist."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n\nWithout additional context or specific knowledge of these substances and whether they are indeed NK3R (neurokinin 3 receptor) antagonists, it is not possible to determine the truthfulness of these statements. These compounds appear to be labeled in a manner that could suggest they are research chemicals or pharmaceuticals, but without further information, their properties and functions cannot be confirmed.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-2-7b-chat-hf_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is called BMS-986177.",
    "llama-2-7b-chat-hf_fact_raw": "1. BMS-986177 is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.",
    "llama-2-7b-chat-hf_fact": [
      "BMS-986177 is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-2-7b-chat-hf_response": "The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be around 70-80% in preventing clinical illness and 50-60% in preventing severe illness, including hospitalization and death.",
    "llama-2-7b-chat-hf_fact_raw": "1. Vaxchora's protective efficacy against moderate to severe cholera in preventing clinical illness is estimated to be around 70-80%.\n2. Vaxchora's protective efficacy against severe cholera, which includes hospitalization and death, is estimated to be around 50-60%.",
    "llama-2-7b-chat-hf_fact": [
      "Vaxchora's protective efficacy against moderate to severe cholera in preventing clinical illness is estimated to be around 70-80%.",
      "Vaxchora's protective efficacy against severe cholera, which includes hospitalization and death, is estimated to be around 50-60%."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n\n[Explanation]: Without specific data or a reference to a clinical study or regulatory approval documents that provide these efficacy estimates for Vaxchora, it is not possible to validate the accuracy of these statements. These types of statistics would typically be reported in peer-reviewed scientific literature or by public health agencies.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-2-7b-chat-hf_response": "The first cholera vaccine approved in the US was Shanchol, which was approved in 2016.",
    "llama-2-7b-chat-hf_fact_raw": "1. Shanchol was the first cholera vaccine approved in the US.\n2. Shanchol was approved in the US in 2016.",
    "llama-2-7b-chat-hf_fact": [
      "Shanchol was the first cholera vaccine approved in the US.",
      "Shanchol was approved in the US in 2016."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Shanchol is not the first cholera vaccine approved for use in the US; Vaxchora, approved in 2016, is the first.\n2. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-2-7b-chat-hf_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is mutations in the gene encoding the protein TACI, specifically the R40X mutation. This mutation is found in approximately 70% of CVID patients of European descent.",
    "llama-2-7b-chat-hf_fact_raw": "1. The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is mutations in the gene encoding the protein TACI.\n2. The specific mutation associated with CVID in Europeans is R40X.\n3. Approximately 70% of CVID patients of European descent have the R40X mutation.",
    "llama-2-7b-chat-hf_fact": [
      "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is mutations in the gene encoding the protein TACI.",
      "The specific mutation associated with CVID in Europeans is R40X.",
      "Approximately 70% of CVID patients of European descent have the R40X mutation."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: The specific mutation frequently associated with CVID in Europeans is C104R, not R40X.\n3. FALSE [correction]: The R40X mutation, or any other specific mutation in TACI, is not found in 70% of CVID patients. The prevalence of TACI mutations among CVID patients is much lower.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-2-7b-chat-hf_response": "The IFIT1 gene has been found to be associated with an increased risk of developing Systemic Lupus Erythematosus (SLE) in some studies. The exact role of the IFIT1 gene in SLE is not fully understood, but it is thought to play a role in the immune system and the development of autoantibodies.",
    "llama-2-7b-chat-hf_fact_raw": "1. The IFIT1 gene is associated with an increased risk of developing Systemic Lupus Erythematosus (SLE) according to some studies.\n2. The exact role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE) is not fully understood.\n3. The IFIT1 gene is thought to play a role in the immune system.\n4. The IFIT1 gene is believed to be involved in the development of autoantibodies in SLE.",
    "llama-2-7b-chat-hf_fact": [
      "The IFIT1 gene is associated with an increased risk of developing Systemic Lupus Erythematosus (SLE) according to some studies.",
      "The exact role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE) is not fully understood.",
      "The IFIT1 gene is thought to play a role in the immune system.",
      "The IFIT1 gene is believed to be involved in the development of autoantibodies in SLE."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE: Some studies suggest that variations in the IFIT1 gene, among others, are associated with an increased risk of developing Systemic Lupus Erythematosus (SLE).\n2. TRUE: The exact role of the IFIT1 gene in the pathogenesis of Systemic Lupus Erythematosus (SLE) is complex and not fully understood, as is typical with the genetic contributions to many autoimmune diseases.\n3. TRUE: The IFIT1 gene is known to be involved in the immune response, particularly in the interferon response, which is relevant to autoimmune disorders such as SLE.\n4. UNKNOWN: While the IFIT1 gene does play a role in the immune system and could influence the development or maintenance of autoimmunity, without specific evidence or studies detailing its involvement in the development of autoantibodies in SLE, the statement remains uncertain.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-2-7b-chat-hf_response": "The Liverpool Elbow Score is a clinical assessment tool used to evaluate the severity of elbow pain and stiffness in patients with tennis elbow (lateral epicondylitis) or golfer's elbow (medial epicondylitis). The score is based on a combination of six components: pain, tenderness, grip strength, palmar tunnel syndrome, elbow range of motion, and functional ability. The score can help healthcare providers determine the severity of the condition and monitor progress after treatment.",
    "llama-2-7b-chat-hf_fact_raw": "1. The Liverpool Elbow Score is used to evaluate the severity of elbow pain and stiffness in patients.\n2. The tool is specifically employed for cases of tennis elbow (lateral epicondylitis) or golfer's elbow (medial epicondylitis).\n3. The Liverpool Elbow Score includes six components: pain, tenderness, grip strength, palmar tunnel syndrome, elbow range of motion, and functional ability.\n4. The score assists healthcare providers in determining the severity of elbow conditions.\n5. It is also used to monitor patient progress after treatment.",
    "llama-2-7b-chat-hf_fact": [
      "The Liverpool Elbow Score is used to evaluate the severity of elbow pain and stiffness in patients.",
      "The tool is specifically employed for cases of tennis elbow (lateral epicondylitis) or golfer's elbow (medial epicondylitis).",
      "The Liverpool Elbow Score includes six components: pain, tenderness, grip strength, palmar tunnel syndrome, elbow range of motion, and functional ability.",
      "The score assists healthcare providers in determining the severity of elbow conditions.",
      "It is also used to monitor patient progress after treatment."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. UNKNOWN\n3. FALSE [correction]: The Liverpool Elbow Score includes five components: pain, function, social-psychological, daily living, and social function.\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-2-7b-chat-hf_response": "The 100,000 Genomes Project was a large-scale genomics initiative launched in 2012 in the UK with the goal of analyzing the genomes of 100,000 individuals, including those with rare and aggressive cancers such as sarcoma. The project aimed to identify genetic variations associated with these cancers and to develop new diagnostic and treatment approaches.\nSarcoma is a rare and complex cancer that arises from the abnormal growth of connective tissue cells, such as bone, cartilage, and fat. There are over 50 subtypes of sarcoma, each with different genetic mutations and clinical behaviors. Despite their rarity, sarcomas account for approximately 1% of all adult cancers and 15% of all pediatric cancers.\nThe 100,000 Genomes Project included a significant number of sarcoma cases, and the data generated from these analyses have contributed to a better understanding of the genetic landscape of this disease. Some of the key findings from the project include:\n1. High frequency of genetic alterations: The project identified a high frequency of genetic alterations in sarcoma cases, including point mutations, copy number variations, and structural variations. These alterations were found to be specific to each subtype of sarcoma, highlighting the diversity of genetic changes in this disease.\n2. Identification of new therapeutic targets: The project identified several potential therapeutic targets for sarcoma, including genes involved in cell signaling pathways, DNA repair, and cell cycle regulation. These findings may lead to the development of new targeted therapies for sarcoma.\n3. Improved diagnostic accuracy: The project demonstrated the potential of genomic analysis for improving diagnostic accuracy in sarcoma. By analyzing the genomic profiles of sarcoma cases, clinicians may be able to identify specific genetic markers that can help distinguish between different subtypes of sarcoma and distinguish between sarcoma and other types of cancer.\n4. Identification of novel prognostic markers: The project identified several novel prognostic markers for sarcoma, including genes involved in cell proliferation and apoptosis.",
    "llama-2-7b-chat-hf_fact_raw": "1. The 100,000 Genomes Project was initiated in 2012 in the UK to analyze the genomes of 100,000 individuals, including those with sarcoma.\n2. Sarcomas constitute approximately 1% of all adult cancers and 15% of all pediatric cancers.\n3. The 100,000 Genomes Project has identified a high frequency of genetic alterations such as point mutations, copy number variations, and structural variations in sarcoma cases.\n4. The project has identified several potential therapeutic targets for sarcoma that are involved in cell signaling pathways, DNA repair, and cell cycle regulation.\n5. The genomic analysis from the 100,000 Genomes Project has the potential to improve diagnostic accuracy for sarcoma by identifying specific genetic markers.",
    "llama-2-7b-chat-hf_fact": [
      "The 100,000 Genomes Project was initiated in 2012 in the UK to analyze the genomes of 100,000 individuals, including those with sarcoma.",
      "Sarcomas constitute approximately 1% of all adult cancers and 15% of all pediatric cancers.",
      "The 100,000 Genomes Project has identified a high frequency of genetic alterations such as point mutations, copy number variations, and structural variations in sarcoma cases.",
      "The project has identified several potential therapeutic targets for sarcoma that are involved in cell signaling pathways, DNA repair, and cell cycle regulation.",
      "The genomic analysis from the 100,000 Genomes Project has the potential to improve diagnostic accuracy for sarcoma by identifying specific genetic markers."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-2-7b-chat-hf_response": "Yes, ALEX1 protein contains multiple armadillo repeats.",
    "llama-2-7b-chat-hf_fact_raw": "1. Protein ALEX1 contains armadillo repeats.",
    "llama-2-7b-chat-hf_fact": [
      "Protein ALEX1 contains armadillo repeats."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-2-7b-chat-hf_response": "There are several enzymes that remove histone modifications, including:\n1. Histone demethylases: These enzymes remove methyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone demethylases include KDM4B, KDM5, and JMJD2.\n2. Histone acetyltransferases: These enzymes add acetyl groups to histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone acetyltransferases include p300 and CBP (CREB-binding protein).\n3. Histone deacetylases: These enzymes remove acetyl groups from histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone deacetylases include HDAC1, HDAC2, and HDAC3.\n4. Histone ubiquitin ligases: These enzymes remove histone modifications by ubiquitinating them, leading to their degradation. Examples of histone ubiquitin ligases include ARF-BP1 and RING1B.\n5. Histone chaperones: These enzymes help to regulate the folding and unfolding of histone proteins, which can affect their interactions with other proteins and their ability to modify chromatin. Examples of histone chaperones include HSP90 and HSP70.\n6. Histone-specific proteases: These enzymes degrade histone proteins, leading to changes in chromatin structure and gene expression. Examples of histone-specific proteases include histone-specific protease 1 (HSPP1) and histone-specific protease 2 (HSPP2).\n7. Ubiquitin-specific proteases: These enzymes degrade ubiquitinated histone proteins, leading to their removal from chromatin. Examples of ubiquitin-specific proteases include USP1 and USP9X.\n8. Chromodomain-containing proteins: These enzymes recognize and remove specific histone modifications, leading to changes in chromatin structure and gene expression. Examples of chromodomain-containing proteins include CHD1, CHD2",
    "llama-2-7b-chat-hf_fact_raw": "1. Histone demethylase enzymes, such as KDM4B, KDM5, and JMJD2, remove methyl groups from histone proteins.\n2. Histone acetyltransferases, such as p300 and CBP (CREB-binding protein), add acetyl groups to histone proteins.\n3. Histone deacetylases, such as HDAC1, HDAC2, and HDAC3, remove acetyl groups from histone proteins.\n4. Histone ubiquitin ligases, such as ARF-BP1 and RING1B, remove histone modifications by ubiquitination leading to degradation.\n5. Histone-specific proteases, such as histone-specific protease 1 (HSPP1) and histone-specific protease 2 (HSPP2), degrade histone proteins.",
    "llama-2-7b-chat-hf_fact": [
      "Histone demethylase enzymes, such as KDM4B, KDM5, and JMJD2, remove methyl groups from histone proteins.",
      "Histone acetyltransferases, such as p300 and CBP (CREB-binding protein), add acetyl groups to histone proteins.",
      "Histone deacetylases, such as HDAC1, HDAC2, and HDAC3, remove acetyl groups from histone proteins.",
      "Histone ubiquitin ligases, such as ARF-BP1 and RING1B, remove histone modifications by ubiquitination leading to degradation.",
      "Histone-specific proteases, such as histone-specific protease 1 (HSPP1) and histone-specific protease 2 (HSPP2), degrade histone proteins."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Histone ubiquitin ligases, such as ARF-BP1 and RING1B, add ubiquitin groups to histones, which can signal for different processes, one of which is degradation, but the ubiquitination itself does not remove histone modifications.\n5. FALSE [correction]: There are no enzymes specifically named \"histone-specific protease 1 (HSPP1)\" and \"histone-specific protease 2 (HSPP2)\" that degrade histone proteins. Histone proteins can be degraded by the proteasome, a protease complex, following ubiquitination, but not by proteases with these names.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-2-7b-chat-hf_response": "No, head CT scans are not known to increase the risk of developing a brain tumor. While CT scans use ionizing radiation, which can increase the risk of cancer, the risk associated with a single CT scan is relatively low and is unlikely to cause a brain tumor. However, it is important to weigh the potential benefits and risks of a CT scan in any given situation and to discuss any concerns with a healthcare professional.",
    "llama-2-7b-chat-hf_fact_raw": "1. Head CT scans use ionizing radiation.\n2. Ionizing radiation can increase the risk of cancer.\n3. The risk associated with a single CT scan is relatively low.\n4. A single CT scan is unlikely to cause a brain tumor.\n5. It is important to weigh the potential benefits and risks of a CT scan with a healthcare professional.",
    "llama-2-7b-chat-hf_fact": [
      "Head CT scans use ionizing radiation.",
      "Ionizing radiation can increase the risk of cancer.",
      "The risk associated with a single CT scan is relatively low.",
      "A single CT scan is unlikely to cause a brain tumor.",
      "It is important to weigh the potential benefits and risks of a CT scan with a healthcare professional."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-2-7b-chat-hf_response": "Otx2 is associated with neural pluripotency.",
    "llama-2-7b-chat-hf_fact_raw": "1. Otx2 is associated with neural pluripotency.",
    "llama-2-7b-chat-hf_fact": [
      "Otx2 is associated with neural pluripotency."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Otx2 is not typically associated with neural pluripotency. Instead, it is a gene critical for the development of the brain and eyes during embryogenesis. Transcription factors more commonly associated with pluripotency include OCT4, SOX2, and NANOG.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-2-7b-chat-hf_response": "The murine beta globin locus region has approximately 20-25 DNaseI hypersensitive sites (DHS).",
    "llama-2-7b-chat-hf_fact_raw": "1. The murine beta globin locus region has approximately 20-25 DNaseI hypersensitive sites.",
    "llama-2-7b-chat-hf_fact": [
      "The murine beta globin locus region has approximately 20-25 DNaseI hypersensitive sites."
    ],
    "llama-2-7b-chat-hf_judge_raw": "UNKNOWN\n\nExplanation: Without specific context such as research findings, the number of DNaseI hypersensitive sites in the murine beta globin locus region cannot be confirmed as it requires specialized scientific knowledge and might be subject to findings from particular studies.",
    "llama-2-7b-chat-hf_judge": [
      "unknown"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-2-7b-chat-hf_response": "Here are some European influenza vaccines:\n1. Fluarix Tetra (GlaxoSmithKline) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n2. Fluvirin (Novartis) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n3. Fluad (GlaxoSmithKline) - contains inactivated influenza viruses of four strains (two A strains and two B strains), as well as a weakened H1N1 strain\n4. Flucelvax (Novartis) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n5. Fluarix (GlaxoSmithKline) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n6. Vaxigrip (Sanofi Pasteur) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n7. Aflunax (Baxter) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n8. Fluvir (Boehringer Ingelheim) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n9. Flu-Tetra (Cangene) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\n10. Flu-Vac (ID Biomedical) - contains inactivated influenza viruses of four strains (two A strains and two B strains)\nPlease note that this list may not be exhaustive and is subject to change as new vaccines are developed and approved. It's always best to consult with a healthcare professional for the most up-to-date information on available vaccines.",
    "llama-2-7b-chat-hf_fact_raw": "1. Fluarix Tetra, manufactured by GlaxoSmithKline, contains inactivated influenza viruses of four strains (two A strains and two B strains).\n2. Fluvirin, produced by Novartis, contains inactivated influenza viruses of four strains (two A strains and two B strains).\n3. Fluad, by GlaxoSmithKline, contains inactivated influenza viruses of four strains (two A strains and two B strains) and a weakened H1N1 strain.\n4. Flucelvax, produced by Novartis, contains inactivated influenza viruses of four strains (two A strains and two B strains).\n5. Vaxigrip, manufactured by Sanofi Pasteur, contains inactivated influenza viruses of four strains (two A strains and two B strains).",
    "llama-2-7b-chat-hf_fact": [
      "Fluarix Tetra, manufactured by GlaxoSmithKline, contains inactivated influenza viruses of four strains (two A strains and two B strains).",
      "Fluvirin, produced by Novartis, contains inactivated influenza viruses of four strains (two A strains and two B strains).",
      "Fluad, by GlaxoSmithKline, contains inactivated influenza viruses of four strains (two A strains and two B strains) and a weakened H1N1 strain.",
      "Flucelvax, produced by Novartis, contains inactivated influenza viruses of four strains (two A strains and two B strains).",
      "Vaxigrip, manufactured by Sanofi Pasteur, contains inactivated influenza viruses of four strains (two A strains and two B strains)."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Fluvirin, previously produced by Novartis, contains inactivated influenza viruses, but it traditionally contained three strains (two A strains and one B strain), not four. Additionally, the production and distribution of Fluvirin have been discontinued in the United States.\n3. FALSE [correction]: Fluad, manufactured by Seqirus, contains inactivated influenza virus of three strains (two A strains and one B strain) and an adjuvant to help create a stronger immune response. It does not contain a weakened H1N1 strain.\n4. FALSE [correction]: Flucelvax, produced by Seqirus, not Novartis, contains inactivated influenza viruses of four strains (two A strains and two B strains).\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-2-7b-chat-hf_response": "Yes, the geneome of Paramyxovirus is segmented, negative-sense RNA.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-2-7b-chat-hf_response": "Roflumilast cream is effective for the treatment of plaque psoriasis.",
    "llama-2-7b-chat-hf_fact_raw": "1. Roflumilast cream is used in the treatment of plaque psoriasis.",
    "llama-2-7b-chat-hf_fact": [
      "Roflumilast cream is used in the treatment of plaque psoriasis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Roflumilast is primarily known as an orally administered drug used for treating chronic obstructive pulmonary disease (COPD). As of my last update, there is no widely recognized use of a formulation of roflumilast as a cream specifically for the treatment of plaque psoriasis. However, medications can have off-label uses or be under research for new applications, so this status could change.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-2-7b-chat-hf_response": "Several tools have been developed for identifying and visualizing non-coding RNA (ncRNA) promoters. Some of the popular tools include:\n1. RNAhybrid: This tool uses a hidden Markov model to identify putative promoter regions in ncRNA genes. It can also predict the orientation and strength of the promoter.\n2. PrognoseR: This tool uses a Bayesian approach to predict the location and strength of ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n3. PROMoterFinder: This tool uses a combination of machine learning algorithms and feature-based methods to identify ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n4. RNApromoter: This tool uses a combination of sequence and structural features to predict the location and strength of ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n5. ncRNApromoter: This tool uses a combination of machine learning algorithms and feature-based methods to identify ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n6. CpG-RNA: This tool uses a combination of sequence and chromatin structure features to predict the location and strength of ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n7. RNApromoterFinder: This tool uses a combination of machine learning algorithms and feature-based methods to identify ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n8. RNApromoterLocator: This tool uses a combination of sequence and structural features to predict the location of ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n9. ncRNApromoterLocator: This tool uses a combination of machine learning algorithms and feature-based methods to identify ncRNA promoters. It can also predict the transcriptional orientation and the presence of regulatory elements.\n10. RNApromoterVisualizer: This tool uses a combination of sequence and structural features to visualize the location",
    "llama-2-7b-chat-hf_fact_raw": "1. RNAhybrid is a tool that identifies putative promoter regions in ncRNA genes using a hidden Markov model.\n2. PrognoseR predicts the location and strength of ncRNA promoters using a Bayesian approach.\n3. PROMoterFinder identifies ncRNA promoters by combining machine learning algorithms and feature-based methods.\n4. RNApromoter predicts the location and strength of ncRNA promoters through a combination of sequence and structural features.\n5. CpG-RNA uses sequence and chromatin structure features to predict the location and strength of ncRNA promoters.",
    "llama-2-7b-chat-hf_fact": [
      "RNAhybrid is a tool that identifies putative promoter regions in ncRNA genes using a hidden Markov model.",
      "PrognoseR predicts the location and strength of ncRNA promoters using a Bayesian approach.",
      "PROMoterFinder identifies ncRNA promoters by combining machine learning algorithms and feature-based methods.",
      "RNApromoter predicts the location and strength of ncRNA promoters through a combination of sequence and structural features.",
      "CpG-RNA uses sequence and chromatin structure features to predict the location and strength of ncRNA promoters."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: RNAhybrid is a tool that predicts microRNA targets, not putative promoter regions in ncRNA genes.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nExplanation: RNAhybrid is known for its function in miRNA target prediction, not for identifying promoter regions. The tasks and functions of PrognoseR, PROMoterFinder, RNApromoter, and CpG-RNA are not widely recognized or standardized terms, therefore, without specific context or definitions for these terms, their truthfulness cannot be assessed.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-2-7b-chat-hf_response": "The SWIM tool is a computational method for identifying tumor-specific genes in RNA sequencing data. Here are some examples of genes that have been identified as down-regulated in glioblastoma using the SWIM tool:\n1. PTEN (phosphatase and tensin homolog deleted on chromosome 10)\n2. PDCD4 (programmed cell death 4)\n3. TP53 (tumor protein p53)\n4. CDKN2A (cyclin-dependent kinase inhibitor 2A)\n5. CDKN1A (cyclin-dependent kinase inhibitor 1A)\n6. STK11 (serine/threonine kinase 11)\n7. PTCH1 (patched 1)\n8. SMO (smoothened)\nPlease note that these are just a few examples and the list of down-regulated genes may vary depending on the specific dataset and methodology used by the SWIM tool.",
    "llama-2-7b-chat-hf_fact_raw": "1. The SWIM tool is used for identifying tumor-specific genes in RNA sequencing data.\n2. PTEN is identified as a gene down-regulated in glioblastoma by the SWIM tool.\n3. PDCD4 has been identified as a down-regulated gene in glioblastoma using the SWIM tool.\n4. TP53 is among the genes that the SWIM tool has determined to be down-regulated in glioblastoma.\n5. CDKN2A is identified by the SWIM tool as down-regulated in glioblastoma.",
    "llama-2-7b-chat-hf_fact": [
      "The SWIM tool is used for identifying tumor-specific genes in RNA sequencing data.",
      "PTEN is identified as a gene down-regulated in glioblastoma by the SWIM tool.",
      "PDCD4 has been identified as a down-regulated gene in glioblastoma using the SWIM tool.",
      "TP53 is among the genes that the SWIM tool has determined to be down-regulated in glioblastoma.",
      "CDKN2A is identified by the SWIM tool as down-regulated in glioblastoma."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. True\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe SWIM tool (Somewhat of a Misnomer for Identifying Modules) is indeed designed for the identification of modules of tumor-specific genes in RNA sequencing data, making statement 1 true. However, without specific results presented from a study that used the SWIM tool to analyze glioblastoma RNA sequencing data, the claims regarding the regulation of PTEN, PDCD4, TP53, and CDKN2A (statements 2, 3, 4, and 5) cannot be accurately assessed as true or false, thus they are marked as UNKNOWN.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-2-7b-chat-hf_response": "There are several R packages that have been developed for studying Topologically Associating Domains (TADs), including:\n1. TADbit: A package for the analysis of TADs in chromatin interaction data.\n2. TADseq: A package for the analysis of TADs in sequencing data.\n3. Topolog: A package for the analysis of TADs in 3D chromatin structure.\n4. ChromHMM: A package for the analysis of TADs in chromatin structure and gene regulation.\n5. TADtrack: A package for the analysis of TADs in gene expression data.\nThese packages provide a range of functions for identifying, characterizing, and interpreting TADs, including the ability to analyze chromatin interaction data, gene expression data, and 3D chromatin structure data.",
    "llama-2-7b-chat-hf_fact_raw": "1. TADbit is an R package developed for analyzing Topologically Associating Domains in chromatin interaction data.\n2. TADseq is an R package developed for analyzing Topologically Associating Domains in sequencing data.\n3. Topolog is an R package developed for analyzing Topologically Associating Domains in 3D chromatin structure.\n4. ChromHMM is an R package developed for analyzing Topologically Associating Domains in chromatin structure and gene regulation.\n5. TADtrack is an R package developed for analyzing Topologically Associating Domains in gene expression data.",
    "llama-2-7b-chat-hf_fact": [
      "TADbit is an R package developed for analyzing Topologically Associating Domains in chromatin interaction data.",
      "TADseq is an R package developed for analyzing Topologically Associating Domains in sequencing data.",
      "Topolog is an R package developed for analyzing Topologically Associating Domains in 3D chromatin structure.",
      "ChromHMM is an R package developed for analyzing Topologically Associating Domains in chromatin structure and gene regulation.",
      "TADtrack is an R package developed for analyzing Topologically Associating Domains in gene expression data."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: As of my knowledge cutoff in 2023, there is no widely recognized R package specifically named \"TADseq\" for analyzing Topologically Associating Domains in sequencing data. However, TADbit, mentioned in statement 1, can analyze sequencing data to study TADs.\n3. UNKNOWN: Without more context or information, it is difficult to determine the veracity of this statement. \"Topolog\" is not well-known, or may not exist as an R package for this specific purpose.\n4. FALSE [correction]: ChromHMM is a software tool that uses a hidden Markov model to learn and characterize chromatin states, but it is not specifically an R package nor is it primarily for analyzing Topologically Associating Domains in chromatin structure and gene regulation. It is better known for identifying chromatin states across the genome.\n5. UNKNOWN: As of my knowledge cutoff in 2023, there is no widely recognized R package specifically named \"TADtrack\" for analyzing Topologically Associating Domains in gene expression data. Without additional information or context, I cannot verify the truth of this statement.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-2-7b-chat-hf_response": "The Bioconductor tool that has been developed for accessing bacterial regulatory networks is called \"BioCyc\".",
    "llama-2-7b-chat-hf_fact_raw": "1. The Bioconductor tool developed for accessing bacterial regulatory networks is called \"BioCyc\".",
    "llama-2-7b-chat-hf_fact": [
      "The Bioconductor tool developed for accessing bacterial regulatory networks is called \"BioCyc\"."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: The Bioconductor tool for accessing bacterial regulatory networks is not called \"BioCyc\"; instead, \"BioCyc\" is a collection of Pathway/Genome Databases, while Bioconductor provides tools for the analysis and comprehension of high-throughput genomic data.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-2-7b-chat-hf_response": "The end products of the shikimate pathway are aromatic amino acids, including phenylalanine, tyrosine, and tryptophan, as well as the antibiotic erythromycin.",
    "llama-2-7b-chat-hf_fact_raw": "1. The end products of the shikimate pathway include aromatic amino acids such as phenylalanine, tyrosine, and tryptophan.\n2. The antibiotic erythromycin is also an end product of the shikimate pathway.",
    "llama-2-7b-chat-hf_fact": [
      "The end products of the shikimate pathway include aromatic amino acids such as phenylalanine, tyrosine, and tryptophan.",
      "The antibiotic erythromycin is also an end product of the shikimate pathway."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. FALSE [correction]: Erythromycin is produced by the bacterium Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus) and is not a direct end product of the shikimate pathway; however, erythromycin is a secondary metabolite derived from primary metabolites, which include precursors from the shikimate pathway.",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "false"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-2-7b-chat-hf_response": "Yes, cabergoline is used for the treatment of Nelson's syndrome, which is a rare condition that can occur after surgery or radiation therapy for pituitary tumors. Cabergoline can help to reduce the growth of the tumor and alleviate symptoms such as headache, vision problems, and hormonal imbalances.",
    "llama-2-7b-chat-hf_fact_raw": "1. Cabergoline is used for the treatment of Nelson's syndrome.\n2. Nelson's syndrome can occur after surgery or radiation therapy for pituitary tumors.\n3. Cabergoline can help to reduce the tumor growth associated with Nelson's syndrome.\n4. Symptoms of Nelson's syndrome may include headache and vision problems.\n5. Hormonal imbalances can be a symptom of Nelson's syndrome.",
    "llama-2-7b-chat-hf_fact": [
      "Cabergoline is used for the treatment of Nelson's syndrome.",
      "Nelson's syndrome can occur after surgery or radiation therapy for pituitary tumors.",
      "Cabergoline can help to reduce the tumor growth associated with Nelson's syndrome.",
      "Symptoms of Nelson's syndrome may include headache and vision problems.",
      "Hormonal imbalances can be a symptom of Nelson's syndrome."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Cabergoline is used for the treatment of prolactinomas, which are pituitary tumors that produce the hormone prolactin. Nelson's syndrome involves the growth of ACTH-secreting pituitary tumors after the removal of adrenal glands and is not primarily treated with cabergoline.\n2. TRUE\n3. FALSE [correction]: Though cabergoline is effective for prolactinomas, it is not the standard treatment for Nelson's syndrome, which typically involves corticotroph adenomas. These may require different management strategies including surgery, radiation therapy, or medication to suppress ACTH.\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-2-7b-chat-hf_response": "The main manifestation of Liebenberg syndrome is the presence of multiple, painful, and tender nodules on the hands and feet, known as \"Liebenberg nodules.\" These nodules are usually found on the palmar surfaces of the hands and the plantar surfaces of the feet.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-2-7b-chat-hf_response": "There are several orally bioavailable MPS1 kinase inhibitors that have been identified and investigated for the treatment of various diseases, including cancer and neurodegenerative disorders. Here are some examples:\n1. AZD3965: A potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer.\n2. BAY-1000394: A highly selective MPS1 kinase inhibitor that has been shown to have antitumor activity in preclinical studies and is being investigated for the treatment of various cancers.\n3. BAY-1003956: A potent and selective MPS1 kinase inhibitor that has been shown to have antitumor activity in preclinical studies and is being investigated for the treatment of various cancers.\n4. LB-100: A potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer.\n5. MLN0128: A potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer.\n6. RX-0201: A potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer.\n7. RX-0202: A potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer.\n8. S63845: A potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various cancers, including breast, lung, and colon cancer.\n9. S64045: A potent and selective MPS1 kinase inhibitor that has shown promise in preclinical studies for the treatment of various can",
    "llama-2-7b-chat-hf_fact_raw": "1. AZD3965 is a potent and selective MPS1 kinase inhibitor that has been investigated in preclinical studies for the treatment of various cancers.\n2. BAY-1000394 is a highly selective MPS1 kinase inhibitor that has shown antitumor activity in preclinical studies.\n3. LB-100 is a potent and selective MPS1 kinase inhibitor that has been studied preclinically for the treatment of various cancers.\n4. MLN0128 is a potent and selective MPS1 kinase inhibitor that has been investigated in preclinical studies for the treatment of various cancers.\n5. RX-0201 is a potent and selective MPS1 kinase inhibitor that has been the subject of preclinical studies for cancer treatment.",
    "llama-2-7b-chat-hf_fact": [
      "AZD3965 is a potent and selective MPS1 kinase inhibitor that has been investigated in preclinical studies for the treatment of various cancers.",
      "BAY-1000394 is a highly selective MPS1 kinase inhibitor that has shown antitumor activity in preclinical studies.",
      "LB-100 is a potent and selective MPS1 kinase inhibitor that has been studied preclinically for the treatment of various cancers.",
      "MLN0128 is a potent and selective MPS1 kinase inhibitor that has been investigated in preclinical studies for the treatment of various cancers.",
      "RX-0201 is a potent and selective MPS1 kinase inhibitor that has been the subject of preclinical studies for cancer treatment."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: AZD3965 is not an MPS1 kinase inhibitor; it is a monocarboxylate transporter 1 (MCT1) inhibitor that has been investigated in preclinical studies for the treatment of various cancers.\n2. UNKNOWN: Without further information, the selective activity of BAY-1000394 on MPS1 kinase can't be determined, as there are no well-known inhibitors by this name. More context is needed to validate the claim.\n3. FALSE [correction]: LB-100 is not an MPS1 kinase inhibitor; it is a small molecule inhibitor of protein phosphatase 2A (PP2A) that has been studied in clinical trials for the treatment of various cancers.\n4. FALSE [correction]: MLN0128 (also known as sapanisertib) is a dual mTORC1/mTORC2 inhibitor, not an MPS1 kinase inhibitor, that has been investigated in clinical trials for cancer treatment.\n5. FALSE [correction]: RX-0201 (also known as archexin) is a Akt1 antisense oligonucleotide, not an MPS1 kinase inhibitor, that has been studied in preclinical and clinical trials for the treatment of cancer.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-2-7b-chat-hf_response": "No, golimumab has not been tested for the treatment of diabetes. It is a medication used to treat certain autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.",
    "llama-2-7b-chat-hf_fact_raw": "1. Golimumab has not been tested for the treatment of diabetes.\n2. Golimumab is used to treat certain autoimmune diseases.\n3. Golimumab is used to treat rheumatoid arthritis.\n4. Golimumab is used to treat psoriatic arthritis.\n5. Golimumab is used to treat ulcerative colitis.",
    "llama-2-7b-chat-hf_fact": [
      "Golimumab has not been tested for the treatment of diabetes.",
      "Golimumab is used to treat certain autoimmune diseases.",
      "Golimumab is used to treat rheumatoid arthritis.",
      "Golimumab is used to treat psoriatic arthritis.",
      "Golimumab is used to treat ulcerative colitis."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-2-7b-chat-hf_response": "Yes, Progeria, also known as Hutchinson-Gilford Progeria Syndrome, is caused by an autosomal recessive mutation in the LMNA gene.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-2-7b-chat-hf_response": "The 12q14 and 12q24 regions of the human genome have been associated with several common variants that are associated with an increased risk of developing certain diseases, including:\n12q14:\n* Type 2 diabetes: Variants in the KCNJ11, GCKR, and HHEX genes in the 12q14 region have been associated with an increased risk of developing type 2 diabetes.\n* Obesity: Variants in the FTO gene in the 12q14 region have been associated with an increased risk of obesity and weight gain.\n* Cardiovascular disease: Variants in the LPA gene in the 12q14 region have been associated with an increased risk of cardiovascular disease, including heart attack and stroke.\n12q24:\n* Prostate cancer: Variants in the BRCA1 and BRCA2 genes in the 12q24 region have been associated with an increased risk of developing prostate cancer.\n* Breast cancer: Variants in the BRCA1 and BRCA2 genes in the 12q24 region have been associated with an increased risk of developing breast cancer.\n* Ovarian cancer: Variants in the BRCA1 and BRCA2 genes in the 12q24 region have been associated with an increased risk of developing ovarian cancer.\nIt's important to note that the risk of developing these diseases is increased, but not all individuals with these variants will necessarily develop the disease. Additionally, there are many other genetic and environmental factors that can contribute to the development of these diseases.",
    "llama-2-7b-chat-hf_fact_raw": "1. Variants in the KCNJ11, GCKR, and HHEX genes in the 12q14 region of the human genome are associated with an increased risk of developing type 2 diabetes.\n2. Variants in the FTO gene in the 12q14 region are associated with an increased risk of obesity and weight gain.\n3. Variants in the LPA gene in the 12q14 region are associated with an increased risk of cardiovascular disease, including heart attack and stroke.\n4. Variants in the BRCA1 and BRCA2 genes in the 12q24 region are associated with an increased risk of developing prostate cancer.\n5. Variants in the BRCA1 and BRCA2 genes in the 12q24 region are associated with an increased risk of developing breast and ovarian cancer.",
    "llama-2-7b-chat-hf_fact": [
      "Variants in the KCNJ11, GCKR, and HHEX genes in the 12q14 region of the human genome are associated with an increased risk of developing type 2 diabetes.",
      "Variants in the FTO gene in the 12q14 region are associated with an increased risk of obesity and weight gain.",
      "Variants in the LPA gene in the 12q14 region are associated with an increased risk of cardiovascular disease, including heart attack and stroke.",
      "Variants in the BRCA1 and BRCA2 genes in the 12q24 region are associated with an increased risk of developing prostate cancer.",
      "Variants in the BRCA1 and BRCA2 genes in the 12q24 region are associated with an increased risk of developing breast and ovarian cancer."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Variants in the LPA gene are associated with an increased risk of cardiovascular disease, but LPA is located at the 6q26-27 region, not the 12q14 region.\n4. FALSE [correction]: Variants in the BRCA1 and BRCA2 genes are associated with an increased risk of developing breast and ovarian cancer, and there's an elevated risk for other cancers including male breast cancer and prostate cancer, but the BRCA1 and BRCA2 genes are located on the 17q21 and 13q13 regions respectively, not the 12q24 region.\n5. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-2-7b-chat-hf_response": "The ligands of the Roundabout (Robo) receptors are the Robo ligands, which include Robo1, Robo2, Robo3, and Robo4. These ligands bind to the Robo receptors and activate or inhibit their signaling pathways.",
    "llama-2-7b-chat-hf_fact_raw": "NO FACTS",
    "llama-2-7b-chat-hf_fact": [],
    "llama-2-7b-chat-hf_judge": []
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-2-7b-chat-hf_response": "Yes, TFII-I has been shown to play a role in megakaryopoiesis, the process by which megakaryocytes (blood cells that give rise to platelets) develop from hematopoietic stem cells.",
    "llama-2-7b-chat-hf_fact_raw": "1. TFII-I plays a role in megakaryopoiesis.\n2. Megakaryopoiesis is the process through which megakaryocytes develop.\n3. Megakaryocytes are blood cells that give rise to platelets.\n4. Megakaryocytes develop from hematopoietic stem cells.",
    "llama-2-7b-chat-hf_fact": [
      "TFII-I plays a role in megakaryopoiesis.",
      "Megakaryopoiesis is the process through which megakaryocytes develop.",
      "Megakaryocytes are blood cells that give rise to platelets.",
      "Megakaryocytes develop from hematopoietic stem cells."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-2-7b-chat-hf_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-2-7b-chat-hf_response": "Yes, atenolol is metabolized by CYP2D6.",
    "llama-2-7b-chat-hf_fact_raw": "1. Atenolol is metabolized by CYP2D6.",
    "llama-2-7b-chat-hf_fact": [
      "Atenolol is metabolized by CYP2D6."
    ],
    "llama-2-7b-chat-hf_judge_raw": "FALSE [correction]: Atenolol is not significantly metabolized by the liver, and it is not metabolized by the enzyme CYP2D6. It is primarily excreted unchanged in the urine.",
    "llama-2-7b-chat-hf_judge": [
      "false"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-2-7b-chat-hf_response": "ExpansionHunter is a tool for identifying potential gene fusion hotspots in cancer genomes. Here are some versions of ExpansionHunter:\n1. ExpansionHunter 1.0: The initial release of ExpansionHunter, which introduced the concept of using gene fusion hotspot prediction based on the analysis of genomic expansion segments.\n2. ExpansionHunter 2.0: This version included improvements to the algorithms and increased the accuracy of the predictions. It also introduced the ability to predict gene fusions in both coding and non-coding regions.\n3. ExpansionHunter 3.0: This release included several new features, such as the ability to predict gene fusions in multiple cancer types, and the integration of additional genomic data, such as copy number alterations and methylation profiles.\n4. ExpansionHunter 4.0: This version included significant updates to the algorithms and the introduction of a new machine learning-based approach for predicting gene fusions. It also included improved visualization and analysis tools.\n5. ExpansionHunter 5.0: This is the latest version of ExpansionHunter, which includes several new features, such as the ability to predict gene fusions in single-cell RNA-seq data, and the integration of additional genomic data, such as RNA structure and splicing information.\nPlease note that these are the major versions of ExpansionHunter, and there may be additional updates and bug fixes in between these versions.",
    "llama-2-7b-chat-hf_fact_raw": "1. ExpansionHunter 1.0 was the initial release that introduced the concept of using gene fusion hotspot prediction based on the analysis of genomic expansion segments.\n2. ExpansionHunter 2.0 improved prediction algorithms and included the ability to predict gene fusions in both coding and non-coding regions.\n3. ExpansionHunter 3.0 introduced features for predicting gene fusions in multiple cancer types and integrated additional genomic data, such as copy number alterations and methylation profiles.\n4. ExpansionHunter 4.0 involved updates to the algorithms and introduced a machine learning-based approach for predicting gene fusions.\n5. ExpansionHunter 5.0 includes the ability to predict gene fusions in single-cell RNA-seq data and integrates additional genomic data, such as RNA structure and splicing information.",
    "llama-2-7b-chat-hf_fact": [
      "ExpansionHunter 1.0 was the initial release that introduced the concept of using gene fusion hotspot prediction based on the analysis of genomic expansion segments.",
      "ExpansionHunter 2.0 improved prediction algorithms and included the ability to predict gene fusions in both coding and non-coding regions.",
      "ExpansionHunter 3.0 introduced features for predicting gene fusions in multiple cancer types and integrated additional genomic data, such as copy number alterations and methylation profiles.",
      "ExpansionHunter 4.0 involved updates to the algorithms and introduced a machine learning-based approach for predicting gene fusions.",
      "ExpansionHunter 5.0 includes the ability to predict gene fusions in single-cell RNA-seq data and integrates additional genomic data, such as RNA structure and splicing information."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: ExpansionHunter is software developed by Illumina for the analysis of repeat expansions in genetic data, not for gene fusion hotspot prediction.\n2. UNKNOWN: Without specific release notes or documentation for ExpansionHunter 2.0, the improvements over the initial release cannot be confirmed.\n3. UNKNOWN: There is not enough information provided to confirm if these specific features were introduced in ExpansionHunter 3.0.\n4. UNKNOWN: Without specific details or documentation, it is unclear if a machine learning-based approach was introduced in ExpansionHunter 4.0.\n5. UNKNOWN: Information is insufficient to verify the capabilities of ExpansionHunter 5.0 regarding single-cell RNA-seq data and additional genomic data integration.\n\nThe responses above are based on the typical understanding that ExpansionHunter deals with repeat expansions, particularly in the context of genomics and genetic research. If this task assumes a fictional scenario where there is a hypothetical software named ExpansionHunter with versions focused on gene fusions, then all responses would need to be marked as UNKNOWN given the lack of context provided.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-2-7b-chat-hf_response": "Adamts18 (A Disintegrin and Metalloproteinase Domain-Containing Protein 18) is involved in the regulation of hormone receptor signaling, specifically in the context of estrogen receptor (ER) signaling. Adamts18 is an extracellular matrix protein that can interact with and modulate the activity of ER, influencing the response to estrogen and other hormones. Specifically, Adamts18 has been shown to enhance the activity of ERα (estrogen receptor alpha) and ERβ (estrogen receptor beta) by promoting their translocation to the nucleus and activating their transcriptional activity. This suggests that Adamts18 may play a role in regulating hormone-sensitive tissues, such as bone, breast, and uterus, and may be involved in the development of hormone-dependent diseases, such as breast cancer.",
    "llama-2-7b-chat-hf_fact_raw": "1. Adamts18 is involved in the regulation of hormone receptor signaling.\n2. Adamts18 can interact with and modulate the activity of the estrogen receptor (ER).\n3. Adamts18 has been shown to enhance the activity of ERα (estrogen receptor alpha) and ERβ (estrogen receptor beta).\n4. Adamts18 promotes the translocation of ERα and ERβ to the nucleus and activates their transcriptional activity.\n5. Adamts18 may play a role in regulating hormone-sensitive tissues, such as bone, breast, and uterus.",
    "llama-2-7b-chat-hf_fact": [
      "Adamts18 is involved in the regulation of hormone receptor signaling.",
      "Adamts18 can interact with and modulate the activity of the estrogen receptor (ER).",
      "Adamts18 has been shown to enhance the activity of ERα (estrogen receptor alpha) and ERβ (estrogen receptor beta).",
      "Adamts18 promotes the translocation of ERα and ERβ to the nucleus and activates their transcriptional activity.",
      "Adamts18 may play a role in regulating hormone-sensitive tissues, such as bone, breast, and uterus."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific scientific context or references, it's difficult to confirm the accuracy of statements regarding the function of a protein like Adamts18. These statements would require supporting information from credible scientific research or literature to determine their validity. If indeed Adamts18 interacts with estrogen receptors and has the functions described, that would be based on experimental evidence that is not provided here.",
    "llama-2-7b-chat-hf_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-2-7b-chat-hf_response": "Thiazovivin is a small molecule inhibitor of the enzyme histone deacetylase (HDAC). It works by binding to the HDAC enzyme and preventing it from deacetylating histone proteins, leading to changes in gene expression and the activation of pro-apoptotic pathways in cancer cells.",
    "llama-2-7b-chat-hf_fact_raw": "1. Thiazovivin is an inhibitor of the enzyme histone deacetylase (HDAC).\n2. It functions by binding to the HDAC enzyme.\n3. Thiazovivin prevents the HDAC enzyme from deacetylating histone proteins.\n4. This inhibition can lead to changes in gene expression.\n5. Thiazovivin's mode of action involves the activation of pro-apoptotic pathways in cancer cells.",
    "llama-2-7b-chat-hf_fact": [
      "Thiazovivin is an inhibitor of the enzyme histone deacetylase (HDAC).",
      "It functions by binding to the HDAC enzyme.",
      "Thiazovivin prevents the HDAC enzyme from deacetylating histone proteins.",
      "This inhibition can lead to changes in gene expression.",
      "Thiazovivin's mode of action involves the activation of pro-apoptotic pathways in cancer cells."
    ],
    "llama-2-7b-chat-hf_judge_raw": "1. FALSE [correction]: Thiazovivin is not an inhibitor of histone deacetylase (HDAC); it is a selective inhibitor of Rho-associated coiled-coil kinase (ROCK).\n2. UNKNOWN: Since Thiazovivin is not an HDAC inhibitor, its binding to the HDAC enzyme is not relevant; however, without specific context, it's uncertain what enzyme or target Thiazovivin binds to in a scientific context.\n3. FALSE [correction]: Thiazovivin does not prevent the HDAC enzyme from deacetylating histone proteins since it is not an HDAC inhibitor but a ROCK inhibitor.\n4. UNKNOWN: The statement is generic, and while inhibition of certain enzymes can lead to changes in gene expression, this needs to be evaluated in the specific context of Thiazovivin's action as a ROCK inhibitor, not an HDAC inhibitor.\n5. FALSE [correction]: Thiazovivin's mode of action involves the inhibition of ROCK, which impacts cytoskeletal organization and other cellular functions, and its effects on pro-apoptotic pathways would not be directly due to activation but could be a downstream consequence of ROCK inhibition.",
    "llama-2-7b-chat-hf_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "false"
    ]
  }
]